data_2jm4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jm4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.8 mt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.54 2.76 84.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -141.31 156.61 45.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -140.53 145.78 42.14 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.24 146.81 36.58 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.754 2.302 . . . . 0.0 112.252 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.9 m -70.26 -22.8 62.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.87 -116.36 0.82 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -87.58 9.88 19.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -1.13 . . . . 0.0 109.49 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 mt -102.24 138.53 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.0 m -74.03 93.72 2.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.494 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 ttmm -171.76 145.94 2.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.5 m -135.72 142.32 45.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.139 -0.976 . . . . 0.0 109.11 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.2 mt -139.44 149.75 61.39 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.351 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.38 153.82 68.04 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.761 2.307 . . . . 0.0 112.213 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.48 -21.87 40.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.907 . . . . 0.0 109.518 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.13 -37.4 71.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.498 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.02 5.46 50.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 109.511 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -79.64 121.18 24.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.9 m 52.08 34.01 13.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.427 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -90.53 5.73 46.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.432 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.16 38.23 59.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.2 t -136.45 138.96 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -1.153 . . . . 0.0 109.586 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -79.32 123.01 27.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.474 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.9 OUTLIER -145.9 -52.35 0.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.492 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 56.6 m -57.07 -27.2 61.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.522 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.36 -50.14 2.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -86.22 8.72 20.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.447 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 53.41 33.34 15.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.398 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.33 -40.89 57.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.6 p-10 -64.1 -31.71 73.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 78.2 mm-40 -93.3 17.18 11.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 60.2 t0 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.91 . . . . 0.0 109.483 -179.682 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.67 3.84 66.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 11' ' ' TYR . 32.0 m-85 -127.64 156.51 42.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -1.151 . . . . 0.0 109.451 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -141.98 145.83 37.87 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.431 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.34 145.17 37.96 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.821 2.348 . . . . 0.0 112.24 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.0 -23.79 65.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.496 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.36 -109.8 0.49 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.74 8.41 22.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -1.136 . . . . 0.0 109.526 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 mt -103.85 138.66 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.433 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.31 60.61 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -139.06 130.12 26.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.28 -0.887 . . . . 0.0 109.515 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -121.29 143.81 48.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 108.503 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.6 mt -138.93 150.93 67.06 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.8 147.84 2.95 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.784 2.323 . . . . 0.0 112.22 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -59.72 -24.75 64.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.585 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -55.79 -38.16 69.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.474 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.2 mt -85.1 12.93 6.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -81.8 114.07 20.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.481 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m 50.86 40.49 25.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.486 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -93.15 6.86 46.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.35 33.37 58.92 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.2 t -131.87 137.62 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -1.147 . . . . 0.0 109.487 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -78.9 124.07 27.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.449 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.463 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -146.93 -54.26 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.964 . . . . 0.0 109.393 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.5 m -59.0 -23.65 62.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.631 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.01 -52.22 1.91 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.691 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -86.32 8.09 22.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -1.179 . . . . 0.0 109.489 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.48 ' N ' HD21 ' A' ' 35' ' ' ASN . 93.2 mt-30 52.96 31.55 11.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.434 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.691 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -73.06 -36.76 66.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.456 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 22.2 p-10 -62.77 -30.66 71.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -79.05 3.84 16.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.6 t70 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 179.795 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.1 tp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.528 ' C ' HE22 ' A' ' 23' ' ' GLN . . . 90.42 5.76 69.2 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -128.51 153.68 46.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -1.181 . . . . 0.0 109.464 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 16.2 p90 -143.88 146.68 35.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.89 . . . . 0.0 109.481 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.87 145.19 55.76 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.767 2.311 . . . . 0.0 112.239 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.28 -25.42 68.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 109.514 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.22 -99.83 0.21 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.2 10.23 34.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -1.114 . . . . 0.0 109.354 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 mt -107.63 136.54 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.472 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.58 62.45 1.03 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.45 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -142.9 132.17 23.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.91 . . . . 0.0 109.412 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.96 143.26 46.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 109.124 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -138.76 149.36 61.83 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.361 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.88 154.73 73.58 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.755 2.303 . . . . 0.0 112.229 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.528 HE22 ' C ' ' A' ' 10' ' ' GLY . 28.2 mp0 -57.01 -22.33 37.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.5 mt -53.99 -35.81 62.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.558 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 28.8 mt -91.12 16.24 10.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.551 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.596 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.9 t-80 -85.14 124.27 31.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.885 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.596 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 80.3 m 50.83 87.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.7 p30 -144.39 3.17 1.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.04 15.38 80.65 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 t -124.34 134.97 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -1.166 . . . . 0.0 109.44 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -91.05 102.65 15.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.542 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.96 -53.31 3.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.488 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.9 m -57.5 -21.24 36.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.13 -43.73 2.22 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -88.55 6.66 36.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -1.133 . . . . 0.0 109.5 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 52.21 34.05 13.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.452 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.14 -39.1 69.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.49 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.86 -31.47 72.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -78.67 -28.66 45.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.28 -0.888 . . . . 0.0 109.417 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 59.2 t0 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 -179.608 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.07 2.62 66.21 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -121.56 149.95 42.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -1.156 . . . . 0.0 109.467 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -138.55 146.19 49.74 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.863 . . . . 0.0 109.478 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.18 144.34 41.72 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.745 2.297 . . . . 0.0 112.262 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.2 m -63.54 -30.84 71.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.19 -108.23 0.38 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -86.24 6.52 29.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -1.11 . . . . 0.0 109.475 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.5 mt -98.8 139.87 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 109.43 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.6 m -80.48 90.37 5.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 0.0 109.44 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -172.28 167.11 5.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.504 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.15 142.94 30.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 108.939 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.2 mt -136.21 149.06 66.91 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.378 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.41 153.47 76.74 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.688 2.258 . . . . 0.0 112.247 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -56.99 -22.67 40.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.462 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -56.23 -35.0 66.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 0.0 109.476 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.4 mt -93.65 13.45 22.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.514 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.458 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 47.9 t-80 -83.32 115.86 22.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.434 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.458 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 74.0 m 51.39 34.82 12.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.422 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -89.54 6.23 41.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.46 56.67 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.54 138.09 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -1.163 . . . . 0.0 109.529 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -80.45 122.33 26.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -145.33 -52.99 0.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 67.6 m -58.48 -23.79 58.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.95 -52.43 2.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.671 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -88.01 10.11 20.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -1.137 . . . . 0.0 109.45 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.465 ' N ' HD21 ' A' ' 35' ' ' ASN . 50.9 mt-30 53.69 32.96 15.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.412 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.671 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -72.19 -38.17 69.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 109.507 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.0 p-10 -65.66 -30.74 71.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 0.0 109.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 72.0 mm-40 -80.13 10.6 4.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.488 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.186 -0.946 . . . . 0.0 109.427 179.774 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 -3.03 68.07 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.461 ' N ' ' CD1' ' A' ' 11' ' ' TYR . 26.0 m-85 -116.13 135.5 53.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -1.163 . . . . 0.0 109.431 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -113.84 146.68 36.08 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.463 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.82 138.08 28.19 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.837 2.358 . . . . 0.0 112.182 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.4 m -65.16 -11.38 39.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.98 -124.1 2.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -82.93 11.4 6.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.274 -1.133 . . . . 0.0 109.447 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.551 ' CD1' HD22 ' A' ' 35' ' ' ASN . 10.9 mt -100.2 140.42 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.429 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.8 m -77.28 79.13 3.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.467 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -170.03 122.09 0.68 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.5 m -112.86 151.38 30.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 108.619 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.1 mt -138.97 151.34 67.94 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.41 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -46.66 146.5 5.36 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.706 2.27 . . . . 0.0 112.255 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -59.33 -27.65 66.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.568 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.77 -36.14 73.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.536 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 mt -84.4 11.05 9.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.505 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.494 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 57.5 t-80 -80.27 120.67 24.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.444 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 83.9 m 47.11 38.24 6.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -90.74 6.19 45.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.29 32.38 58.16 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.07 137.23 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.181 -1.188 . . . . 0.0 109.479 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 26.8 p30 -82.85 108.87 16.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.467 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 1.2 p30 -132.91 -43.21 0.89 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.441 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.555 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 59.8 m -53.91 -24.62 16.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 109.31 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.73 -2.63 32.11 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.551 HD22 ' CD1' ' A' ' 17' ' ' ILE . 2.1 p30 -149.37 -92.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -1.144 . . . . 0.0 109.47 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.42 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 16.7 pt20 -176.85 22.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.411 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.73 76.19 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.15 -0.969 . . . . 0.0 109.519 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 25.0 p-10 -67.53 -30.64 70.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.438 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 73.3 mm-40 -87.56 15.95 6.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 109.446 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 39' ' ' GLU . 51.2 p30 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.37 0.61 67.31 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -118.99 147.36 44.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -1.123 . . . . 0.0 109.493 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.512 ' CD1' ' OE1' ' A' ' 23' ' ' GLN . 14.5 p90 -132.96 146.44 61.29 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.24 -0.912 . . . . 0.0 109.472 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.24 143.8 44.75 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.782 2.321 . . . . 0.0 112.248 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.5 m -67.45 -21.73 65.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.11 -114.77 0.73 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -84.96 9.47 14.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -1.157 . . . . 0.0 109.423 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 mt -100.16 136.38 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 m -75.59 62.8 1.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -143.42 140.74 30.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -127.34 143.29 51.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 108.756 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.3 mt -138.51 149.9 64.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.422 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.07 154.3 71.22 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.819 2.346 . . . . 0.0 112.174 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.512 ' OE1' ' CD1' ' A' ' 12' ' ' PHE . 15.0 mm100 -57.23 -20.81 29.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.465 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.8 mt -56.69 -36.1 69.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.481 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.22 12.52 22.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.589 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.7 t-80 -80.95 118.43 22.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.975 . . . . 0.0 109.459 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.589 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 60.9 m 51.45 39.14 23.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -89.27 4.52 48.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.511 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.84 26.78 68.33 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.13 135.74 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -1.139 . . . . 0.0 109.521 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -77.42 129.32 35.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.49 -51.77 0.3 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 109.422 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.501 ' SG ' ' OD1' ' A' ' 38' ' ' ASP . 87.7 m -52.08 -20.85 2.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.222 -0.924 . . . . 0.0 109.366 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.36 -2.73 34.78 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 36' ' ' GLN . 1.8 p30 -149.46 -92.17 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -1.131 . . . . 0.0 109.525 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.528 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 14.2 pt20 -176.1 22.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.12 82.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.469 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 1.1 p-10 -66.35 -30.13 70.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -82.07 11.14 5.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.45 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 40' ' ' ASP . 51.7 p30 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 mt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.7 -6.68 74.05 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -120.5 149.17 42.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -1.15 . . . . 0.0 109.418 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.38 146.43 48.49 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.393 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.14 142.98 39.06 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.789 2.326 . . . . 0.0 112.19 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.3 m -62.35 -28.34 69.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.434 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.69 -110.98 0.49 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -85.64 7.86 21.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.197 -1.178 . . . . 0.0 109.435 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.5 mt -99.46 139.22 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.494 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.74 91.31 5.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -171.27 167.36 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 109.44 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -143.75 143.41 31.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 108.801 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.7 mt -136.85 148.98 65.36 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.361 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.65 155.07 72.13 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.804 2.336 . . . . 0.0 112.182 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -57.12 -22.06 37.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 9.7 mp -54.89 -37.98 66.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.5 mt -88.34 14.93 8.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.484 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -76.96 104.72 7.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.455 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 m 49.96 45.36 25.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -92.06 6.48 46.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.97 29.15 55.07 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.3 t -130.83 138.81 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -1.187 . . . . 0.0 109.556 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -80.59 127.73 32.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.452 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.438 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -148.49 -53.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.456 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 50.9 m -58.8 -22.05 57.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.94 -58.98 3.23 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.568 ' N ' HD21 ' A' ' 35' ' ' ASN . 0.0 OUTLIER -81.48 11.19 4.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -1.158 . . . . 0.0 109.446 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 53.76 35.18 20.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.546 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -71.7 -40.71 69.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.488 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 18.0 p-10 -63.56 -30.69 71.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.531 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -82.86 10.56 7.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.473 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 47.9 t0 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.452 -179.61 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.92 4.87 66.75 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -137.18 156.32 48.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -1.151 . . . . 0.0 109.49 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -143.39 147.19 39.01 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.476 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.82 139.83 34.21 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.845 2.363 . . . . 0.0 112.23 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.7 m -64.87 -20.91 66.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.9 -114.26 0.84 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -83.0 5.89 20.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -1.088 . . . . 0.0 109.419 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.469 HD12 HG22 ' A' ' 17' ' ' ILE . 8.0 mm -91.68 154.55 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.497 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.3 p -94.3 65.33 3.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.73 165.19 37.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.486 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -143.98 147.44 33.9 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.1 mt -136.21 149.87 69.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.451 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.49 152.54 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.793 2.329 . . . . 0.0 112.162 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -62.13 -26.86 68.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 mt -56.91 -35.34 68.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.53 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.9 mt -89.26 11.63 18.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.468 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.0 t-80 -79.36 115.92 19.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.93 . . . . 0.0 109.483 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 61.3 m 46.31 39.77 6.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 109.519 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -91.95 7.91 39.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.09 36.7 64.13 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.29 137.32 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -1.149 . . . . 0.0 109.486 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -78.32 123.54 27.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -148.27 -54.69 0.2 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.483 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.3 m -59.03 -25.17 63.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.602 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.01 -46.57 1.87 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -87.09 5.64 36.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 109.475 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.527 ' N ' HD21 ' A' ' 35' ' ' ASN . 89.6 mt-30 52.43 28.25 5.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.347 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.67 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -70.12 -37.64 75.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 17.6 p-10 -64.73 -31.08 72.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 77.5 mm-40 -87.66 20.52 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.442 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.8 t0 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.951 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.9 mt . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.53 4.49 83.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -142.24 156.35 45.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.151 . . . . 0.0 109.466 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.53 146.01 49.02 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.8 143.19 29.48 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.853 2.369 . . . . 0.0 112.2 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.2 m -69.1 -21.06 64.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.905 . . . . 0.0 109.537 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.48 -116.42 0.87 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -88.64 11.08 18.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -1.135 . . . . 0.0 109.469 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 mt -100.83 141.66 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.452 ' O ' ' CG2' ' A' ' 18' ' ' THR . 7.2 t -77.01 86.61 3.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -170.31 151.69 3.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.6 m -142.49 144.75 33.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 108.799 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 84.5 mt -135.04 150.3 72.7 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.471 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.2 146.12 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.841 2.361 . . . . 0.0 112.128 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -58.71 -26.59 64.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.481 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.0 mt -57.45 -36.12 70.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.7 mt -86.3 14.38 6.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.183 -0.948 . . . . 0.0 109.525 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.458 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 59.9 t-80 -90.26 123.13 33.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.406 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.458 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 98.6 m 50.91 34.27 10.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.481 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -92.42 7.23 43.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.469 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.55 34.8 63.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.0 t -132.03 141.58 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -1.182 . . . . 0.0 109.452 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -85.25 117.91 24.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.288 -0.883 . . . . 0.0 109.497 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -142.4 -52.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.469 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 20.2 m -55.78 -35.62 66.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.041 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.13 -39.95 2.58 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.745 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -88.96 2.93 53.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.159 . . . . 0.0 109.532 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.541 ' N ' HD21 ' A' ' 35' ' ' ASN . 37.0 tp60 59.51 18.39 6.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.877 . . . . 0.0 109.385 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.745 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -75.34 -31.91 60.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.498 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 32' ' ' ASP . 27.1 p-10 -62.56 -31.59 72.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.497 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.437 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 65.4 mm-40 -87.75 16.57 5.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 40' ' ' ASP . 49.7 p30 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.477 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.402 ' O ' ' CD2' ' A' ' 11' ' ' TYR . 37.3 mt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.07 4.89 81.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 9' ' ' LEU . 25.0 m-85 -138.2 156.79 47.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -1.18 . . . . 0.0 109.471 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -136.73 146.28 54.62 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.409 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.92 145.27 35.74 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.843 2.362 . . . . 0.0 112.242 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.6 m -70.36 -20.11 62.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.508 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.41 -118.63 1.03 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -87.6 11.69 14.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -1.172 . . . . 0.0 109.449 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.64 139.17 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.8 p -74.11 90.06 2.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.539 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.452 ' HZ2' ' CD2' ' A' ' 21' ' ' LEU . 31.5 tttm -171.24 149.54 2.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.439 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.4 m -140.81 143.91 35.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 108.74 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.452 ' CD2' ' HZ2' ' A' ' 19' ' ' LYS . 91.8 mt -137.82 150.92 69.34 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.362 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -47.12 143.99 9.47 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.797 2.331 . . . . 0.0 112.292 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.22 -21.91 49.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 mt -59.99 -35.33 74.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.4 mt -85.77 7.68 22.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.456 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -78.15 108.81 11.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.428 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 38' ' ' ASP . 51.9 m 51.82 50.33 18.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.43 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.531 HD22 ' CG1' ' A' ' 30' ' ' VAL . 17.2 p-10 -95.2 -39.97 9.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.449 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.06 29.72 0.29 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.531 ' CG1' HD22 ' A' ' 28' ' ' ASN . 8.4 p -144.07 143.46 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -1.161 . . . . 0.0 109.406 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -84.93 103.61 14.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.52 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.446 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -114.22 -51.24 2.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.48 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 57.8 m -54.44 -30.76 53.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.59 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.77 -44.89 2.53 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -86.2 10.1 15.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -1.15 . . . . 0.0 109.494 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 52.86 23.79 2.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.427 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.93 -37.72 67.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.522 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 21.3 p-10 -64.38 -30.98 72.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.52 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -85.9 10.42 13.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 59.3 t0 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 109.436 -179.89 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 tp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.89 -0.44 67.11 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -115.94 152.62 33.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.507 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -136.99 146.27 54.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.472 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.44 144.09 49.4 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.788 2.325 . . . . 0.0 112.222 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.5 m -65.81 -21.41 66.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.53 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.86 -110.96 0.6 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -84.78 9.69 13.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -1.139 . . . . 0.0 109.403 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 mm -97.98 141.01 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 109.423 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.5 t -81.73 59.06 4.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.511 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -146.44 148.17 32.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.406 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.05 145.49 50.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 108.938 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.2 mt -137.5 149.56 65.62 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.77 155.69 65.89 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.821 2.347 . . . . 0.0 112.236 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -56.74 -25.34 54.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.573 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.4 tp -51.0 -39.4 55.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -89.05 19.61 4.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.527 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -79.52 112.48 16.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -0.942 . . . . 0.0 109.454 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.4 m 47.19 45.52 16.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.439 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -87.04 4.22 42.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.16 10.2 80.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.21 134.39 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.42 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -86.2 103.32 14.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 0.0 109.459 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -103.32 -53.64 2.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.445 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 63.1 m -57.44 -25.95 60.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.46 -33.11 5.49 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -89.93 5.03 48.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -1.162 . . . . 0.0 109.469 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 52.08 26.01 3.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.88 . . . . 0.0 109.402 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.48 -34.21 67.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.187 -0.946 . . . . 0.0 109.519 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 8.7 p30 -65.19 -30.7 71.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -81.67 11.93 4.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.496 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.872 . . . . 0.0 109.54 179.842 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.2 mt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.98 6.86 66.57 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -132.31 156.43 46.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -1.134 . . . . 0.0 109.447 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -141.52 146.75 43.25 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.509 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.64 140.42 39.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.708 2.272 . . . . 0.0 112.289 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.7 m -61.58 -41.48 97.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.479 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.58 108.53 0.61 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 54.7 19.59 2.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -1.129 . . . . 0.0 109.438 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mm -124.13 138.47 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.878 . . . . 0.0 109.439 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 m -74.87 52.13 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.875 . . . . 0.0 109.478 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -140.98 142.76 34.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.431 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -132.18 148.63 52.48 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.9 mt -139.59 149.8 61.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.376 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.58 144.48 3.25 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.783 2.322 . . . . 0.0 112.19 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.47 -24.58 60.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.472 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 9.6 mp -58.96 -36.1 74.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.7 mt -84.92 11.98 8.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -81.51 118.71 22.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.948 . . . . 0.0 109.445 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.4 m 50.34 34.51 9.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.424 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -88.99 6.76 38.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.82 38.32 65.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.0 t -133.75 136.37 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.485 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.9 p-10 -83.97 103.01 12.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.411 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -122.28 -51.94 1.96 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.259 -0.901 . . . . 0.0 109.475 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 76.2 m -58.73 -25.07 62.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 0.0 109.251 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.74 -43.18 2.47 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -87.91 6.25 36.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.467 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 52.26 33.66 13.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.22 -38.13 60.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 109.496 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 15.5 p30 -65.59 -31.07 71.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.519 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -81.22 0.99 34.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 109.474 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.856 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.2 mt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.91 4.07 69.79 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -130.18 156.58 44.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -1.145 . . . . 0.0 109.457 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -140.08 146.65 47.31 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.449 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.34 142.57 37.47 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.748 2.299 . . . . 0.0 112.262 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.1 m -66.96 -20.85 65.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.515 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.13 -112.51 0.69 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -85.63 9.34 16.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -1.111 . . . . 0.0 109.393 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 mt -102.84 140.5 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.872 . . . . 0.0 109.429 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -78.58 58.96 2.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.921 . . . . 0.0 109.495 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -139.1 140.13 37.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 109.437 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.67 145.9 51.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.5 mt -138.93 150.41 65.22 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.361 -0.837 . . . . 0.0 109.391 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.04 152.69 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.796 2.331 . . . . 0.0 112.199 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -61.69 -28.42 69.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.6 mt -55.05 -36.19 65.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.434 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.5 mt -88.67 15.49 8.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.955 . . . . 0.0 109.488 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.431 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 55.7 t-80 -82.57 114.72 21.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.408 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 38' ' ' ASP . 57.0 m 47.26 38.81 7.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.443 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -89.83 8.26 32.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.905 . . . . 0.0 109.497 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.96 31.14 62.33 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t -127.38 138.59 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 0.0 109.501 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 36.1 p-10 -83.24 115.15 21.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -139.29 -51.22 0.53 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.46 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 66.6 m -56.94 -39.26 74.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.905 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 36' ' ' GLN . . . 134.76 -72.96 0.46 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -86.93 20.96 2.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -1.125 . . . . 0.0 109.463 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 34' ' ' GLY . 27.2 mp0 53.9 40.66 31.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.28 77.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.882 . . . . 0.0 109.449 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.49 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 9.0 p30 -63.57 -31.27 72.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.0 OUTLIER -82.11 10.19 7.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.503 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.7 p30 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.472 179.844 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' A' ' 9' ' ' LEU . 8.6 mp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.34 -7.53 77.98 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.26 151.98 41.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -1.158 . . . . 0.0 109.459 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 13.5 p90 -142.22 125.29 9.42 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.2 141.09 13.72 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.832 2.355 . . . . 0.0 112.17 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.1 m -64.76 -22.75 67.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 0.0 109.494 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.01 -113.88 0.66 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -84.46 8.47 16.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -1.112 . . . . 0.0 109.484 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.9 mt -98.82 140.36 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 109.504 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 p -78.89 57.9 2.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -142.49 142.75 32.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -126.7 144.49 50.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 108.983 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.0 mt -137.23 149.78 66.99 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.413 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.79 155.63 68.27 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.795 2.33 . . . . 0.0 112.257 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -57.67 -20.24 32.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.479 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.3 tp -56.27 -36.65 68.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.488 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.4 mt -91.2 10.2 28.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.819 . . . . 0.0 109.524 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -74.25 104.25 4.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.413 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.7 m 52.11 50.21 18.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.537 HD22 ' CG1' ' A' ' 30' ' ' VAL . 15.5 p-10 -91.16 -35.42 14.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.421 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.13 26.76 0.67 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.537 ' CG1' HD22 ' A' ' 28' ' ' ASN . 8.5 p -144.73 142.75 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.472 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -85.73 103.59 14.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -112.32 -52.37 2.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.866 . . . . 0.0 109.475 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.418 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 37.2 m -48.68 -45.03 38.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.64 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.07 -59.73 0.66 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.672 ' ND2' ' H ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -90.25 -89.49 0.16 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 109.478 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.672 ' H ' ' ND2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -173.17 23.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.882 . . . . 0.0 109.389 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.71 -47.58 80.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.2 p-10 -65.71 -30.43 71.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.415 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -85.2 21.61 1.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 54.2 p30 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.418 -179.919 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.5 mt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.76 2.44 84.4 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -142.31 156.91 45.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.385 -1.067 . . . . 0.0 109.441 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -141.24 146.99 45.18 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.09 143.54 28.9 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.818 2.345 . . . . 0.0 112.216 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.7 m -69.45 -14.79 63.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.499 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.03 -118.45 1.55 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -83.47 9.77 10.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -1.152 . . . . 0.0 109.442 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.465 HG22 HD11 ' A' ' 17' ' ' ILE . 9.9 mm -94.71 141.3 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.487 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.6 m -81.48 87.98 6.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 33' ' ' CYS . 14.9 ptpt -173.14 168.14 4.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.5 m -148.82 142.98 26.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.93 150.12 70.54 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.489 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.18 145.44 5.51 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.76 2.306 . . . . 0.0 112.219 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.22 -27.12 65.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.51 -34.98 73.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 109.558 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.35 9.67 14.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 109.528 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.593 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 53.7 t-80 -78.92 119.65 22.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.593 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 84.3 m 46.83 39.32 7.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.431 ' ND2' ' CG2' ' A' ' 30' ' ' VAL . 41.0 p-10 -93.05 5.63 50.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.62 33.83 55.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.431 ' CG2' ' ND2' ' A' ' 28' ' ' ASN . 59.7 t -127.74 136.19 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -1.137 . . . . 0.0 109.469 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 35.1 p-10 -81.73 103.57 11.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.94 . . . . 0.0 109.524 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -127.86 -49.74 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.518 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 86.0 m -59.54 -27.17 65.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.951 . . . . 0.0 109.598 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.72 -44.85 2.37 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.654 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -87.04 6.23 33.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -1.174 . . . . 0.0 109.472 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.468 ' N ' HD21 ' A' ' 35' ' ' ASN . 93.2 mt-30 52.14 28.14 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.874 . . . . 0.0 109.41 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.654 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -73.91 -38.19 64.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.475 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 20.6 p-10 -64.45 -31.1 72.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 75.1 mm-40 -84.87 13.33 6.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.903 . . . . 0.0 109.438 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 51.4 p30 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.2 mt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.7 -4.21 86.41 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -127.02 153.68 45.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.144 . . . . 0.0 109.49 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CD1' ' NE2' ' A' ' 23' ' ' GLN . 20.8 p90 -143.53 147.28 38.94 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.23 143.28 48.08 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.808 2.339 . . . . 0.0 112.21 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.46 -24.44 64.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.37 -110.32 0.54 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -84.73 6.91 22.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -1.147 . . . . 0.0 109.482 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.2 mt -102.35 137.67 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.6 p -78.1 62.63 2.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -144.93 145.47 31.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.409 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.13 146.06 51.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 108.844 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 71.3 mt -140.53 152.46 66.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 109.38 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -52.73 149.76 24.19 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.783 2.322 . . . . 0.0 112.224 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.515 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 94.0 mm-40 -60.56 -25.61 66.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 9.7 mp -60.06 -34.33 73.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.565 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.553 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 31.1 mt -85.72 9.9 15.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 109.558 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.494 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 55.1 t-80 -91.13 131.41 36.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.397 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 64.0 m 51.71 79.68 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.432 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.553 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 12.5 p30 -143.28 -3.77 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.413 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.63 3.24 89.74 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.94 140.37 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -1.142 . . . . 0.0 109.48 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -89.0 125.43 34.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.477 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.443 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -138.16 -51.8 0.6 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.4 m -53.9 -41.2 67.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.935 . . . . 0.0 109.63 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 145.37 -27.01 1.84 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.56 ' CG ' ' H ' ' A' ' 36' ' ' GLN . 1.2 p30 -136.22 -99.66 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -1.162 . . . . 0.0 109.481 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.56 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 72.7 mt-30 -155.93 15.36 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.391 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.99 91.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.489 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 33.3 p-10 -63.63 -31.54 72.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.901 . . . . 0.0 109.548 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 64.6 mm-40 -76.15 -54.64 6.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.462 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.427 ' O ' ' O ' ' A' ' 39' ' ' GLU . 43.2 t0 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.477 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' H ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.77 -0.11 69.71 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -130.56 156.02 45.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -1.179 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CD1' ' NE2' ' A' ' 23' ' ' GLN . 12.6 p90 -148.56 146.59 22.8 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.394 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.529 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 57.4 Cg_endo -73.84 148.56 41.17 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.786 2.324 . . . . 0.0 112.197 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.61 -7.04 59.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 17' ' ' ILE . . . 88.77 132.27 4.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m120 68.01 -25.95 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -1.109 . . . . 0.0 109.447 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.633 ' H ' ' C ' ' A' ' 15' ' ' GLY . 24.1 mm -104.37 130.12 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.479 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.24 57.66 2.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.504 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.536 ' HZ2' ' CD2' ' A' ' 21' ' ' LEU . 33.5 tttm -146.6 137.03 23.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.47 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 1.6 m -117.17 147.38 42.52 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.536 ' CD2' ' HZ2' ' A' ' 19' ' ' LYS . 67.6 mt -137.51 151.96 72.07 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.382 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.36 149.3 13.02 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.829 2.352 . . . . 0.0 112.178 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.515 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 92.9 mm-40 -60.24 -25.43 65.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.534 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.8 tp -58.12 -36.75 73.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.495 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.96 5.53 28.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.519 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -84.34 131.59 34.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.7 m 51.36 26.76 3.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.486 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -84.81 3.51 37.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.01 36.55 81.48 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -133.43 137.01 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.0 109.535 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -82.76 104.1 12.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.517 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.83 -58.66 2.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -0.97 . . . . 0.0 109.467 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.8 m -63.49 -27.55 69.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.3 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.07 -31.35 5.7 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.659 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -83.83 4.6 28.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -1.161 . . . . 0.0 109.475 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.551 ' N ' HD21 ' A' ' 35' ' ' ASN . 94.2 mt-30 48.67 13.69 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.421 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.659 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -64.77 -38.83 92.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 109.488 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 27.9 p-10 -65.81 -30.66 71.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.452 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 81.2 mm-40 -91.24 13.5 17.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 0.0 109.533 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 40' ' ' ASP . 52.0 p30 . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.494 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 9' ' ' LEU . 9.2 mp . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.69 -4.03 81.73 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -127.64 152.39 47.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -1.13 . . . . 0.0 109.524 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -143.68 145.75 32.38 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.417 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.33 143.99 40.33 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.855 2.37 . . . . 0.0 112.186 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.5 m -62.94 -28.36 70.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.511 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.0 -106.82 0.32 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -86.9 8.19 24.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -1.161 . . . . 0.0 109.468 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 mt -102.54 140.93 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 109.424 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.7 m -80.93 63.5 5.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -144.09 131.98 21.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -116.16 143.6 45.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.489 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.0 mt -137.21 149.29 65.5 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 109.407 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.16 155.27 66.02 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.75 2.3 . . . . 0.0 112.189 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.21 -22.18 60.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.536 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 10.3 mp -57.34 -36.07 70.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.4 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 63.0 mt -91.95 3.9 54.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.41 ' NE2' ' SG ' ' A' ' 27' ' ' CYS . 11.8 t-80 -81.56 125.95 31.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 109.367 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' ' NE2' ' A' ' 26' ' ' HIS . 80.3 m 52.7 28.77 6.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.4 ' ND2' ' HA ' ' A' ' 25' ' ' LEU . 43.5 p-10 -88.34 5.77 40.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 109.447 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.87 42.4 78.75 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -138.86 140.25 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -1.151 . . . . 0.0 109.481 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -80.22 121.58 25.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.5 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -144.15 -52.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.437 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.422 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 69.1 m -59.58 -22.34 61.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.367 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.41 -54.84 1.75 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.561 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -89.45 13.82 12.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -1.102 . . . . 0.0 109.485 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 52.76 34.28 15.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.394 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.561 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -70.72 -29.84 66.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.474 ' OD2' ' OD1' ' A' ' 32' ' ' ASP . 36.2 p-10 -79.82 -27.92 40.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.514 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 74.1 mm-40 -84.08 -31.44 25.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.494 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 37' ' ' ALA . 53.8 p30 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.902 . . . . 0.0 109.446 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 11' ' ' TYR . 20.1 mt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.323 0.582 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.93 16.45 1.97 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.494 ' H ' ' C ' ' A' ' 9' ' ' LEU . 29.2 m-85 -101.04 139.23 37.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.148 . . . . 0.0 109.451 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -139.74 146.73 48.65 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.43 139.93 42.63 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.809 2.34 . . . . 0.0 112.235 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.1 m -61.53 -33.56 74.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 0.0 109.545 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.0 -104.14 0.26 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -91.18 8.46 35.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -1.183 . . . . 0.0 109.416 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.3 mt -99.86 145.25 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 0.0 109.421 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.8 p -82.18 82.41 7.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.487 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -172.12 165.05 6.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.6 m -145.42 144.2 30.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 108.748 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.82 149.84 71.72 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.349 -0.844 . . . . 0.0 109.428 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.83 155.52 63.33 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.755 2.303 . . . . 0.0 112.186 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -58.23 -23.21 55.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.454 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt -53.57 -39.11 64.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.492 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.3 mt -88.8 13.72 11.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.507 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.581 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.5 t-80 -77.96 117.1 18.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.581 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 14.3 m 46.86 40.29 8.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.534 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -89.04 6.48 39.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.22 -0.925 . . . . 0.0 109.464 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.43 32.25 60.06 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.4 t -135.2 137.56 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -1.137 . . . . 0.0 109.483 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -79.41 127.48 32.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -146.92 -58.53 0.28 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.912 . . . . 0.0 109.441 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.504 ' SG ' ' OD2' ' A' ' 38' ' ' ASP . 55.6 m -55.87 -25.19 41.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.352 -0.842 . . . . 0.0 109.251 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.06 -48.38 1.59 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -89.44 7.18 37.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -1.14 . . . . 0.0 109.399 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 52.96 36.31 21.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.407 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' ' OD1' ' A' ' 40' ' ' ASP . . . -75.02 -24.49 58.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' OD2' ' SG ' ' A' ' 33' ' ' CYS . 0.4 OUTLIER -80.47 -31.19 37.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.478 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -74.45 -37.58 63.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.224 -0.923 . . . . 0.0 109.472 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 37' ' ' ALA . 53.2 p30 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.477 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.569 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.02 1.6 67.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 44.7 m-85 -120.26 155.81 32.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -1.164 . . . . 0.0 109.491 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -141.87 146.1 39.37 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.41 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.64 148.39 53.13 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.811 2.341 . . . . 0.0 112.247 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 m -88.37 47.23 1.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.6 -154.38 28.29 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -50.34 -26.3 4.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -1.192 . . . . 0.0 109.451 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 17' ' ' ILE . 16.4 mm -54.83 132.11 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 m -84.95 63.09 7.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.162 -0.961 . . . . 0.0 109.445 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -146.14 130.58 17.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -112.72 143.61 43.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 108.877 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.6 mt -138.06 149.65 64.56 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.937 . . . . 0.0 109.39 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.05 154.84 71.48 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.809 2.339 . . . . 0.0 112.178 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -57.07 -22.48 39.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.494 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.8 tp -53.73 -37.27 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.6 mt -90.92 16.46 9.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.518 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.589 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.5 t-80 -84.22 127.37 33.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.589 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 97.5 m 49.62 32.57 5.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.409 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 30' ' ' VAL . 54.1 p30 -83.88 2.17 39.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.378 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.39 25.67 75.27 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.437 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 48.2 t -128.64 138.28 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -1.131 . . . . 0.0 109.51 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.6 p-10 -88.29 101.87 14.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.537 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.43 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -104.58 -58.07 1.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.49 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.6 m -62.61 -25.74 68.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.265 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.88 -32.36 6.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.679 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -85.2 5.09 31.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -1.18 . . . . 0.0 109.506 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.463 ' N ' HD21 ' A' ' 35' ' ' ASN . 56.1 mt-30 48.85 19.56 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.477 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.679 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -65.87 -37.16 85.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.139 -0.975 . . . . 0.0 109.487 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 11.5 p30 -64.17 -31.84 73.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.493 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -76.76 -30.92 56.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -0.871 . . . . 0.0 109.441 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 -179.731 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' A' ' 9' ' ' LEU . 9.5 mp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.02 -8.21 80.37 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -131.81 151.57 51.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -145.01 146.84 32.46 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.498 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.12 148.22 55.84 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.822 2.348 . . . . 0.0 112.247 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -82.8 -10.76 58.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.01 -126.96 2.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -80.74 8.14 8.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -1.146 . . . . 0.0 109.486 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.402 HG22 HD12 ' A' ' 17' ' ' ILE . 9.2 mm -88.01 131.79 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.429 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -76.55 85.02 3.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 -179.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -171.96 164.78 6.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 109.449 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -141.4 142.62 33.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 108.57 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.1 148.87 66.43 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.408 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.77 158.19 52.09 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.844 2.363 . . . . 0.0 112.205 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -60.37 -23.03 63.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.444 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 10.3 mp -56.79 -34.76 67.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 -179.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.3 mt -94.12 11.24 30.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.526 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 45.3 t-80 -85.59 122.17 29.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.427 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 72.2 m 51.46 31.36 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 109.431 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -86.51 5.98 32.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.49 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.67 39.37 77.76 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -140.01 140.28 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -83.56 125.47 31.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.38 -60.48 0.61 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 0.0 109.451 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.1 m -65.08 -23.28 67.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 0.0 109.211 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.81 -33.7 4.71 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -86.45 3.94 41.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -1.176 . . . . 0.0 109.465 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.559 ' N ' HD21 ' A' ' 35' ' ' ASN . 93.1 mt-30 48.23 18.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.872 . . . . 0.0 109.439 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.682 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -65.51 -36.96 85.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.418 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -28.22 67.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.501 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -83.56 9.3 11.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.498 179.996 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.04 -1.3 80.17 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -121.4 148.29 44.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -1.173 . . . . 0.0 109.509 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -134.98 146.63 59.39 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.421 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.23 144.41 51.45 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.828 2.352 . . . . 0.0 112.199 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.8 m -67.75 -21.2 65.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.443 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.76 -112.6 0.62 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -87.41 10.14 18.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -1.132 . . . . 0.0 109.367 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 mt -102.09 137.75 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -75.31 59.72 1.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.465 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 2.7 ttmp? -139.46 138.83 36.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.377 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -125.96 143.56 51.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 108.746 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.8 mt -138.29 149.71 64.22 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 109.388 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.56 154.56 64.01 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.738 2.292 . . . . 0.0 112.196 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -56.48 -25.02 49.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.322 -0.861 . . . . 0.0 109.519 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.7 tp -52.99 -37.97 61.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.499 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.5 mt -91.76 19.74 6.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.561 -179.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -82.88 114.5 21.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.507 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.1 m 46.93 36.65 4.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.477 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -85.63 8.3 20.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.382 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.75 29.22 63.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.3 t -129.4 139.67 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -1.169 . . . . 0.0 109.509 179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -84.45 122.0 28.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.88 . . . . 0.0 109.503 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -143.78 -47.77 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.455 179.862 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 56.5 m -57.84 -30.11 65.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.729 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.65 0.65 69.16 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 p30 -140.61 13.18 2.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -1.115 . . . . 0.0 109.439 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 51.94 22.9 1.93 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 109.415 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.76 -37.46 73.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 20.1 p30 -65.6 -30.48 71.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.467 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.2 mp0 -78.71 10.53 3.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.2 p30 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.441 179.95 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.37 1.99 85.62 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -130.95 152.59 50.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -1.117 . . . . 0.0 109.505 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CD1' ' NE2' ' A' ' 23' ' ' GLN . 17.3 p90 -143.96 146.45 34.28 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.888 . . . . 0.0 109.477 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.71 148.05 58.1 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.814 2.343 . . . . 0.0 112.222 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -63.34 -24.98 68.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.536 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.91 -76.37 0.28 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -119.86 15.01 12.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -1.118 . . . . 0.0 109.413 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.3 mt -111.33 138.03 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.456 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.77 59.42 0.22 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.458 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -141.63 135.3 29.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.5 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -122.8 143.57 49.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.028 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.5 mt -138.0 149.3 63.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.358 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.34 155.08 59.42 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.788 2.325 . . . . 0.0 112.183 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.463 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 98.6 mm-40 -57.87 -23.97 55.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.57 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -55.14 -37.06 66.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.47 -179.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.4 mt -92.09 11.57 24.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 -179.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.547 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.7 t-80 -84.28 123.54 30.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.458 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.547 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 98.1 m 50.86 29.65 4.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -85.78 5.8 30.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.45 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.34 39.21 62.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.3 t -136.08 139.31 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -1.157 . . . . 0.0 109.444 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 38.3 p-10 -86.61 103.57 15.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.49 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.435 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -119.78 -53.33 2.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.454 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.428 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 97.1 m -60.14 -26.49 66.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.185 -0.947 . . . . 0.0 109.527 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.19 -42.94 2.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -85.29 6.22 27.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -1.169 . . . . 0.0 109.428 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 52.43 27.88 5.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.868 . . . . 0.0 109.401 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.32 -37.09 71.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.445 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 12.3 p30 -66.27 -31.09 71.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -88.48 15.87 7.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.54 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.9 t0 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 -179.717 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 mt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.29 -0.09 68.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 31.0 m-85 -121.59 152.84 38.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -1.14 . . . . 0.0 109.458 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -144.6 146.06 30.81 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.296 -0.878 . . . . 0.0 109.482 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.86 145.74 41.12 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.728 2.285 . . . . 0.0 112.214 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -92.42 81.9 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.545 179.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.73 -145.23 31.13 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -83.89 10.91 8.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -1.19 . . . . 0.0 109.421 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.7 mt -78.58 138.1 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -82.17 61.58 5.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 109.483 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -143.85 126.17 15.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.451 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -112.61 143.02 44.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.7 mt -139.09 149.84 62.72 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.95 154.01 72.58 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.795 2.33 . . . . 0.0 112.241 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -57.07 -21.05 28.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.81 -38.47 70.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.461 -179.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.6 mt -89.82 15.06 10.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 0.0 109.535 -179.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.582 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 53.5 t-80 -83.12 123.81 29.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.505 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.582 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 73.6 m 49.08 32.64 4.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.506 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -85.25 5.37 30.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 109.445 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.45 35.0 68.35 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -133.68 137.28 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -1.184 . . . . 0.0 109.479 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.4 p-10 -84.68 103.47 13.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.486 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.4 OUTLIER -117.77 -57.86 2.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.882 . . . . 0.0 109.47 -179.824 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.494 ' SG ' ' OD2' ' A' ' 38' ' ' ASP . 74.3 m -61.65 -19.69 62.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.512 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.27 -47.52 2.4 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.666 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -82.66 3.36 29.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -1.136 . . . . 0.0 109.502 179.977 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.534 ' N ' HD21 ' A' ' 35' ' ' ASN . 94.0 mt-30 51.19 31.04 6.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.666 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -67.1 -38.78 86.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.496 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.494 ' OD2' ' SG ' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -66.82 -29.95 70.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -78.74 7.82 6.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 40' ' ' ASP . 50.6 p30 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.772 0 N-CA-C 119.424 2.53 . . . . 0.0 119.424 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.511 ' O ' ' NE2' ' A' ' 3' ' ' GLN . 46.8 m -63.86 149.61 46.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -1.154 . . . . 0.0 109.379 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 2' ' ' SER . 94.4 mm-40 -137.44 155.54 49.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.088 -1.008 . . . . 0.0 109.504 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 52.06 47.27 25.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.491 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 6' ' ' LYS . 7.5 p -110.32 127.38 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.505 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 5' ' ' VAL . 29.4 mmtm 49.81 179.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 109.468 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 70.3 m -112.65 162.73 15.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.639 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.7 m -65.45 174.62 2.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.8 mt -64.98 141.79 58.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.444 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.54 2.76 84.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -141.31 156.61 45.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -140.53 145.78 42.14 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.526 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 57.9 Cg_endo -74.24 146.81 36.58 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.754 2.302 . . . . 0.0 112.252 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.9 m -70.26 -22.8 62.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.87 -116.36 0.82 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -87.58 9.88 19.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -1.13 . . . . 0.0 109.49 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 mt -102.24 138.53 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.0 m -74.03 93.72 2.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.494 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 ttmm -171.76 145.94 2.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.5 m -135.72 142.32 45.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.139 -0.976 . . . . 0.0 109.11 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.2 mt -139.44 149.75 61.39 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.351 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.38 153.82 68.04 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.761 2.307 . . . . 0.0 112.213 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.48 -21.87 40.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.907 . . . . 0.0 109.518 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.13 -37.4 71.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.498 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.02 5.46 50.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 109.511 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -79.64 121.18 24.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.9 m 52.08 34.01 13.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.427 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -90.53 5.73 46.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.432 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.16 38.23 59.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.2 t -136.45 138.96 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -1.153 . . . . 0.0 109.586 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -79.32 123.01 27.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.474 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.9 OUTLIER -145.9 -52.35 0.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.492 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 56.6 m -57.07 -27.2 61.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.522 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.36 -50.14 2.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -86.22 8.72 20.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.447 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 53.41 33.34 15.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.398 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.33 -40.89 57.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.6 p-10 -64.1 -31.71 73.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 78.2 mm-40 -93.3 17.18 11.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 41' ' ' ASN . 60.2 t0 -81.97 112.42 19.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.91 . . . . 0.0 109.483 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.527 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 6.5 p-10 40.49 57.06 2.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 38' ' ' ASP . 1.7 m -58.71 -32.37 69.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.184 -0.948 . . . . 0.0 109.453 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.598 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.528 4.815 0 N-CA-C 119.422 2.529 . . . . 0.0 119.422 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 1' ' ' GLY . 44.2 t 48.49 93.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -1.183 . . . . 0.0 109.432 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 46.29 -114.9 0.53 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.47 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 5' ' ' VAL . 59.5 t0 52.39 -122.22 1.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 109.523 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.422 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 7.8 p -135.88 145.6 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -82.18 7.53 13.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.2 m -99.19 134.28 42.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.064 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.5 m -78.33 -175.21 4.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.509 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 3.7 mm? -74.36 143.54 44.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.432 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.67 3.84 66.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 11' ' ' TYR . 32.0 m-85 -127.64 156.51 42.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -1.151 . . . . 0.0 109.451 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -141.98 145.83 37.87 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.431 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.34 145.17 37.96 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.821 2.348 . . . . 0.0 112.24 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.0 -23.79 65.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.496 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.36 -109.8 0.49 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.74 8.41 22.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -1.136 . . . . 0.0 109.526 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 mt -103.85 138.66 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.433 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.31 60.61 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -139.06 130.12 26.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.28 -0.887 . . . . 0.0 109.515 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -121.29 143.81 48.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 108.503 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.6 mt -138.93 150.93 67.06 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.8 147.84 2.95 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.784 2.323 . . . . 0.0 112.22 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -59.72 -24.75 64.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.585 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -55.79 -38.16 69.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.474 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.2 mt -85.1 12.93 6.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -81.8 114.07 20.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.481 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m 50.86 40.49 25.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.486 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -93.15 6.86 46.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.35 33.37 58.92 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.2 t -131.87 137.62 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -1.147 . . . . 0.0 109.487 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -78.9 124.07 27.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.449 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.463 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -146.93 -54.26 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.964 . . . . 0.0 109.393 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.5 m -59.0 -23.65 62.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.631 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.01 -52.22 1.91 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.691 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -86.32 8.09 22.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -1.179 . . . . 0.0 109.489 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.48 ' N ' HD21 ' A' ' 35' ' ' ASN . 93.2 mt-30 52.96 31.55 11.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.434 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.691 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -73.06 -36.76 66.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.456 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 22.2 p-10 -62.77 -30.66 71.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -79.05 3.84 16.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.462 ' O ' ' C ' ' A' ' 41' ' ' ASN . 21.6 t70 -65.64 157.32 30.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.531 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 4.3 p-10 41.84 45.76 3.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.478 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.0 m -150.79 -3.11 0.34 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.475 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.965 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 5' ' ' VAL . . . . . . . . 1 N--CA 1.529 4.857 0 N-CA-C 119.406 2.522 . . . . 0.0 119.406 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.2 p -60.98 -41.11 95.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -1.122 . . . . 0.0 109.552 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.496 ' CG ' ' N ' ' A' ' 4' ' ' ASP . 12.7 pt20 -172.34 -52.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.41 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.496 ' N ' ' CG ' ' A' ' 3' ' ' GLN . 94.1 m-20 -140.04 7.91 2.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.433 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 1' ' ' GLY . 46.5 t -97.27 137.89 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 109.486 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -136.03 130.19 33.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.45 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.0 m -124.66 166.47 16.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.309 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.7 m -56.54 163.34 1.82 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.905 . . . . 0.0 109.479 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.1 tp -68.95 139.71 55.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.526 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.528 ' C ' HE22 ' A' ' 23' ' ' GLN . . . 90.42 5.76 69.2 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -128.51 153.68 46.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -1.181 . . . . 0.0 109.464 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 16.2 p90 -143.88 146.68 35.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.89 . . . . 0.0 109.481 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.87 145.19 55.76 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.767 2.311 . . . . 0.0 112.239 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.28 -25.42 68.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 109.514 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.22 -99.83 0.21 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.2 10.23 34.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -1.114 . . . . 0.0 109.354 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 mt -107.63 136.54 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.472 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.58 62.45 1.03 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.45 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -142.9 132.17 23.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.91 . . . . 0.0 109.412 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.96 143.26 46.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 109.124 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -138.76 149.36 61.83 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.361 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.88 154.73 73.58 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.755 2.303 . . . . 0.0 112.229 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.528 HE22 ' C ' ' A' ' 10' ' ' GLY . 28.2 mp0 -57.01 -22.33 37.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.5 mt -53.99 -35.81 62.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.558 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 28.8 mt -91.12 16.24 10.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.551 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.674 ' HE2' ' ND2' ' A' ' 41' ' ' ASN . 51.9 t-80 -85.14 124.27 31.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.885 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.596 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 80.3 m 50.83 87.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.7 p30 -144.39 3.17 1.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.04 15.38 80.65 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 t -124.34 134.97 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -1.166 . . . . 0.0 109.44 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -91.05 102.65 15.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.542 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.96 -53.31 3.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.488 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.9 m -57.5 -21.24 36.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.13 -43.73 2.22 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -88.55 6.66 36.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -1.133 . . . . 0.0 109.5 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 52.21 34.05 13.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.452 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' ' OD1' ' A' ' 41' ' ' ASN . . . -72.14 -39.1 69.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.49 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 1.0 OUTLIER -64.86 -31.47 72.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -78.67 -28.66 45.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.28 -0.888 . . . . 0.0 109.417 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -81.75 49.17 1.3 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.674 ' ND2' ' HE2' ' A' ' 26' ' ' HIS . 2.6 p-10 -172.15 22.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.479 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 87.6 m -69.4 -22.07 63.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.94 . . . . 0.0 109.454 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 CA-C-O 117.973 -1.46 . . . . 0.0 109.54 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.528 4.796 0 N-CA-C 119.453 2.541 . . . . 0.0 119.453 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 1' ' ' GLY . 20.1 m 50.46 -178.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -1.161 . . . . 0.0 109.452 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 52.68 45.34 28.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.475 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -86.92 120.44 28.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.494 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -123.87 136.2 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.553 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -139.21 151.61 46.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 68.1 m -113.14 161.99 16.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.259 -0.901 . . . . 0.0 109.376 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.8 m -57.93 165.61 1.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.471 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.7 tp -71.71 142.01 49.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.07 2.62 66.21 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -121.56 149.95 42.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -1.156 . . . . 0.0 109.467 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -138.55 146.19 49.74 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.863 . . . . 0.0 109.478 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.18 144.34 41.72 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.745 2.297 . . . . 0.0 112.262 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.2 m -63.54 -30.84 71.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.19 -108.23 0.38 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -86.24 6.52 29.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -1.11 . . . . 0.0 109.475 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.5 mt -98.8 139.87 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 109.43 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.6 m -80.48 90.37 5.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 0.0 109.44 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -172.28 167.11 5.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.504 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.15 142.94 30.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 108.939 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.2 mt -136.21 149.06 66.91 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.378 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.41 153.47 76.74 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.688 2.258 . . . . 0.0 112.247 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -56.99 -22.67 40.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.462 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -56.23 -35.0 66.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 0.0 109.476 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.4 mt -93.65 13.45 22.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.514 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.458 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 47.9 t-80 -83.32 115.86 22.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.434 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.458 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 74.0 m 51.39 34.82 12.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.422 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -89.54 6.23 41.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.46 56.67 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.54 138.09 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -1.163 . . . . 0.0 109.529 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -80.45 122.33 26.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -145.33 -52.99 0.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.477 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 67.6 m -58.48 -23.79 58.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.95 -52.43 2.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.671 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -88.01 10.11 20.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -1.137 . . . . 0.0 109.45 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.465 ' N ' HD21 ' A' ' 35' ' ' ASN . 50.9 mt-30 53.69 32.96 15.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.412 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.671 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -72.19 -38.17 69.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 109.507 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.0 p-10 -65.66 -30.74 71.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 0.0 109.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 72.0 mm-40 -80.13 10.6 4.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.488 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 23.4 t70 -60.1 144.14 50.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.186 -0.946 . . . . 0.0 109.427 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 40' ' ' ASP . 9.5 p30 42.73 42.61 3.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.1 m -144.45 -32.41 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 CA-C-O 118.004 -1.442 . . . . 0.0 109.544 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.852 0 N-CA-C 119.385 2.514 . . . . 0.0 119.385 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -57.87 -37.22 73.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -1.141 . . . . 0.0 109.53 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -149.2 159.67 44.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 109.46 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -165.0 161.25 19.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.495 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.2 m -98.89 135.34 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.492 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -142.17 126.21 17.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.5 m -142.24 143.61 32.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 108.67 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.5 m -66.47 176.3 1.92 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.427 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp -75.88 143.2 41.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.469 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 -3.03 68.07 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.461 ' N ' ' CD1' ' A' ' 11' ' ' TYR . 26.0 m-85 -116.13 135.5 53.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -1.163 . . . . 0.0 109.431 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -113.84 146.68 36.08 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.463 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.82 138.08 28.19 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.837 2.358 . . . . 0.0 112.182 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.4 m -65.16 -11.38 39.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.98 -124.1 2.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -82.93 11.4 6.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.274 -1.133 . . . . 0.0 109.447 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.551 ' CD1' HD22 ' A' ' 35' ' ' ASN . 10.9 mt -100.2 140.42 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.429 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.8 m -77.28 79.13 3.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.467 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -170.03 122.09 0.68 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.5 m -112.86 151.38 30.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 108.619 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.1 mt -138.97 151.34 67.94 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.41 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -46.66 146.5 5.36 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.706 2.27 . . . . 0.0 112.255 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -59.33 -27.65 66.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.568 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.77 -36.14 73.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.536 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 mt -84.4 11.05 9.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.505 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.494 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 57.5 t-80 -80.27 120.67 24.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.444 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 83.9 m 47.11 38.24 6.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -90.74 6.19 45.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.29 32.38 58.16 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.07 137.23 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.181 -1.188 . . . . 0.0 109.479 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 26.8 p30 -82.85 108.87 16.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.467 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 1.2 p30 -132.91 -43.21 0.89 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.441 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.555 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 59.8 m -53.91 -24.62 16.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 109.31 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.73 -2.63 32.11 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.551 HD22 ' CD1' ' A' ' 17' ' ' ILE . 2.1 p30 -149.37 -92.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -1.144 . . . . 0.0 109.47 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.42 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 16.7 pt20 -176.85 22.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.411 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.73 76.19 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.15 -0.969 . . . . 0.0 109.519 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 25.0 p-10 -67.53 -30.64 70.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.438 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 73.3 mm-40 -87.56 15.95 6.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 109.446 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 39' ' ' GLU . 51.2 p30 -54.16 -172.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 42' ' ' CYS . 48.2 p-10 -46.85 -20.83 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.466 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.509 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 91.8 m 50.92 77.44 0.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.497 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.849 0 N-CA-C 119.412 2.525 . . . . 0.0 119.412 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.2 t -58.45 -35.16 71.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -1.119 . . . . 0.0 109.449 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -63.4 151.97 39.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.401 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.35 150.86 8.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 109.548 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 6' ' ' LYS . 6.0 m -51.4 135.47 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.519 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' VAL . 44.0 tttp -62.04 -127.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 109.489 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.3 m -106.21 159.17 16.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.92 . . . . 0.0 109.073 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.3 m -59.29 166.2 2.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.486 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp -71.84 139.32 48.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.37 0.61 67.31 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -118.99 147.36 44.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -1.123 . . . . 0.0 109.493 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.512 ' CD1' ' OE1' ' A' ' 23' ' ' GLN . 14.5 p90 -132.96 146.44 61.29 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.24 -0.912 . . . . 0.0 109.472 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.24 143.8 44.75 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.782 2.321 . . . . 0.0 112.248 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.5 m -67.45 -21.73 65.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.11 -114.77 0.73 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -84.96 9.47 14.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -1.157 . . . . 0.0 109.423 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 mt -100.16 136.38 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 m -75.59 62.8 1.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -143.42 140.74 30.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -127.34 143.29 51.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 108.756 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.3 mt -138.51 149.9 64.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.422 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.07 154.3 71.22 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.819 2.346 . . . . 0.0 112.174 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.512 ' OE1' ' CD1' ' A' ' 12' ' ' PHE . 15.0 mm100 -57.23 -20.81 29.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.465 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.8 mt -56.69 -36.1 69.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.481 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.22 12.52 22.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.589 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.7 t-80 -80.95 118.43 22.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.975 . . . . 0.0 109.459 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.589 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 60.9 m 51.45 39.14 23.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -89.27 4.52 48.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.511 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.84 26.78 68.33 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.13 135.74 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -1.139 . . . . 0.0 109.521 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -77.42 129.32 35.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.49 -51.77 0.3 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 109.422 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.501 ' SG ' ' OD1' ' A' ' 38' ' ' ASP . 87.7 m -52.08 -20.85 2.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.222 -0.924 . . . . 0.0 109.366 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.36 -2.73 34.78 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 36' ' ' GLN . 1.8 p30 -149.46 -92.17 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -1.131 . . . . 0.0 109.525 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.528 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 14.2 pt20 -176.1 22.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.12 82.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.469 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 1.1 p-10 -66.35 -30.13 70.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -82.07 11.14 5.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.45 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.473 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 51.7 p30 -63.41 158.7 19.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.473 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 21.4 p30 41.11 35.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.424 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.2 m -147.16 159.71 43.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 CA-C-O 117.978 -1.457 . . . . 0.0 109.591 179.948 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.427 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.529 4.868 0 N-CA-C 119.39 2.516 . . . . 0.0 119.39 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 1' ' ' GLY . 16.8 p 46.16 35.08 2.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -1.111 . . . . 0.0 109.493 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -58.23 -37.23 74.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.482 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.31 120.09 27.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.456 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.52 122.65 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.46 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.61 11.2 34.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.165 -0.959 . . . . 0.0 109.462 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.0 m -99.54 155.78 17.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.559 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -65.4 168.75 6.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.41 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 mt -67.23 150.67 48.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.7 -6.68 74.05 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -120.5 149.17 42.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -1.15 . . . . 0.0 109.418 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.38 146.43 48.49 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.393 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.14 142.98 39.06 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.789 2.326 . . . . 0.0 112.19 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.3 m -62.35 -28.34 69.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.434 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.69 -110.98 0.49 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -85.64 7.86 21.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.197 -1.178 . . . . 0.0 109.435 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.5 mt -99.46 139.22 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.494 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.74 91.31 5.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -171.27 167.36 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 109.44 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -143.75 143.41 31.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 108.801 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.7 mt -136.85 148.98 65.36 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.361 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.65 155.07 72.13 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.804 2.336 . . . . 0.0 112.182 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -57.12 -22.06 37.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 9.7 mp -54.89 -37.98 66.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.5 mt -88.34 14.93 8.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.484 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.531 ' NE2' ' SG ' ' A' ' 42' ' ' CYS . 11.7 t-80 -76.96 104.72 7.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.455 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 m 49.96 45.36 25.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -92.06 6.48 46.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.97 29.15 55.07 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.3 t -130.83 138.81 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -1.187 . . . . 0.0 109.556 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -80.59 127.73 32.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.452 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.438 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -148.49 -53.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.456 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 50.9 m -58.8 -22.05 57.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.94 -58.98 3.23 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.568 ' N ' HD21 ' A' ' 35' ' ' ASN . 0.0 OUTLIER -81.48 11.19 4.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -1.158 . . . . 0.0 109.446 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 53.76 35.18 20.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.546 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -71.7 -40.71 69.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.488 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 18.0 p-10 -63.56 -30.69 71.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.531 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -82.86 10.56 7.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.473 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 41' ' ' ASN . 47.9 t0 -74.54 75.47 1.97 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.452 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 40' ' ' ASP . 6.0 p-10 38.64 90.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.467 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.531 ' SG ' ' NE2' ' A' ' 26' ' ' HIS . 38.2 m -68.12 154.06 42.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.286 -0.884 . . . . 0.0 109.479 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.548 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.771 0 N-CA-C 119.398 2.519 . . . . 0.0 119.398 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.3 m -64.0 156.32 28.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -1.188 . . . . 0.0 109.466 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.466 ' CD ' ' H ' ' A' ' 3' ' ' GLN . 9.0 mp0 -59.02 -34.38 71.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.483 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 50.05 -125.03 2.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.167 -0.958 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 p -137.83 144.86 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.493 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -128.27 130.53 48.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.28 -0.888 . . . . 0.0 109.457 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 m -128.28 136.64 51.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.031 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.6 m -84.14 -170.81 3.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.455 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt -72.54 147.39 46.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.252 -0.905 . . . . 0.0 109.441 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.92 4.87 66.75 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -137.18 156.32 48.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -1.151 . . . . 0.0 109.49 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -143.39 147.19 39.01 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.476 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.82 139.83 34.21 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.845 2.363 . . . . 0.0 112.23 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.7 m -64.87 -20.91 66.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.9 -114.26 0.84 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -83.0 5.89 20.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -1.088 . . . . 0.0 109.419 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.469 HD12 HG22 ' A' ' 17' ' ' ILE . 8.0 mm -91.68 154.55 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.497 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.3 p -94.3 65.33 3.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.73 165.19 37.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.486 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -143.98 147.44 33.9 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.1 mt -136.21 149.87 69.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.451 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.49 152.54 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.793 2.329 . . . . 0.0 112.162 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -62.13 -26.86 68.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 mt -56.91 -35.34 68.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.53 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.9 mt -89.26 11.63 18.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.468 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.0 t-80 -79.36 115.92 19.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.93 . . . . 0.0 109.483 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 61.3 m 46.31 39.77 6.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 109.519 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -91.95 7.91 39.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.09 36.7 64.13 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.29 137.32 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -1.149 . . . . 0.0 109.486 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -78.32 123.54 27.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -148.27 -54.69 0.2 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.483 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.3 m -59.03 -25.17 63.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.602 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.01 -46.57 1.87 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -87.09 5.64 36.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 109.475 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.527 ' N ' HD21 ' A' ' 35' ' ' ASN . 89.6 mt-30 52.43 28.25 5.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.347 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.67 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -70.12 -37.64 75.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 17.6 p-10 -64.73 -31.08 72.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 77.5 mm-40 -87.66 20.52 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.442 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 57.8 t0 -138.85 153.41 48.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.494 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 22.1 p30 41.08 45.02 2.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.485 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 56.4 m -58.12 -30.74 66.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.496 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.528 4.799 0 N-CA-C 119.451 2.54 . . . . 0.0 119.451 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 1' ' ' GLY . 28.7 t 50.72 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -1.122 . . . . 0.0 109.484 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 54.79 73.45 0.41 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.232 -0.917 . . . . 0.0 109.5 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -58.7 148.81 28.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.484 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.2 m -129.95 154.59 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.918 . . . . 0.0 109.488 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HZ1' ' CB ' ' A' ' 6' ' ' LYS . 7.9 ttpm? -141.48 139.72 33.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.459 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 29.3 m -99.99 160.67 14.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.655 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.1 m -66.46 169.87 6.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.895 . . . . 0.0 109.508 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.9 mt -61.09 143.6 55.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 0.0 109.486 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.53 4.49 83.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -142.24 156.35 45.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.151 . . . . 0.0 109.466 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.53 146.01 49.02 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.46 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 59.5 Cg_endo -74.8 143.19 29.48 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.853 2.369 . . . . 0.0 112.2 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.2 m -69.1 -21.06 64.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.905 . . . . 0.0 109.537 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.48 -116.42 0.87 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -88.64 11.08 18.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -1.135 . . . . 0.0 109.469 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 mt -100.83 141.66 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.452 ' O ' ' CG2' ' A' ' 18' ' ' THR . 7.2 t -77.01 86.61 3.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -170.31 151.69 3.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.6 m -142.49 144.75 33.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 108.799 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 84.5 mt -135.04 150.3 72.7 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.471 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.2 146.12 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.841 2.361 . . . . 0.0 112.128 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -58.71 -26.59 64.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.481 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.0 mt -57.45 -36.12 70.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.7 mt -86.3 14.38 6.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.183 -0.948 . . . . 0.0 109.525 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.458 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 59.9 t-80 -90.26 123.13 33.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.406 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.458 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 98.6 m 50.91 34.27 10.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.481 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -92.42 7.23 43.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.469 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.55 34.8 63.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.0 t -132.03 141.58 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -1.182 . . . . 0.0 109.452 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -85.25 117.91 24.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.288 -0.883 . . . . 0.0 109.497 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -142.4 -52.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.469 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 20.2 m -55.78 -35.62 66.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.041 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.13 -39.95 2.58 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.745 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -88.96 2.93 53.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.159 . . . . 0.0 109.532 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.541 ' N ' HD21 ' A' ' 35' ' ' ASN . 37.0 tp60 59.51 18.39 6.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.877 . . . . 0.0 109.385 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.745 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -75.34 -31.91 60.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.498 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 32' ' ' ASP . 27.1 p-10 -62.56 -31.59 72.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.497 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.437 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 65.4 mm-40 -87.75 16.57 5.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.464 ' O ' ' C ' ' A' ' 41' ' ' ASN . 49.7 p30 -62.27 152.16 34.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.477 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' A' ' 40' ' ' ASP . 15.9 p30 41.21 34.23 0.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.16 -0.963 . . . . 0.0 109.467 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 94.7 m -142.48 158.96 43.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.451 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.883 0 N-CA-C 119.356 2.502 . . . . 0.0 119.356 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.3 p -62.78 -24.57 67.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -1.167 . . . . 0.0 109.458 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -57.56 -36.23 71.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' VAL . 57.1 t0 49.95 50.16 18.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.87 . . . . 0.0 109.504 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 4' ' ' ASP . 2.2 t -62.22 -136.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 109.515 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 66.6 mmtt 51.07 -153.67 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.514 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 73.1 m -99.91 158.4 15.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.673 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.2 m -78.33 178.39 7.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.402 ' O ' ' CD2' ' A' ' 11' ' ' TYR . 37.3 mt -69.02 139.51 54.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.439 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.07 4.89 81.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 9' ' ' LEU . 25.0 m-85 -138.2 156.79 47.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -1.18 . . . . 0.0 109.471 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -136.73 146.28 54.62 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.409 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.475 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 57.5 Cg_endo -73.92 145.27 35.74 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.843 2.362 . . . . 0.0 112.242 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.6 m -70.36 -20.11 62.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.508 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.41 -118.63 1.03 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -87.6 11.69 14.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -1.172 . . . . 0.0 109.449 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.64 139.17 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.8 p -74.11 90.06 2.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.539 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.452 ' HZ2' ' CD2' ' A' ' 21' ' ' LEU . 31.5 tttm -171.24 149.54 2.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.439 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.4 m -140.81 143.91 35.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 108.74 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.452 ' CD2' ' HZ2' ' A' ' 19' ' ' LYS . 91.8 mt -137.82 150.92 69.34 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.362 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -47.12 143.99 9.47 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.797 2.331 . . . . 0.0 112.292 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.22 -21.91 49.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 mt -59.99 -35.33 74.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.4 mt -85.77 7.68 22.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.456 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -78.15 108.81 11.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.428 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 38' ' ' ASP . 51.9 m 51.82 50.33 18.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.43 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.531 HD22 ' CG1' ' A' ' 30' ' ' VAL . 17.2 p-10 -95.2 -39.97 9.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.449 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.06 29.72 0.29 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.531 ' CG1' HD22 ' A' ' 28' ' ' ASN . 8.4 p -144.07 143.46 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -1.161 . . . . 0.0 109.406 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -84.93 103.61 14.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.52 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.446 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -114.22 -51.24 2.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.48 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 57.8 m -54.44 -30.76 53.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.59 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.77 -44.89 2.53 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -86.2 10.1 15.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -1.15 . . . . 0.0 109.494 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 52.86 23.79 2.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.427 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.93 -37.72 67.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.522 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 21.3 p-10 -64.38 -30.98 72.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.52 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -85.9 10.42 13.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' O ' ' C ' ' A' ' 41' ' ' ASN . 59.3 t0 -77.78 126.3 30.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 109.436 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.476 ' C ' ' O ' ' A' ' 40' ' ' ASP . 6.3 p-10 39.62 84.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.472 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 88.0 m -90.48 158.04 17.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 CA-C-O 117.916 -1.491 . . . . 0.0 109.522 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.775 0 N-CA-C 119.402 2.521 . . . . 0.0 119.402 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 t 51.49 -150.37 0.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -1.171 . . . . 0.0 109.474 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -148.0 166.46 27.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.9 . . . . 0.0 109.404 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.36 146.7 28.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.509 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 6' ' ' LYS . 7.5 p -131.75 133.82 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.491 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 5' ' ' VAL . 96.6 mttt 44.8 -129.9 0.98 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 109.404 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.4 m -101.03 157.49 16.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.92 . . . . 0.0 109.229 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.3 m -72.74 175.15 6.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.508 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 tp -76.18 138.83 40.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.89 -0.44 67.11 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -115.94 152.62 33.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.507 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -136.99 146.27 54.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.472 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.44 144.09 49.4 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.788 2.325 . . . . 0.0 112.222 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.5 m -65.81 -21.41 66.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.53 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.86 -110.96 0.6 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -84.78 9.69 13.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -1.139 . . . . 0.0 109.403 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 mm -97.98 141.01 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 109.423 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.5 t -81.73 59.06 4.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.511 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -146.44 148.17 32.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.406 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.05 145.49 50.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 108.938 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.2 mt -137.5 149.56 65.62 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.77 155.69 65.89 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.821 2.347 . . . . 0.0 112.236 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -56.74 -25.34 54.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.573 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.4 tp -51.0 -39.4 55.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -89.05 19.61 4.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.527 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -79.52 112.48 16.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -0.942 . . . . 0.0 109.454 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.4 m 47.19 45.52 16.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.439 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -87.04 4.22 42.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.16 10.2 80.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.21 134.39 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.42 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -86.2 103.32 14.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 0.0 109.459 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -103.32 -53.64 2.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.445 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 63.1 m -57.44 -25.95 60.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.46 -33.11 5.49 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -89.93 5.03 48.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -1.162 . . . . 0.0 109.469 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 52.08 26.01 3.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.88 . . . . 0.0 109.402 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.48 -34.21 67.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.187 -0.946 . . . . 0.0 109.519 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 8.7 p30 -65.19 -30.7 71.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -81.67 11.93 4.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.496 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.469 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 93.8 m-20 -68.27 156.71 37.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.872 . . . . 0.0 109.54 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 4.2 p-10 42.0 44.66 3.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.494 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.9 m -144.74 162.04 37.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 109.552 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.539 -179.955 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.852 0 N-CA-C 119.331 2.492 . . . . 0.0 119.331 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.4 p -160.94 -23.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -1.153 . . . . 0.0 109.458 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -151.82 86.73 1.32 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -88.03 120.36 29.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 109.478 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.0 t -124.17 135.16 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.317 -0.864 . . . . 0.0 109.517 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -157.81 -130.86 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 109.503 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 m -126.68 136.31 52.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.331 -0.855 . . . . 0.0 109.122 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -83.03 -173.57 4.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.2 mt -73.67 145.46 45.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.431 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.98 6.86 66.57 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -132.31 156.43 46.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -1.134 . . . . 0.0 109.447 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -141.52 146.75 43.25 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.509 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.64 140.42 39.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.708 2.272 . . . . 0.0 112.289 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.7 m -61.58 -41.48 97.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.479 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.58 108.53 0.61 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 54.7 19.59 2.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -1.129 . . . . 0.0 109.438 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mm -124.13 138.47 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.878 . . . . 0.0 109.439 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 m -74.87 52.13 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.875 . . . . 0.0 109.478 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -140.98 142.76 34.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.431 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -132.18 148.63 52.48 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.9 mt -139.59 149.8 61.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.376 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.58 144.48 3.25 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.783 2.322 . . . . 0.0 112.19 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.47 -24.58 60.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.472 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 9.6 mp -58.96 -36.1 74.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.7 mt -84.92 11.98 8.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -81.51 118.71 22.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.948 . . . . 0.0 109.445 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.4 m 50.34 34.51 9.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.424 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -88.99 6.76 38.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.82 38.32 65.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.0 t -133.75 136.37 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.485 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.9 p-10 -83.97 103.01 12.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.411 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -122.28 -51.94 1.96 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.259 -0.901 . . . . 0.0 109.475 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 76.2 m -58.73 -25.07 62.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 0.0 109.251 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.74 -43.18 2.47 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -87.91 6.25 36.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.467 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 52.26 33.66 13.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.22 -38.13 60.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 109.496 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 15.5 p30 -65.59 -31.07 71.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.519 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -81.22 0.99 34.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 109.474 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 42' ' ' CYS . 95.1 m-20 -50.28 173.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 43.6 p-10 -46.63 91.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.547 ' N ' ' O ' ' A' ' 40' ' ' ASP . 58.0 m -61.58 -24.98 67.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 109.471 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.949 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.527 4.763 0 N-CA-C 119.381 2.512 . . . . 0.0 119.381 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.443 ' HG ' ' H ' ' A' ' 3' ' ' GLN . 11.7 t 47.2 -123.73 1.48 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -1.156 . . . . 0.0 109.498 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.443 ' H ' ' HG ' ' A' ' 2' ' ' SER . 54.9 tp60 52.28 53.46 12.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.411 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -86.07 7.79 23.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.51 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' LYS . 48.2 t -71.87 129.77 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.422 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' VAL . 60.3 mttp 50.46 179.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 109.513 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 29.0 m -99.25 139.3 35.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.102 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.0 m -68.94 -177.83 1.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.2 mt -75.65 147.67 39.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.91 4.07 69.79 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -130.18 156.58 44.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -1.145 . . . . 0.0 109.457 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -140.08 146.65 47.31 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.449 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.34 142.57 37.47 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.748 2.299 . . . . 0.0 112.262 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.1 m -66.96 -20.85 65.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.515 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.13 -112.51 0.69 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -85.63 9.34 16.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -1.111 . . . . 0.0 109.393 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 mt -102.84 140.5 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.872 . . . . 0.0 109.429 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -78.58 58.96 2.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.921 . . . . 0.0 109.495 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -139.1 140.13 37.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 109.437 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.67 145.9 51.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.5 mt -138.93 150.41 65.22 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.361 -0.837 . . . . 0.0 109.391 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.04 152.69 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.796 2.331 . . . . 0.0 112.199 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -61.69 -28.42 69.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.6 mt -55.05 -36.19 65.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.434 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.5 mt -88.67 15.49 8.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.955 . . . . 0.0 109.488 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.431 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 55.7 t-80 -82.57 114.72 21.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.408 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 38' ' ' ASP . 57.0 m 47.26 38.81 7.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.443 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -89.83 8.26 32.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.905 . . . . 0.0 109.497 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.96 31.14 62.33 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t -127.38 138.59 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 0.0 109.501 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 36.1 p-10 -83.24 115.15 21.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -139.29 -51.22 0.53 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.46 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 66.6 m -56.94 -39.26 74.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.905 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 36' ' ' GLN . . . 134.76 -72.96 0.46 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -86.93 20.96 2.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -1.125 . . . . 0.0 109.463 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 34' ' ' GLY . 27.2 mp0 53.9 40.66 31.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.28 77.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.882 . . . . 0.0 109.449 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.49 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 9.0 p30 -63.57 -31.27 72.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.0 OUTLIER -82.11 10.19 7.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.503 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 42' ' ' CYS . 50.7 p30 -60.54 -170.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.472 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 43' ' ' GLY . 31.7 p30 -46.52 -17.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.333 -0.854 . . . . 0.0 109.503 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.498 ' N ' ' O ' ' A' ' 40' ' ' ASP . 93.3 m 51.2 -89.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 3' ' ' GLN . . . . . . . . 1 N--CA 1.529 4.858 0 N-CA-C 119.382 2.513 . . . . 0.0 119.382 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 67.08 -43.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -1.153 . . . . 0.0 109.475 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 1' ' ' GLY . 92.0 mt-30 52.96 44.02 30.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.482 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -89.31 11.1 19.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.466 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.6 m -128.72 157.03 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.491 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -154.06 45.48 0.58 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.5 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.4 m -98.7 141.64 31.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 108.88 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.2 m -66.73 173.26 3.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' A' ' 9' ' ' LEU . 8.6 mp -67.84 151.49 47.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.454 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.34 -7.53 77.98 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.26 151.98 41.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -1.158 . . . . 0.0 109.459 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 13.5 p90 -142.22 125.29 9.42 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.2 141.09 13.72 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.832 2.355 . . . . 0.0 112.17 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.1 m -64.76 -22.75 67.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 0.0 109.494 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.01 -113.88 0.66 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -84.46 8.47 16.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -1.112 . . . . 0.0 109.484 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.9 mt -98.82 140.36 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 109.504 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 p -78.89 57.9 2.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -142.49 142.75 32.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -126.7 144.49 50.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 108.983 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.0 mt -137.23 149.78 66.99 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.413 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.79 155.63 68.27 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.795 2.33 . . . . 0.0 112.257 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -57.67 -20.24 32.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.479 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.3 tp -56.27 -36.65 68.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.488 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.4 mt -91.2 10.2 28.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.819 . . . . 0.0 109.524 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.591 ' CE1' ' SG ' ' A' ' 42' ' ' CYS . 45.0 t-80 -74.25 104.25 4.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.413 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.7 m 52.11 50.21 18.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.537 HD22 ' CG1' ' A' ' 30' ' ' VAL . 15.5 p-10 -91.16 -35.42 14.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.421 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.13 26.76 0.67 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.537 ' CG1' HD22 ' A' ' 28' ' ' ASN . 8.5 p -144.73 142.75 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.472 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -85.73 103.59 14.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -112.32 -52.37 2.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.866 . . . . 0.0 109.475 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.418 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 37.2 m -48.68 -45.03 38.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.64 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.07 -59.73 0.66 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.672 ' ND2' ' H ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -90.25 -89.49 0.16 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 109.478 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.672 ' H ' ' ND2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -173.17 23.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.882 . . . . 0.0 109.389 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.71 -47.58 80.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.2 p-10 -65.71 -30.43 71.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.415 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -85.2 21.61 1.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -65.82 179.55 0.85 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.418 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.42 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 6.2 p30 -58.32 92.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.45 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.591 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 93.1 m -87.92 157.21 19.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -0.844 . . . . 0.0 109.512 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.537 179.897 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.879 0 N-CA-C 119.385 2.514 . . . . 0.0 119.385 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -145.16 150.51 36.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -1.14 . . . . 0.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 53.6 90.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.524 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -65.69 146.56 54.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.91 . . . . 0.0 109.508 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.8 t -98.52 134.75 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.501 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -80.91 160.55 24.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.462 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 84.8 m -99.45 159.76 14.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.63 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.7 m -68.07 176.37 2.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.29 -0.882 . . . . 0.0 109.524 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.5 mt -66.18 142.53 57.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.76 2.44 84.4 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -142.31 156.91 45.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.385 -1.067 . . . . 0.0 109.441 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -141.24 146.99 45.18 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.498 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 59.8 Cg_endo -75.09 143.54 28.9 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.818 2.345 . . . . 0.0 112.216 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.7 m -69.45 -14.79 63.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.499 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.03 -118.45 1.55 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -83.47 9.77 10.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -1.152 . . . . 0.0 109.442 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.465 HG22 HD11 ' A' ' 17' ' ' ILE . 9.9 mm -94.71 141.3 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.487 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.6 m -81.48 87.98 6.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 33' ' ' CYS . 14.9 ptpt -173.14 168.14 4.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.5 m -148.82 142.98 26.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.93 150.12 70.54 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.489 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.18 145.44 5.51 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.76 2.306 . . . . 0.0 112.219 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.22 -27.12 65.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.51 -34.98 73.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 109.558 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.35 9.67 14.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 109.528 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.593 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 53.7 t-80 -78.92 119.65 22.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.593 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 84.3 m 46.83 39.32 7.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.431 ' ND2' ' CG2' ' A' ' 30' ' ' VAL . 41.0 p-10 -93.05 5.63 50.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.62 33.83 55.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.431 ' CG2' ' ND2' ' A' ' 28' ' ' ASN . 59.7 t -127.74 136.19 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -1.137 . . . . 0.0 109.469 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 35.1 p-10 -81.73 103.57 11.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.94 . . . . 0.0 109.524 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -127.86 -49.74 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.518 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 86.0 m -59.54 -27.17 65.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.951 . . . . 0.0 109.598 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.72 -44.85 2.37 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.654 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -87.04 6.23 33.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -1.174 . . . . 0.0 109.472 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.468 ' N ' HD21 ' A' ' 35' ' ' ASN . 93.2 mt-30 52.14 28.14 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.874 . . . . 0.0 109.41 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.654 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -73.91 -38.19 64.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.475 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 20.6 p-10 -64.45 -31.1 72.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 75.1 mm-40 -84.87 13.33 6.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.903 . . . . 0.0 109.438 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 42' ' ' CYS . 51.4 p30 -56.44 -171.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 42' ' ' CYS . 31.8 p30 -46.88 -18.87 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.879 . . . . 0.0 109.436 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 89.3 m 51.61 53.29 12.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 CA-C-O 117.994 -1.448 . . . . 0.0 109.525 179.998 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.868 0 N-CA-C 119.378 2.511 . . . . 0.0 119.378 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 t -145.74 149.48 34.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -1.125 . . . . 0.0 109.392 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -55.82 -35.88 66.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -65.92 144.49 56.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 0.0 109.501 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.4 134.96 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.503 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -73.46 144.88 46.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.436 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.8 m -114.83 158.8 21.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 108.983 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.7 m -61.79 170.46 2.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.498 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.44 150.5 48.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.961 . . . . 0.0 109.444 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.7 -4.21 86.41 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -127.02 153.68 45.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.144 . . . . 0.0 109.49 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CD1' ' NE2' ' A' ' 23' ' ' GLN . 20.8 p90 -143.53 147.28 38.94 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.23 143.28 48.08 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.808 2.339 . . . . 0.0 112.21 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.46 -24.44 64.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.37 -110.32 0.54 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -84.73 6.91 22.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -1.147 . . . . 0.0 109.482 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.2 mt -102.35 137.67 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.6 p -78.1 62.63 2.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -144.93 145.47 31.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.409 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.13 146.06 51.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 108.844 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 71.3 mt -140.53 152.46 66.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 109.38 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -52.73 149.76 24.19 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.783 2.322 . . . . 0.0 112.224 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.515 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 94.0 mm-40 -60.56 -25.61 66.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 9.7 mp -60.06 -34.33 73.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.565 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.553 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 31.1 mt -85.72 9.9 15.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 109.558 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.494 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 55.1 t-80 -91.13 131.41 36.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.397 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 64.0 m 51.71 79.68 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.432 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.553 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 12.5 p30 -143.28 -3.77 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.413 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.63 3.24 89.74 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.94 140.37 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -1.142 . . . . 0.0 109.48 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -89.0 125.43 34.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.477 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.443 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -138.16 -51.8 0.6 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.4 m -53.9 -41.2 67.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.935 . . . . 0.0 109.63 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 145.37 -27.01 1.84 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.56 ' CG ' ' H ' ' A' ' 36' ' ' GLN . 1.2 p30 -136.22 -99.66 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -1.162 . . . . 0.0 109.481 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.56 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 72.7 mt-30 -155.93 15.36 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.391 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.99 91.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.489 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 33.3 p-10 -63.63 -31.54 72.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.901 . . . . 0.0 109.548 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.466 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 64.6 mm-40 -76.15 -54.64 6.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.462 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 41' ' ' ASN . 43.2 t0 44.79 -166.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.477 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.542 HD21 ' N ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -76.41 3.73 10.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.908 . . . . 0.0 109.415 179.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.542 ' N ' HD21 ' A' ' 41' ' ' ASN . 73.0 m 47.46 -172.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -0.906 . . . . 0.0 109.526 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 CA-C-O 118.003 -1.443 . . . . 0.0 109.543 179.977 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.865 0 N-CA-C 119.38 2.512 . . . . 0.0 119.38 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 m -57.22 -36.03 70.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -1.134 . . . . 0.0 109.474 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -94.66 116.65 29.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.186 -0.946 . . . . 0.0 109.407 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -78.99 138.09 37.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.312 -0.867 . . . . 0.0 109.527 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.88 140.81 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.907 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -97.02 33.95 1.82 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.88 . . . . 0.0 109.461 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -134.63 141.81 46.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.131 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -86.63 -161.57 0.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.895 . . . . 0.0 109.493 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' H ' ' CD2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -81.11 142.24 33.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.437 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.77 -0.11 69.71 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -130.56 156.02 45.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -1.179 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CD1' ' NE2' ' A' ' 23' ' ' GLN . 12.6 p90 -148.56 146.59 22.8 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.394 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.529 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 57.4 Cg_endo -73.84 148.56 41.17 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.786 2.324 . . . . 0.0 112.197 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.61 -7.04 59.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 17' ' ' ILE . . . 88.77 132.27 4.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m120 68.01 -25.95 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -1.109 . . . . 0.0 109.447 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.633 ' H ' ' C ' ' A' ' 15' ' ' GLY . 24.1 mm -104.37 130.12 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.479 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.24 57.66 2.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.504 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.536 ' HZ2' ' CD2' ' A' ' 21' ' ' LEU . 33.5 tttm -146.6 137.03 23.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.47 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 1.6 m -117.17 147.38 42.52 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.536 ' CD2' ' HZ2' ' A' ' 19' ' ' LYS . 67.6 mt -137.51 151.96 72.07 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.382 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.36 149.3 13.02 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.829 2.352 . . . . 0.0 112.178 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.515 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 92.9 mm-40 -60.24 -25.43 65.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.534 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.8 tp -58.12 -36.75 73.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.495 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.96 5.53 28.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.519 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -84.34 131.59 34.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.7 m 51.36 26.76 3.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.486 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -84.81 3.51 37.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.01 36.55 81.48 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -133.43 137.01 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.0 109.535 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -82.76 104.1 12.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.517 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.83 -58.66 2.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -0.97 . . . . 0.0 109.467 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.8 m -63.49 -27.55 69.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.3 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.07 -31.35 5.7 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.659 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -83.83 4.6 28.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -1.161 . . . . 0.0 109.475 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.551 ' N ' HD21 ' A' ' 35' ' ' ASN . 94.2 mt-30 48.67 13.69 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.421 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.659 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -64.77 -38.83 92.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 109.488 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 27.9 p-10 -65.81 -30.66 71.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.452 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 41' ' ' ASN . 81.2 mm-40 -91.24 13.5 17.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 0.0 109.533 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 41' ' ' ASN . 52.0 p30 -63.25 77.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.494 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 43' ' ' GLY . 20.3 p30 41.56 32.95 0.26 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.362 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 73.4 m 46.79 -92.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.46 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.294 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.579 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 3' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.918 0 N-CA-C 119.402 2.521 . . . . 0.0 119.402 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.7 t 53.12 6.5 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.352 -1.087 . . . . 0.0 109.547 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.54 ' H ' ' C ' ' A' ' 1' ' ' GLY . 62.7 tt0 -97.0 126.88 42.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.497 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 5' ' ' VAL . 49.5 t0 -155.37 163.63 39.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 109.5 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.403 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 10.6 p -89.04 138.66 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 109.546 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -135.34 154.29 51.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.499 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.9 m -100.96 158.59 15.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.272 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.0 m -58.76 165.04 2.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 9' ' ' LEU . 9.2 mp -66.24 149.37 50.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.69 -4.03 81.73 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -127.64 152.39 47.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -1.13 . . . . 0.0 109.524 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -143.68 145.75 32.38 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.417 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.33 143.99 40.33 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.855 2.37 . . . . 0.0 112.186 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.5 m -62.94 -28.36 70.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.511 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.0 -106.82 0.32 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -86.9 8.19 24.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -1.161 . . . . 0.0 109.468 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 mt -102.54 140.93 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 109.424 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.7 m -80.93 63.5 5.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -144.09 131.98 21.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -116.16 143.6 45.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.489 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.0 mt -137.21 149.29 65.5 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 109.407 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.16 155.27 66.02 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.75 2.3 . . . . 0.0 112.189 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.21 -22.18 60.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.536 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 10.3 mp -57.34 -36.07 70.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.4 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 63.0 mt -91.95 3.9 54.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.41 ' NE2' ' SG ' ' A' ' 27' ' ' CYS . 11.8 t-80 -81.56 125.95 31.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 109.367 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' ' NE2' ' A' ' 26' ' ' HIS . 80.3 m 52.7 28.77 6.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.4 ' ND2' ' HA ' ' A' ' 25' ' ' LEU . 43.5 p-10 -88.34 5.77 40.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 109.447 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.87 42.4 78.75 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -138.86 140.25 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -1.151 . . . . 0.0 109.481 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -80.22 121.58 25.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.5 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -144.15 -52.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.437 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.422 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 69.1 m -59.58 -22.34 61.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.367 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.41 -54.84 1.75 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.561 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -89.45 13.82 12.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -1.102 . . . . 0.0 109.485 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 52.76 34.28 15.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.394 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.561 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -70.72 -29.84 66.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 36.2 p-10 -79.82 -27.92 40.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.514 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 74.1 mm-40 -84.08 -31.44 25.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.494 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 37' ' ' ALA . 53.8 p30 -88.87 47.92 1.56 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.902 . . . . 0.0 109.446 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 43.7 p-10 -161.22 19.18 0.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.892 . . . . 0.0 109.474 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 19.4 m -93.96 161.03 14.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 109.427 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 CA-C-O 117.938 -1.479 . . . . 0.0 109.545 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.529 4.844 0 N-CA-C 119.339 2.495 . . . . 0.0 119.339 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 1' ' ' GLY . 22.1 t 49.31 -176.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -1.164 . . . . 0.0 109.438 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -85.96 151.43 23.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.855 . . . . 0.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 4' ' ' ASP . 55.1 p30 -91.0 11.81 21.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.49 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.9 137.36 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.476 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -143.84 149.06 36.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.925 . . . . 0.0 109.518 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 66.3 m -99.29 125.23 44.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.178 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.2 m -88.35 -157.87 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.487 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 11' ' ' TYR . 20.1 mt 57.81 -168.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.446 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.93 16.45 1.97 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.494 ' H ' ' C ' ' A' ' 9' ' ' LEU . 29.2 m-85 -101.04 139.23 37.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.148 . . . . 0.0 109.451 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -139.74 146.73 48.65 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.43 139.93 42.63 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.809 2.34 . . . . 0.0 112.235 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.1 m -61.53 -33.56 74.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 0.0 109.545 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.0 -104.14 0.26 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -91.18 8.46 35.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -1.183 . . . . 0.0 109.416 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.3 mt -99.86 145.25 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 0.0 109.421 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.8 p -82.18 82.41 7.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.487 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -172.12 165.05 6.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.6 m -145.42 144.2 30.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 108.748 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.82 149.84 71.72 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.349 -0.844 . . . . 0.0 109.428 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.83 155.52 63.33 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.755 2.303 . . . . 0.0 112.186 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -58.23 -23.21 55.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.454 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt -53.57 -39.11 64.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.492 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.3 mt -88.8 13.72 11.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.507 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.581 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.5 t-80 -77.96 117.1 18.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.581 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 14.3 m 46.86 40.29 8.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.534 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -89.04 6.48 39.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.22 -0.925 . . . . 0.0 109.464 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.43 32.25 60.06 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.4 t -135.2 137.56 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -1.137 . . . . 0.0 109.483 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -79.41 127.48 32.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -146.92 -58.53 0.28 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.912 . . . . 0.0 109.441 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.504 ' SG ' ' OD2' ' A' ' 38' ' ' ASP . 55.6 m -55.87 -25.19 41.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.352 -0.842 . . . . 0.0 109.251 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.06 -48.38 1.59 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -89.44 7.18 37.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -1.14 . . . . 0.0 109.399 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 52.96 36.31 21.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.407 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' ' OD1' ' A' ' 40' ' ' ASP . . . -75.02 -24.49 58.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' OD2' ' SG ' ' A' ' 33' ' ' CYS . 0.4 OUTLIER -80.47 -31.19 37.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.478 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -74.45 -37.58 63.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.224 -0.923 . . . . 0.0 109.472 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 53.2 p30 -88.84 168.32 12.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.477 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER 40.03 45.55 1.65 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.93 . . . . 0.0 109.435 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.6 m -58.33 -31.49 67.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 109.476 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.505 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.529 4.848 0 N-CA-C 119.376 2.51 . . . . 0.0 119.376 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 1' ' ' GLY . 41.6 t 49.63 -177.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -1.192 . . . . 0.0 109.46 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -140.36 29.09 2.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.416 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -75.78 -5.91 48.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.502 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 p -148.25 6.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -86.05 129.16 34.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.6 m -106.42 156.8 18.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 109.337 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.8 m -78.65 175.07 10.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.569 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 3.7 mm? -73.33 140.45 46.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.429 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.02 1.6 67.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 44.7 m-85 -120.26 155.81 32.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -1.164 . . . . 0.0 109.491 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -141.87 146.1 39.37 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.41 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.64 148.39 53.13 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.811 2.341 . . . . 0.0 112.247 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 m -88.37 47.23 1.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.6 -154.38 28.29 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -50.34 -26.3 4.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -1.192 . . . . 0.0 109.451 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 17' ' ' ILE . 16.4 mm -54.83 132.11 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 m -84.95 63.09 7.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.162 -0.961 . . . . 0.0 109.445 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -146.14 130.58 17.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -112.72 143.61 43.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 108.877 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.6 mt -138.06 149.65 64.56 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.937 . . . . 0.0 109.39 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.05 154.84 71.48 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.809 2.339 . . . . 0.0 112.178 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -57.07 -22.48 39.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.494 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.8 tp -53.73 -37.27 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.6 mt -90.92 16.46 9.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.518 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.676 ' CD2' HD22 ' A' ' 41' ' ' ASN . 51.5 t-80 -84.22 127.37 33.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.589 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 97.5 m 49.62 32.57 5.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.409 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 30' ' ' VAL . 54.1 p30 -83.88 2.17 39.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.378 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.39 25.67 75.27 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.437 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 48.2 t -128.64 138.28 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -1.131 . . . . 0.0 109.51 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.6 p-10 -88.29 101.87 14.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.537 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.43 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -104.58 -58.07 1.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.49 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.6 m -62.61 -25.74 68.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.265 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.88 -32.36 6.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.679 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -85.2 5.09 31.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -1.18 . . . . 0.0 109.506 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.463 ' N ' HD21 ' A' ' 35' ' ' ASN . 56.1 mt-30 48.85 19.56 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.477 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.679 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -65.87 -37.16 85.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.139 -0.975 . . . . 0.0 109.487 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 11.5 p30 -64.17 -31.84 73.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.493 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -76.76 -30.92 56.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -0.871 . . . . 0.0 109.441 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.58 57.7 0.74 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.676 HD22 ' CD2' ' A' ' 26' ' ' HIS . 48.7 p-10 -171.19 23.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.451 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 34.0 m -96.03 159.41 14.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.493 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.59 179.995 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.83 0 N-CA-C 119.409 2.524 . . . . 0.0 119.409 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 m -58.1 -36.47 72.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -1.12 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -159.33 10.99 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -65.77 141.07 58.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.876 . . . . 0.0 109.512 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -104.65 135.59 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.871 . . . . 0.0 109.461 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -77.43 132.82 38.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 109.434 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 41.2 m -99.54 137.19 38.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 108.85 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.8 m -71.41 177.06 4.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.267 -0.896 . . . . 0.0 109.507 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' A' ' 9' ' ' LEU . 9.5 mp -62.95 160.52 14.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.02 -8.21 80.37 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -131.81 151.57 51.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -145.01 146.84 32.46 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.498 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.12 148.22 55.84 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.822 2.348 . . . . 0.0 112.247 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -82.8 -10.76 58.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.01 -126.96 2.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -80.74 8.14 8.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -1.146 . . . . 0.0 109.486 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.402 HG22 HD12 ' A' ' 17' ' ' ILE . 9.2 mm -88.01 131.79 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.429 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -76.55 85.02 3.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 -179.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -171.96 164.78 6.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 109.449 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -141.4 142.62 33.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 108.57 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.1 148.87 66.43 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.408 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.77 158.19 52.09 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.844 2.363 . . . . 0.0 112.205 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -60.37 -23.03 63.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.444 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 10.3 mp -56.79 -34.76 67.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 -179.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.3 mt -94.12 11.24 30.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.526 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 45.3 t-80 -85.59 122.17 29.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.427 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 72.2 m 51.46 31.36 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 109.431 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -86.51 5.98 32.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.49 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.67 39.37 77.76 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -140.01 140.28 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -83.56 125.47 31.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.38 -60.48 0.61 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 0.0 109.451 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.1 m -65.08 -23.28 67.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 0.0 109.211 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.81 -33.7 4.71 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -86.45 3.94 41.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -1.176 . . . . 0.0 109.465 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.559 ' N ' HD21 ' A' ' 35' ' ' ASN . 93.1 mt-30 48.23 18.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.872 . . . . 0.0 109.439 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.682 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -65.51 -36.96 85.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.418 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -28.22 67.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.501 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -83.56 9.3 11.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 89.0 m-20 -60.65 151.21 29.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.498 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.516 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 4.0 p-10 41.84 42.71 2.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.945 . . . . 0.0 109.431 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 40.4 m -150.6 -8.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 CA-C-O 117.951 -1.472 . . . . 0.0 109.549 -179.984 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.826 0 N-CA-C 119.355 2.502 . . . . 0.0 119.355 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.5 m -58.38 -35.39 71.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -1.141 . . . . 0.0 109.536 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 45.73 -116.34 0.59 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.892 . . . . 0.0 109.543 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 58.8 t0 48.43 48.31 19.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.867 . . . . 0.0 109.503 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -88.23 132.51 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -165.99 45.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.485 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.5 m -136.95 158.0 45.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.193 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -58.82 164.48 2.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.13 144.94 53.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.439 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.04 -1.3 80.17 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -121.4 148.29 44.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -1.173 . . . . 0.0 109.509 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -134.98 146.63 59.39 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.421 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.23 144.41 51.45 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.828 2.352 . . . . 0.0 112.199 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.8 m -67.75 -21.2 65.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.443 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.76 -112.6 0.62 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -87.41 10.14 18.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -1.132 . . . . 0.0 109.367 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 mt -102.09 137.75 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -75.31 59.72 1.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.465 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 2.7 ttmp? -139.46 138.83 36.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.377 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -125.96 143.56 51.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 108.746 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.8 mt -138.29 149.71 64.22 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 109.388 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.56 154.56 64.01 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.738 2.292 . . . . 0.0 112.196 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -56.48 -25.02 49.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.322 -0.861 . . . . 0.0 109.519 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.7 tp -52.99 -37.97 61.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.499 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.5 mt -91.76 19.74 6.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.561 -179.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -82.88 114.5 21.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.507 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.1 m 46.93 36.65 4.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.477 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -85.63 8.3 20.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.382 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.75 29.22 63.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.3 t -129.4 139.67 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -1.169 . . . . 0.0 109.509 179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -84.45 122.0 28.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.88 . . . . 0.0 109.503 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -143.78 -47.77 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.455 179.862 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 56.5 m -57.84 -30.11 65.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.729 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.65 0.65 69.16 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 p30 -140.61 13.18 2.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -1.115 . . . . 0.0 109.439 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 51.94 22.9 1.93 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 109.415 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.76 -37.46 73.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 20.1 p30 -65.6 -30.48 71.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.467 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.2 mp0 -78.71 10.53 3.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.521 ' OD1' ' ND2' ' A' ' 41' ' ' ASN . 55.2 p30 -71.52 170.98 12.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.441 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.521 ' ND2' ' OD1' ' A' ' 40' ' ' ASP . 22.4 p30 40.6 37.84 0.53 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 109.468 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 90.9 m -146.53 -2.82 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.449 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 CA-C-O 117.944 -1.475 . . . . 0.0 109.575 179.953 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.852 0 N-CA-C 119.434 2.534 . . . . 0.0 119.434 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.7 p -64.34 -19.21 65.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -1.136 . . . . 0.0 109.532 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -56.14 -35.01 66.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 109.432 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 4' ' ' ASP . 44.1 p-10 -164.64 135.39 4.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.502 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.0 m -138.51 159.38 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? 65.17 112.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.7 m -99.28 165.06 11.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.17 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -56.32 163.87 1.53 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.465 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt -66.84 148.11 52.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.435 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.37 1.99 85.62 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -130.95 152.59 50.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -1.117 . . . . 0.0 109.505 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CD1' ' NE2' ' A' ' 23' ' ' GLN . 17.3 p90 -143.96 146.45 34.28 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.888 . . . . 0.0 109.477 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.71 148.05 58.1 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.814 2.343 . . . . 0.0 112.222 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -63.34 -24.98 68.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.536 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.91 -76.37 0.28 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -119.86 15.01 12.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -1.118 . . . . 0.0 109.413 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.3 mt -111.33 138.03 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.456 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.77 59.42 0.22 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.458 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -141.63 135.3 29.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.5 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -122.8 143.57 49.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.028 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.5 mt -138.0 149.3 63.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.358 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.34 155.08 59.42 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.788 2.325 . . . . 0.0 112.183 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.463 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 98.6 mm-40 -57.87 -23.97 55.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.57 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -55.14 -37.06 66.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.47 -179.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.4 mt -92.09 11.57 24.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 -179.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.547 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.7 t-80 -84.28 123.54 30.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.458 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.547 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 98.1 m 50.86 29.65 4.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -85.78 5.8 30.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.45 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.34 39.21 62.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.3 t -136.08 139.31 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -1.157 . . . . 0.0 109.444 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 38.3 p-10 -86.61 103.57 15.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.49 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.435 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -119.78 -53.33 2.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.454 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.428 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 97.1 m -60.14 -26.49 66.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.185 -0.947 . . . . 0.0 109.527 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.19 -42.94 2.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -85.29 6.22 27.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -1.169 . . . . 0.0 109.428 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 52.43 27.88 5.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.868 . . . . 0.0 109.401 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.32 -37.09 71.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.445 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 12.3 p30 -66.27 -31.09 71.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -88.48 15.87 7.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.54 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 41' ' ' ASN . 62.9 t0 -79.46 122.06 25.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.518 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 7.2 p-10 39.77 80.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 109.436 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.2 m -91.84 157.12 17.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.502 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 117.972 -1.46 . . . . 0.0 109.602 179.982 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.529 4.845 0 N-CA-C 119.433 2.533 . . . . 0.0 119.433 . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 1' ' ' GLY . 29.1 t 49.11 -175.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -1.137 . . . . 0.0 109.553 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.425 ' N ' ' OG ' ' A' ' 2' ' ' SER . 63.7 tt0 -87.28 124.49 33.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 109.467 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' VAL . 88.4 m-20 -67.8 143.37 55.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 4' ' ' ASP . 16.0 t 50.9 97.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.507 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -87.02 10.03 17.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.423 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 32.2 m -99.58 155.92 17.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.234 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.2 m -78.4 178.1 7.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.898 . . . . 0.0 109.502 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 mt -74.15 142.71 45.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.429 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.29 -0.09 68.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 31.0 m-85 -121.59 152.84 38.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -1.14 . . . . 0.0 109.458 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -144.6 146.06 30.81 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.296 -0.878 . . . . 0.0 109.482 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.86 145.74 41.12 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.728 2.285 . . . . 0.0 112.214 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -92.42 81.9 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.545 179.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.73 -145.23 31.13 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -83.89 10.91 8.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -1.19 . . . . 0.0 109.421 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.7 mt -78.58 138.1 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -82.17 61.58 5.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 109.483 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -143.85 126.17 15.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.451 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -112.61 143.02 44.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.7 mt -139.09 149.84 62.72 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.95 154.01 72.58 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.795 2.33 . . . . 0.0 112.241 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -57.07 -21.05 28.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.81 -38.47 70.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.461 -179.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.6 mt -89.82 15.06 10.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 0.0 109.535 -179.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.582 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 53.5 t-80 -83.12 123.81 29.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.505 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.582 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 73.6 m 49.08 32.64 4.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.506 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -85.25 5.37 30.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 109.445 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.45 35.0 68.35 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -133.68 137.28 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -1.184 . . . . 0.0 109.479 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.4 p-10 -84.68 103.47 13.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.486 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.4 OUTLIER -117.77 -57.86 2.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.882 . . . . 0.0 109.47 -179.824 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.494 ' SG ' ' OD2' ' A' ' 38' ' ' ASP . 74.3 m -61.65 -19.69 62.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.512 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.27 -47.52 2.4 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.666 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -82.66 3.36 29.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -1.136 . . . . 0.0 109.502 179.977 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.534 ' N ' HD21 ' A' ' 35' ' ' ASN . 94.0 mt-30 51.19 31.04 6.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.666 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -67.1 -38.78 86.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.496 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.494 ' OD2' ' SG ' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -66.82 -29.95 70.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -78.74 7.82 6.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.474 ' O ' ' C ' ' A' ' 41' ' ' ASN . 50.6 p30 -62.76 156.74 22.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.536 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 0.9 OUTLIER 40.87 35.72 0.36 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.429 179.858 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 56.8 m -145.78 160.21 42.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.487 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.984 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.8 mt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.54 2.76 84.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -141.31 156.61 45.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -140.53 145.78 42.14 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.24 146.81 36.58 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.754 2.302 . . . . 0.0 112.252 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.9 m -70.26 -22.8 62.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.87 -116.36 0.82 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -87.58 9.88 19.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -1.13 . . . . 0.0 109.49 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 17' ' ' ILE . 6.2 mt -102.24 138.53 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.0 m -74.03 93.72 2.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.494 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 ttmm -171.76 145.94 2.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.5 m -135.72 142.32 45.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.139 -0.976 . . . . 0.0 109.11 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.2 mt -139.44 149.75 61.39 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.351 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.38 153.82 68.04 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.761 2.307 . . . . 0.0 112.213 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.48 -21.87 40.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.907 . . . . 0.0 109.518 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.3 tt -57.13 -37.4 71.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.498 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.02 5.46 50.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 109.511 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.491 ' CE1' ' HG ' ' A' ' 27' ' ' CYS . 72.4 t60 -79.64 121.18 24.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.491 ' HG ' ' CE1' ' A' ' 26' ' ' HIS . 82.9 m 52.08 34.01 13.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.427 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.414 HD21 ' HB ' ' A' ' 30' ' ' VAL . 43.9 p-10 -90.53 5.73 46.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.432 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.16 38.23 59.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.414 ' HB ' HD21 ' A' ' 28' ' ' ASN . 25.2 t -136.45 138.96 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -1.153 . . . . 0.0 109.586 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -79.32 123.01 27.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.474 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.9 OUTLIER -145.9 -52.35 0.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 56.6 m -57.07 -27.2 61.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.522 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.36 -50.14 2.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.1 p-10 -86.22 8.72 20.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.447 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 53.41 33.34 15.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.398 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.511 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -75.33 -40.89 57.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.6 p-10 -64.1 -31.71 73.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 78.2 mm-40 -93.3 17.18 11.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 60.2 t0 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.91 . . . . 0.0 109.483 -179.682 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.62 HD22 ' N ' ' A' ' 9' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.67 3.84 66.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 11' ' ' TYR . 32.0 m-85 -127.64 156.51 42.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -1.151 . . . . 0.0 109.451 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -141.98 145.83 37.87 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.431 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.34 145.17 37.96 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.821 2.348 . . . . 0.0 112.24 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.0 -23.79 65.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.496 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.36 -109.8 0.49 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.74 8.41 22.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -1.136 . . . . 0.0 109.526 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 mt -103.85 138.66 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.433 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.31 60.61 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -139.06 130.12 26.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.28 -0.887 . . . . 0.0 109.515 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -121.29 143.81 48.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 108.503 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.6 mt -138.93 150.93 67.06 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.8 147.84 2.95 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.784 2.323 . . . . 0.0 112.22 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -59.72 -24.75 64.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.585 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -55.79 -38.16 69.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.474 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.2 mt -85.1 12.93 6.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -81.8 114.07 20.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.481 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m 50.86 40.49 25.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.486 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -93.15 6.86 46.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.35 33.37 58.92 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.2 t -131.87 137.62 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -1.147 . . . . 0.0 109.487 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -78.9 124.07 27.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.449 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.463 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -146.93 -54.26 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.964 . . . . 0.0 109.393 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.5 m -59.0 -23.65 62.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.631 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.01 -52.22 1.91 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 52.1 p-10 -86.32 8.09 22.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -1.179 . . . . 0.0 109.489 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 52.96 31.55 11.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.434 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -73.06 -36.76 66.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.456 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 22.2 p-10 -62.77 -30.66 71.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -79.05 3.84 16.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.6 t70 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 179.795 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.1 tp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.563 ' O ' ' NE2' ' A' ' 23' ' ' GLN . . . 90.42 5.76 69.2 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -128.51 153.68 46.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -1.181 . . . . 0.0 109.464 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 16.2 p90 -143.88 146.68 35.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.89 . . . . 0.0 109.481 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.87 145.19 55.76 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.767 2.311 . . . . 0.0 112.239 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.28 -25.42 68.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 109.514 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.22 -99.83 0.21 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.2 10.23 34.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -1.114 . . . . 0.0 109.354 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 mt -107.63 136.54 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.472 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 18' ' ' THR . 0.3 OUTLIER -74.58 62.45 1.03 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.45 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -142.9 132.17 23.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.91 . . . . 0.0 109.412 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.96 143.26 46.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 109.124 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -138.76 149.36 61.83 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.361 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.88 154.73 73.58 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.755 2.303 . . . . 0.0 112.229 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.746 ' H ' ' NE2' ' A' ' 23' ' ' GLN . 3.0 mp0 -57.01 -22.33 37.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.5 mt -53.99 -35.81 62.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.558 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 28.8 mt -91.12 16.24 10.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.551 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.424 ' CD2' ' HG ' ' A' ' 27' ' ' CYS . 84.7 t60 -85.14 124.27 31.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.885 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.424 ' HG ' ' CD2' ' A' ' 26' ' ' HIS . 80.3 m 50.83 87.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.7 p30 -144.39 3.17 1.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.04 15.38 80.65 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 t -124.34 134.97 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -1.166 . . . . 0.0 109.44 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -91.05 102.65 15.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.542 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.96 -53.31 3.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.488 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.9 m -57.5 -21.24 36.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.13 -43.73 2.22 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.522 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.1 p-10 -88.55 6.66 36.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -1.133 . . . . 0.0 109.5 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 52.21 34.05 13.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.452 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.522 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -72.14 -39.1 69.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.49 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.86 -31.47 72.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -78.67 -28.66 45.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.28 -0.888 . . . . 0.0 109.417 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 59.2 t0 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 -179.608 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.07 2.62 66.21 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -121.56 149.95 42.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -1.156 . . . . 0.0 109.467 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -138.55 146.19 49.74 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.863 . . . . 0.0 109.478 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.18 144.34 41.72 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.745 2.297 . . . . 0.0 112.262 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.2 m -63.54 -30.84 71.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.19 -108.23 0.38 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -86.24 6.52 29.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -1.11 . . . . 0.0 109.475 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.5 mt -98.8 139.87 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 109.43 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.6 m -80.48 90.37 5.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 0.0 109.44 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -172.28 167.11 5.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.504 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.15 142.94 30.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 108.939 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 21' ' ' LEU . 97.2 mt -136.21 149.06 66.91 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.378 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.41 153.47 76.74 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.688 2.258 . . . . 0.0 112.247 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -56.99 -22.67 40.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.462 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -56.23 -35.0 66.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 0.0 109.476 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.4 mt -93.65 13.45 22.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.514 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -83.32 115.86 22.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.434 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m 51.39 34.82 12.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.422 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.405 HD21 ' HB ' ' A' ' 30' ' ' VAL . 39.9 p-10 -89.54 6.23 41.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.46 56.67 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.405 ' HB ' HD21 ' A' ' 28' ' ' ASN . 39.5 t -134.54 138.09 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -1.163 . . . . 0.0 109.529 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -80.45 122.33 26.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -145.33 -52.99 0.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.493 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 67.6 m -58.48 -23.79 58.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.95 -52.43 2.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.472 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 50.7 p-10 -88.01 10.11 20.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -1.137 . . . . 0.0 109.45 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 53.69 32.96 15.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.412 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.472 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -72.19 -38.17 69.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 109.507 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.0 p-10 -65.66 -30.74 71.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 0.0 109.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 72.0 mm-40 -80.13 10.6 4.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.488 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.186 -0.946 . . . . 0.0 109.427 179.774 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 -3.03 68.07 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.461 ' N ' ' CD1' ' A' ' 11' ' ' TYR . 26.0 m-85 -116.13 135.5 53.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -1.163 . . . . 0.0 109.431 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -113.84 146.68 36.08 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.463 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.82 138.08 28.19 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.837 2.358 . . . . 0.0 112.182 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.4 m -65.16 -11.38 39.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.98 -124.1 2.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -82.93 11.4 6.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.274 -1.133 . . . . 0.0 109.447 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.574 ' CD1' HD21 ' A' ' 35' ' ' ASN . 10.9 mt -100.2 140.42 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.429 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.8 m -77.28 79.13 3.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.467 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.551 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 34.9 tttm -170.03 122.09 0.68 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.5 m -112.86 151.38 30.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 108.619 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.551 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 76.1 mt -138.97 151.34 67.94 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.41 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -46.66 146.5 5.36 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.706 2.27 . . . . 0.0 112.255 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -59.33 -27.65 66.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.568 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.77 -36.14 73.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.536 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 mt -84.4 11.05 9.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.505 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -80.27 120.67 24.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.444 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.9 m 47.11 38.24 6.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -90.74 6.19 45.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.29 32.38 58.16 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.07 137.23 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.181 -1.188 . . . . 0.0 109.479 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 26.8 p30 -82.85 108.87 16.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.467 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 1.2 p30 -132.91 -43.21 0.89 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.441 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.555 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 59.8 m -53.91 -24.62 16.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 109.31 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.73 -2.63 32.11 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.574 HD21 ' CD1' ' A' ' 17' ' ' ILE . 2.1 p30 -149.37 -92.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -1.144 . . . . 0.0 109.47 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -176.85 22.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.411 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.73 76.19 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.15 -0.969 . . . . 0.0 109.519 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 25.0 p-10 -67.53 -30.64 70.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.438 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 73.3 mm-40 -87.56 15.95 6.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 109.446 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 39' ' ' GLU . 51.2 p30 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.37 0.61 67.31 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -118.99 147.36 44.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -1.123 . . . . 0.0 109.493 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.512 ' CD1' ' OE1' ' A' ' 23' ' ' GLN . 14.5 p90 -132.96 146.44 61.29 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.24 -0.912 . . . . 0.0 109.472 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.24 143.8 44.75 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.782 2.321 . . . . 0.0 112.248 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.5 m -67.45 -21.73 65.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.11 -114.77 0.73 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -84.96 9.47 14.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -1.157 . . . . 0.0 109.423 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 mt -100.16 136.38 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 m -75.59 62.8 1.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -143.42 140.74 30.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -127.34 143.29 51.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 108.756 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 21' ' ' LEU . 98.3 mt -138.51 149.9 64.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.422 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.07 154.3 71.22 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.819 2.346 . . . . 0.0 112.174 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.512 ' OE1' ' CD1' ' A' ' 12' ' ' PHE . 15.0 mm100 -57.23 -20.81 29.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.465 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.8 mt -56.69 -36.1 69.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.481 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.22 12.52 22.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.461 ' CD2' ' HG ' ' A' ' 27' ' ' CYS . 81.6 t60 -80.95 118.43 22.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.975 . . . . 0.0 109.459 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HG ' ' CD2' ' A' ' 26' ' ' HIS . 60.9 m 51.45 39.14 23.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -89.27 4.52 48.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.511 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.84 26.78 68.33 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.13 135.74 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -1.139 . . . . 0.0 109.521 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -77.42 129.32 35.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.49 -51.77 0.3 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 109.422 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.501 ' SG ' ' OD1' ' A' ' 38' ' ' ASP . 87.7 m -52.08 -20.85 2.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.222 -0.924 . . . . 0.0 109.366 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.36 -2.73 34.78 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -149.46 -92.17 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -1.131 . . . . 0.0 109.525 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -176.1 22.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.12 82.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.469 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 1.1 p-10 -66.35 -30.13 70.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -82.07 11.14 5.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.45 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 40' ' ' ASP . 51.7 p30 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 mt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.7 -6.68 74.05 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -120.5 149.17 42.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -1.15 . . . . 0.0 109.418 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.38 146.43 48.49 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.393 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.14 142.98 39.06 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.789 2.326 . . . . 0.0 112.19 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.3 m -62.35 -28.34 69.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.434 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.69 -110.98 0.49 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -85.64 7.86 21.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.197 -1.178 . . . . 0.0 109.435 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.5 mt -99.46 139.22 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.494 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -79.74 91.31 5.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -171.27 167.36 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 109.44 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -143.75 143.41 31.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 108.801 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.7 mt -136.85 148.98 65.36 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.361 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.65 155.07 72.13 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.804 2.336 . . . . 0.0 112.182 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -57.12 -22.06 37.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.7 mp -54.89 -37.98 66.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.5 mt -88.34 14.93 8.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.484 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -76.96 104.72 7.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.455 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 m 49.96 45.36 25.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -92.06 6.48 46.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.97 29.15 55.07 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.3 t -130.83 138.81 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -1.187 . . . . 0.0 109.556 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -80.59 127.73 32.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.452 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.438 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -148.49 -53.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.456 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 50.9 m -58.8 -22.05 57.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.94 -58.98 3.23 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.5 p-10 -81.48 11.19 4.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -1.158 . . . . 0.0 109.446 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 53.76 35.18 20.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.508 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -71.7 -40.71 69.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.488 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 18.0 p-10 -63.56 -30.69 71.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.531 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -82.86 10.56 7.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.473 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 47.9 t0 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.452 -179.61 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.92 4.87 66.75 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -137.18 156.32 48.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -1.151 . . . . 0.0 109.49 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.414 ' HB3' HE22 ' A' ' 23' ' ' GLN . 22.8 p90 -143.39 147.19 39.01 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.476 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.82 139.83 34.21 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.845 2.363 . . . . 0.0 112.23 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.7 m -64.87 -20.91 66.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.9 -114.26 0.84 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -83.0 5.89 20.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -1.088 . . . . 0.0 109.419 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.0 mm -91.68 154.55 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.497 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.3 p -94.3 65.33 3.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG2' ' HZ2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -154.73 165.19 37.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.486 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -143.98 147.44 33.9 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 21' ' ' LEU . 98.1 mt -136.21 149.87 69.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.451 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.49 152.54 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.793 2.329 . . . . 0.0 112.162 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.414 HE22 ' HB3' ' A' ' 12' ' ' PHE . 83.4 mm-40 -62.13 -26.86 68.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 mt -56.91 -35.34 68.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.53 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.9 mt -89.26 11.63 18.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -79.36 115.92 19.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.93 . . . . 0.0 109.483 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.3 m 46.31 39.77 6.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 109.519 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.408 HD21 ' HB ' ' A' ' 30' ' ' VAL . 41.0 p-10 -91.95 7.91 39.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.09 36.7 64.13 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.408 ' HB ' HD21 ' A' ' 28' ' ' ASN . 47.3 t -132.29 137.32 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -1.149 . . . . 0.0 109.486 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -78.32 123.54 27.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -148.27 -54.69 0.2 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.483 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.3 m -59.03 -25.17 63.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.602 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.01 -46.57 1.87 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -87.09 5.64 36.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 109.475 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 52.43 28.25 5.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.347 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.12 -37.64 75.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 17.6 p-10 -64.73 -31.08 72.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 77.5 mm-40 -87.66 20.52 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.442 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.8 t0 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.951 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.9 mt . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.53 4.49 83.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -142.24 156.35 45.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.151 . . . . 0.0 109.466 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.53 146.01 49.02 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.8 143.19 29.48 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.853 2.369 . . . . 0.0 112.2 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.2 m -69.1 -21.06 64.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.905 . . . . 0.0 109.537 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.48 -116.42 0.87 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -88.64 11.08 18.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -1.135 . . . . 0.0 109.469 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 mt -100.83 141.66 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.708 ' O ' HG23 ' A' ' 18' ' ' THR . 7.2 t -77.01 86.61 3.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 29.4 tttm -170.31 151.69 3.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.6 m -142.49 144.75 33.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 108.799 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.423 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 84.5 mt -135.04 150.3 72.7 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.471 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.2 146.12 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.841 2.361 . . . . 0.0 112.128 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -58.71 -26.59 64.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.481 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.0 mt -57.45 -36.12 70.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.7 mt -86.3 14.38 6.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.183 -0.948 . . . . 0.0 109.525 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -90.26 123.13 33.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.406 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 98.6 m 50.91 34.27 10.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.481 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.422 HD21 ' HB ' ' A' ' 30' ' ' VAL . 46.0 p-10 -92.42 7.23 43.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.469 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.55 34.8 63.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.422 ' HB ' HD21 ' A' ' 28' ' ' ASN . 39.0 t -132.03 141.58 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -1.182 . . . . 0.0 109.452 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -85.25 117.91 24.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.288 -0.883 . . . . 0.0 109.497 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -142.4 -52.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.469 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 20.2 m -55.78 -35.62 66.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.041 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.13 -39.95 2.58 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -88.96 2.93 53.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.159 . . . . 0.0 109.532 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 59.51 18.39 6.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.877 . . . . 0.0 109.385 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.34 -31.91 60.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.498 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 32' ' ' ASP . 27.1 p-10 -62.56 -31.59 72.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.497 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.437 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 65.4 mm-40 -87.75 16.57 5.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 40' ' ' ASP . 49.7 p30 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.477 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.402 ' O ' ' CD2' ' A' ' 11' ' ' TYR . 37.3 mt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.07 4.89 81.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 9' ' ' LEU . 25.0 m-85 -138.2 156.79 47.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -1.18 . . . . 0.0 109.471 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -136.73 146.28 54.62 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.409 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.92 145.27 35.74 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.843 2.362 . . . . 0.0 112.242 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.6 m -70.36 -20.11 62.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.508 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.41 -118.63 1.03 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -87.6 11.69 14.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -1.172 . . . . 0.0 109.449 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.64 139.17 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.8 p -74.11 90.06 2.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.539 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.679 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 31.5 tttm -171.24 149.54 2.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.439 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.4 m -140.81 143.91 35.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 108.74 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.679 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 91.8 mt -137.82 150.92 69.34 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.362 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -47.12 143.99 9.47 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.797 2.331 . . . . 0.0 112.292 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.22 -21.91 49.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 mt -59.99 -35.33 74.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.4 mt -85.77 7.68 22.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.456 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -78.15 108.81 11.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.428 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 38' ' ' ASP . 51.9 m 51.82 50.33 18.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.43 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.638 HD21 HG12 ' A' ' 30' ' ' VAL . 17.2 p-10 -95.2 -39.97 9.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.449 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.06 29.72 0.29 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.638 HG12 HD21 ' A' ' 28' ' ' ASN . 8.4 p -144.07 143.46 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -1.161 . . . . 0.0 109.406 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -84.93 103.61 14.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.52 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.446 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -114.22 -51.24 2.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.48 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.407 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 57.8 m -54.44 -30.76 53.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.59 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.77 -44.89 2.53 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.5 p30 -86.2 10.1 15.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -1.15 . . . . 0.0 109.494 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 52.86 23.79 2.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.427 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -72.93 -37.72 67.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.522 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 21.3 p-10 -64.38 -30.98 72.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.52 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -85.9 10.42 13.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 59.3 t0 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 109.436 -179.89 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 tp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.89 -0.44 67.11 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -115.94 152.62 33.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.507 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -136.99 146.27 54.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.472 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.44 144.09 49.4 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.788 2.325 . . . . 0.0 112.222 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.5 m -65.81 -21.41 66.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.53 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.86 -110.96 0.6 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -84.78 9.69 13.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -1.139 . . . . 0.0 109.403 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 mm -97.98 141.01 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 109.423 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 18' ' ' THR . 1.5 t -81.73 59.06 4.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.511 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -146.44 148.17 32.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.406 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.05 145.49 50.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 108.938 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 21' ' ' LEU . 98.2 mt -137.5 149.56 65.62 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.77 155.69 65.89 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.821 2.347 . . . . 0.0 112.236 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -56.74 -25.34 54.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.573 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.4 tp -51.0 -39.4 55.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -89.05 19.61 4.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.527 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -79.52 112.48 16.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -0.942 . . . . 0.0 109.454 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.4 m 47.19 45.52 16.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.439 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -87.04 4.22 42.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.16 10.2 80.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.21 134.39 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.42 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -86.2 103.32 14.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 0.0 109.459 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -103.32 -53.64 2.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.445 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 63.1 m -57.44 -25.95 60.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.46 -33.11 5.49 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.5 p-10 -89.93 5.03 48.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -1.162 . . . . 0.0 109.469 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 52.08 26.01 3.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.88 . . . . 0.0 109.402 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.509 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -72.48 -34.21 67.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.187 -0.946 . . . . 0.0 109.519 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 8.7 p30 -65.19 -30.7 71.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -81.67 11.93 4.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.496 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.872 . . . . 0.0 109.54 179.842 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.2 mt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.98 6.86 66.57 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -132.31 156.43 46.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -1.134 . . . . 0.0 109.447 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -141.52 146.75 43.25 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.509 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.64 140.42 39.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.708 2.272 . . . . 0.0 112.289 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.7 m -61.58 -41.48 97.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.479 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.58 108.53 0.61 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 54.7 19.59 2.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -1.129 . . . . 0.0 109.438 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mm -124.13 138.47 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.878 . . . . 0.0 109.439 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 m -74.87 52.13 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.875 . . . . 0.0 109.478 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.684 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 37.2 tttm -140.98 142.76 34.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.431 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -132.18 148.63 52.48 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.684 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 86.9 mt -139.59 149.8 61.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.376 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.58 144.48 3.25 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.783 2.322 . . . . 0.0 112.19 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.47 -24.58 60.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.472 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.6 mp -58.96 -36.1 74.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.7 mt -84.92 11.98 8.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -81.51 118.71 22.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.948 . . . . 0.0 109.445 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.4 m 50.34 34.51 9.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.424 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.426 HD21 ' HB ' ' A' ' 30' ' ' VAL . 42.9 p-10 -88.99 6.76 38.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.82 38.32 65.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.426 ' HB ' HD21 ' A' ' 28' ' ' ASN . 48.0 t -133.75 136.37 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.9 p-10 -83.97 103.01 12.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.411 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -122.28 -51.94 1.96 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.259 -0.901 . . . . 0.0 109.475 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 76.2 m -58.73 -25.07 62.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 0.0 109.251 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.74 -43.18 2.47 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 50.5 p30 -87.91 6.25 36.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.467 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 52.26 33.66 13.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.463 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -75.22 -38.13 60.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 109.496 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 15.5 p30 -65.59 -31.07 71.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.519 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -81.22 0.99 34.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 109.474 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.856 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.2 mt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.91 4.07 69.79 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -130.18 156.58 44.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -1.145 . . . . 0.0 109.457 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -140.08 146.65 47.31 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.449 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.34 142.57 37.47 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.748 2.299 . . . . 0.0 112.262 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.1 m -66.96 -20.85 65.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.515 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.13 -112.51 0.69 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -85.63 9.34 16.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -1.111 . . . . 0.0 109.393 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 mt -102.84 140.5 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.872 . . . . 0.0 109.429 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -78.58 58.96 2.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.921 . . . . 0.0 109.495 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -139.1 140.13 37.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 109.437 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.67 145.9 51.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.5 mt -138.93 150.41 65.22 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.361 -0.837 . . . . 0.0 109.391 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.04 152.69 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.796 2.331 . . . . 0.0 112.199 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -61.69 -28.42 69.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.6 mt -55.05 -36.19 65.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.434 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.5 mt -88.67 15.49 8.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.955 . . . . 0.0 109.488 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -82.57 114.72 21.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.408 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.0 m 47.26 38.81 7.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.443 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.402 HD21 ' HB ' ' A' ' 30' ' ' VAL . 44.8 p-10 -89.83 8.26 32.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.905 . . . . 0.0 109.497 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.96 31.14 62.33 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.402 ' HB ' HD21 ' A' ' 28' ' ' ASN . 45.5 t -127.38 138.59 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 36.1 p-10 -83.24 115.15 21.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -139.29 -51.22 0.53 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.46 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 66.6 m -56.94 -39.26 74.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.905 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 36' ' ' GLN . . . 134.76 -72.96 0.46 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -86.93 20.96 2.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -1.125 . . . . 0.0 109.463 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 34' ' ' GLY . 27.2 mp0 53.9 40.66 31.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.28 77.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.882 . . . . 0.0 109.449 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 9.0 p30 -63.57 -31.27 72.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.0 OUTLIER -82.11 10.19 7.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.503 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.7 p30 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.472 179.844 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.661 ' N ' HD12 ' A' ' 9' ' ' LEU . 8.6 mp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.34 -7.53 77.98 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.26 151.98 41.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -1.158 . . . . 0.0 109.459 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 13.5 p90 -142.22 125.29 9.42 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.2 141.09 13.72 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.832 2.355 . . . . 0.0 112.17 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.1 m -64.76 -22.75 67.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 0.0 109.494 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.01 -113.88 0.66 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -84.46 8.47 16.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -1.112 . . . . 0.0 109.484 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.9 mt -98.82 140.36 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 109.504 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 p -78.89 57.9 2.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.699 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 28.5 tttm -142.49 142.75 32.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -126.7 144.49 50.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 108.983 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.699 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 99.0 mt -137.23 149.78 66.99 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.413 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.79 155.63 68.27 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.795 2.33 . . . . 0.0 112.257 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -57.67 -20.24 32.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.479 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.3 tp -56.27 -36.65 68.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.488 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.4 mt -91.2 10.2 28.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.819 . . . . 0.0 109.524 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -74.25 104.25 4.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.413 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.7 m 52.11 50.21 18.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.639 HD21 HG12 ' A' ' 30' ' ' VAL . 15.5 p-10 -91.16 -35.42 14.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.421 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.13 26.76 0.67 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.639 HG12 HD21 ' A' ' 28' ' ' ASN . 8.5 p -144.73 142.75 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.472 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -85.73 103.59 14.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -112.32 -52.37 2.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.866 . . . . 0.0 109.475 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.446 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 37.2 m -48.68 -45.03 38.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.64 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.07 -59.73 0.66 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.513 ' CG ' ' H ' ' A' ' 36' ' ' GLN . 5.9 p30 -90.25 -89.49 0.16 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 109.478 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.513 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -173.17 23.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.882 . . . . 0.0 109.389 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.71 -47.58 80.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.2 p-10 -65.71 -30.43 71.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.415 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -85.2 21.61 1.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 54.2 p30 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.418 -179.919 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.5 mt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.76 2.44 84.4 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -142.31 156.91 45.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.385 -1.067 . . . . 0.0 109.441 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -141.24 146.99 45.18 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.09 143.54 28.9 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.818 2.345 . . . . 0.0 112.216 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.7 m -69.45 -14.79 63.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.499 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.03 -118.45 1.55 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -83.47 9.77 10.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -1.152 . . . . 0.0 109.442 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 mm -94.71 141.3 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.487 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.6 m -81.48 87.98 6.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 33' ' ' CYS . 14.9 ptpt -173.14 168.14 4.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.5 m -148.82 142.98 26.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.93 150.12 70.54 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.489 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.18 145.44 5.51 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.76 2.306 . . . . 0.0 112.219 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.22 -27.12 65.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.51 -34.98 73.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 109.558 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.35 9.67 14.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 109.528 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -78.92 119.65 22.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.3 m 46.83 39.32 7.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.431 ' ND2' ' CG2' ' A' ' 30' ' ' VAL . 41.0 p-10 -93.05 5.63 50.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.62 33.83 55.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.431 ' CG2' ' ND2' ' A' ' 28' ' ' ASN . 59.7 t -127.74 136.19 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -1.137 . . . . 0.0 109.469 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 35.1 p-10 -81.73 103.57 11.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.94 . . . . 0.0 109.524 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -127.86 -49.74 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.518 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 86.0 m -59.54 -27.17 65.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.951 . . . . 0.0 109.598 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.72 -44.85 2.37 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.461 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 49.5 p-10 -87.04 6.23 33.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -1.174 . . . . 0.0 109.472 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 52.14 28.14 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.874 . . . . 0.0 109.41 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -73.91 -38.19 64.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.475 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 20.6 p-10 -64.45 -31.1 72.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 75.1 mm-40 -84.87 13.33 6.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.903 . . . . 0.0 109.438 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 51.4 p30 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.2 mt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.7 -4.21 86.41 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -127.02 153.68 45.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.144 . . . . 0.0 109.49 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -143.53 147.28 38.94 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.23 143.28 48.08 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.808 2.339 . . . . 0.0 112.21 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.46 -24.44 64.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.37 -110.32 0.54 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -84.73 6.91 22.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -1.147 . . . . 0.0 109.482 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.2 mt -102.35 137.67 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.6 p -78.1 62.63 2.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -144.93 145.47 31.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.409 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.13 146.06 51.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 108.844 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 21' ' ' LEU . 71.3 mt -140.53 152.46 66.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 109.38 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -52.73 149.76 24.19 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.783 2.322 . . . . 0.0 112.224 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -60.56 -25.61 66.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.626 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.7 mp -60.06 -34.33 73.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.565 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.553 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 31.1 mt -85.72 9.9 15.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 109.558 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -91.13 131.41 36.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.397 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.0 m 51.71 79.68 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.432 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.553 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 12.5 p30 -143.28 -3.77 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.413 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.63 3.24 89.74 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.94 140.37 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -1.142 . . . . 0.0 109.48 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -89.0 125.43 34.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.477 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.443 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -138.16 -51.8 0.6 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.4 m -53.9 -41.2 67.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.935 . . . . 0.0 109.63 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 145.37 -27.01 1.84 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.532 ' CG ' ' H ' ' A' ' 36' ' ' GLN . 1.2 p30 -136.22 -99.66 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -1.162 . . . . 0.0 109.481 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.532 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 72.7 mt-30 -155.93 15.36 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.391 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.99 91.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.489 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 33.3 p-10 -63.63 -31.54 72.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.901 . . . . 0.0 109.548 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 64.6 mm-40 -76.15 -54.64 6.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.462 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.427 ' O ' ' O ' ' A' ' 39' ' ' GLU . 43.2 t0 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.477 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.423 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.77 -0.11 69.71 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -130.56 156.02 45.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -1.179 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -148.56 146.59 22.8 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.394 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.529 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 57.4 Cg_endo -73.84 148.56 41.17 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.786 2.324 . . . . 0.0 112.197 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.755 ' HB3' HD22 ' A' ' 35' ' ' ASN . 1.7 m -84.61 -7.04 59.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.591 ' C ' ' H ' ' A' ' 17' ' ' ILE . . . 88.77 132.27 4.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m120 68.01 -25.95 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -1.109 . . . . 0.0 109.447 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.591 ' H ' ' C ' ' A' ' 15' ' ' GLY . 24.1 mm -104.37 130.12 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.479 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 18' ' ' THR . 0.6 OUTLIER -80.24 57.66 2.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.504 179.695 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.645 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 33.5 tttm -146.6 137.03 23.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.47 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 1.6 m -117.17 147.38 42.52 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.645 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 67.6 mt -137.51 151.96 72.07 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.382 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.36 149.3 13.02 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.829 2.352 . . . . 0.0 112.178 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -60.24 -25.43 65.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.534 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.8 tp -58.12 -36.75 73.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.495 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.96 5.53 28.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.519 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -84.34 131.59 34.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.7 m 51.36 26.76 3.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.486 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -84.81 3.51 37.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.01 36.55 81.48 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -133.43 137.01 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.0 109.535 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -82.76 104.1 12.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.517 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.83 -58.66 2.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -0.97 . . . . 0.0 109.467 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.8 m -63.49 -27.55 69.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.3 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.07 -31.35 5.7 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.755 HD22 ' HB3' ' A' ' 14' ' ' CYS . 51.8 p-10 -83.83 4.6 28.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -1.161 . . . . 0.0 109.475 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 48.67 13.69 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.421 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 35' ' ' ASN . . . -64.77 -38.83 92.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 109.488 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 27.9 p-10 -65.81 -30.66 71.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.452 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 81.2 mm-40 -91.24 13.5 17.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 0.0 109.533 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 40' ' ' ASP . 52.0 p30 . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.494 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.64 ' N ' HD12 ' A' ' 9' ' ' LEU . 9.2 mp . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.69 -4.03 81.73 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -127.64 152.39 47.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -1.13 . . . . 0.0 109.524 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -143.68 145.75 32.38 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.417 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.33 143.99 40.33 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.855 2.37 . . . . 0.0 112.186 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.5 m -62.94 -28.36 70.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.511 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.0 -106.82 0.32 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -86.9 8.19 24.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -1.161 . . . . 0.0 109.468 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 mt -102.54 140.93 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 109.424 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.7 m -80.93 63.5 5.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.681 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 26.4 tttm -144.09 131.98 21.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -116.16 143.6 45.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.489 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.681 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 98.0 mt -137.21 149.29 65.5 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 109.407 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.16 155.27 66.02 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.75 2.3 . . . . 0.0 112.189 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -59.21 -22.18 60.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.536 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.3 mp -57.34 -36.07 70.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.408 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 63.0 mt -91.95 3.9 54.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.41 ' NE2' ' SG ' ' A' ' 27' ' ' CYS . 11.8 t-80 -81.56 125.95 31.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 109.367 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' ' NE2' ' A' ' 26' ' ' HIS . 80.3 m 52.7 28.77 6.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.421 HD21 ' HB ' ' A' ' 30' ' ' VAL . 43.5 p-10 -88.34 5.77 40.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 109.447 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.87 42.4 78.75 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 28' ' ' ASN . 40.8 t -138.86 140.25 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -1.151 . . . . 0.0 109.481 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -80.22 121.58 25.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.5 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -144.15 -52.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.437 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.422 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 69.1 m -59.58 -22.34 61.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.367 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.41 -54.84 1.75 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.471 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 49.9 p-10 -89.45 13.82 12.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -1.102 . . . . 0.0 109.485 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 52.76 34.28 15.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.394 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -70.72 -29.84 66.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.474 ' OD2' ' OD1' ' A' ' 32' ' ' ASP . 36.2 p-10 -79.82 -27.92 40.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.514 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 74.1 mm-40 -84.08 -31.44 25.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.494 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 37' ' ' ALA . 53.8 p30 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.902 . . . . 0.0 109.446 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 11' ' ' TYR . 20.1 mt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.323 0.582 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.93 16.45 1.97 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.473 ' H ' ' C ' ' A' ' 9' ' ' LEU . 29.2 m-85 -101.04 139.23 37.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.148 . . . . 0.0 109.451 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -139.74 146.73 48.65 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.43 139.93 42.63 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.809 2.34 . . . . 0.0 112.235 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.1 m -61.53 -33.56 74.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 0.0 109.545 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.0 -104.14 0.26 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -91.18 8.46 35.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -1.183 . . . . 0.0 109.416 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.3 mt -99.86 145.25 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 0.0 109.421 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.8 p -82.18 82.41 7.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.487 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -172.12 165.05 6.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.6 m -145.42 144.2 30.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 108.748 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.82 149.84 71.72 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.349 -0.844 . . . . 0.0 109.428 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.83 155.52 63.33 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.755 2.303 . . . . 0.0 112.186 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -58.23 -23.21 55.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.454 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.636 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.3 tt -53.57 -39.11 64.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.492 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.3 mt -88.8 13.72 11.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.507 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.479 ' CD2' ' HG ' ' A' ' 27' ' ' CYS . 84.8 t60 -77.96 117.1 18.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.479 ' HG ' ' CD2' ' A' ' 26' ' ' HIS . 14.3 m 46.86 40.29 8.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.534 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.4 HD21 ' HB ' ' A' ' 30' ' ' VAL . 51.9 p-10 -89.04 6.48 39.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.22 -0.925 . . . . 0.0 109.464 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.43 32.25 60.06 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.4 ' HB ' HD21 ' A' ' 28' ' ' ASN . 41.4 t -135.2 137.56 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -1.137 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -79.41 127.48 32.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -146.92 -58.53 0.28 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.912 . . . . 0.0 109.441 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 55.6 m -55.87 -25.19 41.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.352 -0.842 . . . . 0.0 109.251 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.06 -48.38 1.59 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.2 p-10 -89.44 7.18 37.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -1.14 . . . . 0.0 109.399 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 52.96 36.31 21.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.407 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -75.02 -24.49 58.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' OD2' ' SG ' ' A' ' 33' ' ' CYS . 0.4 OUTLIER -80.47 -31.19 37.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.478 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -74.45 -37.58 63.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.224 -0.923 . . . . 0.0 109.472 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 37' ' ' ALA . 53.2 p30 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.477 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.614 HD22 ' N ' ' A' ' 9' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.02 1.6 67.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 44.7 m-85 -120.26 155.81 32.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -1.164 . . . . 0.0 109.491 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -141.87 146.1 39.37 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.41 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.64 148.39 53.13 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.811 2.341 . . . . 0.0 112.247 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.717 ' HB3' HD22 ' A' ' 35' ' ' ASN . 18.0 m -88.37 47.23 1.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.6 -154.38 28.29 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -50.34 -26.3 4.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -1.192 . . . . 0.0 109.451 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 mm -54.83 132.11 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 m -84.95 63.09 7.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.162 -0.961 . . . . 0.0 109.445 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -146.14 130.58 17.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -112.72 143.61 43.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 108.877 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.428 HD12 ' SG ' ' A' ' 33' ' ' CYS . 98.6 mt -138.06 149.65 64.56 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.937 . . . . 0.0 109.39 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.05 154.84 71.48 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.809 2.339 . . . . 0.0 112.178 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -57.07 -22.48 39.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.494 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.8 tp -53.73 -37.27 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.6 mt -90.92 16.46 9.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.518 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -84.22 127.37 33.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 97.5 m 49.62 32.57 5.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.409 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 54.1 p30 -83.88 2.17 39.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.378 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.39 25.67 75.27 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t -128.64 138.28 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -1.131 . . . . 0.0 109.51 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.6 p-10 -88.29 101.87 14.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.537 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.43 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -104.58 -58.07 1.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.49 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.428 ' SG ' HD12 ' A' ' 21' ' ' LEU . 61.6 m -62.61 -25.74 68.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.265 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.88 -32.36 6.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.717 HD22 ' HB3' ' A' ' 14' ' ' CYS . 52.9 p-10 -85.2 5.09 31.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -1.18 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 48.85 19.56 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.477 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.497 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -65.87 -37.16 85.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.139 -0.975 . . . . 0.0 109.487 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 11.5 p30 -64.17 -31.84 73.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.493 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -76.76 -30.92 56.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -0.871 . . . . 0.0 109.441 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 -179.731 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.636 ' N ' HD12 ' A' ' 9' ' ' LEU . 9.5 mp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.02 -8.21 80.37 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -131.81 151.57 51.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -145.01 146.84 32.46 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.498 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.12 148.22 55.84 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.822 2.348 . . . . 0.0 112.247 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.593 ' HB3' HD22 ' A' ' 35' ' ' ASN . 1.7 m -82.8 -10.76 58.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.01 -126.96 2.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -80.74 8.14 8.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -1.146 . . . . 0.0 109.486 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 mm -88.01 131.79 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.429 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -76.55 85.02 3.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 -179.573 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -171.96 164.78 6.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 109.449 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -141.4 142.62 33.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 108.57 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.1 148.87 66.43 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.408 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.77 158.19 52.09 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.844 2.363 . . . . 0.0 112.205 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -60.37 -23.03 63.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.3 mp -56.79 -34.76 67.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 -179.448 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.3 mt -94.12 11.24 30.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -85.59 122.17 29.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.427 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.2 m 51.46 31.36 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 109.431 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.421 HD21 ' HB ' ' A' ' 30' ' ' VAL . 48.2 p-10 -86.51 5.98 32.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.49 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.67 39.37 77.76 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 28' ' ' ASN . 45.4 t -140.01 140.28 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.46 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -83.56 125.47 31.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.38 -60.48 0.61 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 0.0 109.451 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.1 m -65.08 -23.28 67.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 0.0 109.211 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.81 -33.7 4.71 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.593 HD22 ' HB3' ' A' ' 14' ' ' CYS . 50.5 p-10 -86.45 3.94 41.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -1.176 . . . . 0.0 109.465 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 48.23 18.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.872 . . . . 0.0 109.439 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' A' ' 35' ' ' ASN . . . -65.51 -36.96 85.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.418 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -28.22 67.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.501 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -83.56 9.3 11.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.498 179.996 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.04 -1.3 80.17 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -121.4 148.29 44.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -1.173 . . . . 0.0 109.509 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -134.98 146.63 59.39 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.421 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.23 144.41 51.45 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.828 2.352 . . . . 0.0 112.199 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.8 m -67.75 -21.2 65.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.443 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.76 -112.6 0.62 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -87.41 10.14 18.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -1.132 . . . . 0.0 109.367 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 mt -102.09 137.75 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 18' ' ' THR . 1.4 t -75.31 59.72 1.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.465 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 2.7 ttmp? -139.46 138.83 36.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.377 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -125.96 143.56 51.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 108.746 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.8 mt -138.29 149.71 64.22 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 109.388 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.56 154.56 64.01 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.738 2.292 . . . . 0.0 112.196 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -56.48 -25.02 49.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.322 -0.861 . . . . 0.0 109.519 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.7 tp -52.99 -37.97 61.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.499 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.5 mt -91.76 19.74 6.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.561 -179.34 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -82.88 114.5 21.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.507 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.1 m 46.93 36.65 4.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.477 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -85.63 8.3 20.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.382 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.75 29.22 63.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.3 t -129.4 139.67 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -1.169 . . . . 0.0 109.509 179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -84.45 122.0 28.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.88 . . . . 0.0 109.503 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -143.78 -47.77 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.455 179.862 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 56.5 m -57.84 -30.11 65.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.729 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.65 0.65 69.16 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 52.0 p30 -140.61 13.18 2.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -1.115 . . . . 0.0 109.439 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 51.94 22.9 1.93 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 109.415 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.451 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -70.76 -37.46 73.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 20.1 p30 -65.6 -30.48 71.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.467 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.2 mp0 -78.71 10.53 3.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.2 p30 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.441 179.95 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.37 1.99 85.62 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -130.95 152.59 50.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -1.117 . . . . 0.0 109.505 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -143.96 146.45 34.28 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.888 . . . . 0.0 109.477 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.71 148.05 58.1 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.814 2.343 . . . . 0.0 112.222 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -63.34 -24.98 68.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.536 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.91 -76.37 0.28 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -119.86 15.01 12.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -1.118 . . . . 0.0 109.413 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.3 mt -111.33 138.03 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.456 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 18' ' ' THR . 0.2 OUTLIER -70.77 59.42 0.22 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.458 179.937 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -141.63 135.3 29.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.5 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -122.8 143.57 49.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.028 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.5 mt -138.0 149.3 63.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.358 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.34 155.08 59.42 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.788 2.325 . . . . 0.0 112.183 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -57.87 -23.97 55.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.57 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -55.14 -37.06 66.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.47 -179.405 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.4 mt -92.09 11.57 24.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 -179.175 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -84.28 123.54 30.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.458 179.704 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 98.1 m 50.86 29.65 4.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.4 HD21 ' HB ' ' A' ' 30' ' ' VAL . 44.9 p-10 -85.78 5.8 30.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.45 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.34 39.21 62.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.4 ' HB ' HD21 ' A' ' 28' ' ' ASN . 42.3 t -136.08 139.31 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -1.157 . . . . 0.0 109.444 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 38.3 p-10 -86.61 103.57 15.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.49 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.435 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -119.78 -53.33 2.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.454 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.428 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 97.1 m -60.14 -26.49 66.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.185 -0.947 . . . . 0.0 109.527 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.19 -42.94 2.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 50.8 p30 -85.29 6.22 27.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -1.169 . . . . 0.0 109.428 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 52.43 27.88 5.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.868 . . . . 0.0 109.401 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -71.32 -37.09 71.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.445 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 12.3 p30 -66.27 -31.09 71.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -88.48 15.87 7.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.54 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.9 t0 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 -179.717 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 mt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.29 -0.09 68.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 31.0 m-85 -121.59 152.84 38.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -1.14 . . . . 0.0 109.458 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -144.6 146.06 30.81 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.296 -0.878 . . . . 0.0 109.482 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.86 145.74 41.12 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.728 2.285 . . . . 0.0 112.214 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -92.42 81.9 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.545 179.611 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.73 -145.23 31.13 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -83.89 10.91 8.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -1.19 . . . . 0.0 109.421 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.7 mt -78.58 138.1 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -82.17 61.58 5.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 109.483 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.622 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 27.5 tttm -143.85 126.17 15.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -112.61 143.02 44.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.622 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 96.7 mt -139.09 149.84 62.72 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.95 154.01 72.58 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.795 2.33 . . . . 0.0 112.241 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -57.07 -21.05 28.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.63 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.2 tt -55.81 -38.47 70.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.461 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.6 mt -89.82 15.06 10.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 0.0 109.535 -179.16 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.505 ' CD2' ' HG ' ' A' ' 27' ' ' CYS . 74.0 t60 -83.12 123.81 29.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.505 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.505 ' HG ' ' CD2' ' A' ' 26' ' ' HIS . 73.6 m 49.08 32.64 4.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.506 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.402 HD21 ' HB ' ' A' ' 30' ' ' VAL . 51.2 p-10 -85.25 5.37 30.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 109.445 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.45 35.0 68.35 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.612 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.402 ' HB ' HD21 ' A' ' 28' ' ' ASN . 39.3 t -133.68 137.28 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -1.184 . . . . 0.0 109.479 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.4 p-10 -84.68 103.47 13.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.486 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.4 OUTLIER -117.77 -57.86 2.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.882 . . . . 0.0 109.47 -179.824 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.494 ' SG ' ' OD2' ' A' ' 38' ' ' ASP . 74.3 m -61.65 -19.69 62.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.512 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.27 -47.52 2.4 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.709 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 53.3 p-10 -82.66 3.36 29.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -1.136 . . . . 0.0 109.502 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 51.19 31.04 6.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.541 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -67.1 -38.78 86.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.496 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.494 ' OD2' ' SG ' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -66.82 -29.95 70.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -78.74 7.82 6.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 40' ' ' ASP . 50.6 p30 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.772 0 N-CA-C 119.424 2.53 . . . . 0.0 119.424 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.8 m -63.86 149.61 46.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -1.154 . . . . 0.0 109.379 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -137.44 155.54 49.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.088 -1.008 . . . . 0.0 109.504 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 52.06 47.27 25.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.491 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 6' ' ' LYS . 7.5 p -110.32 127.38 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.505 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 5' ' ' VAL . 29.4 mmtm 49.81 179.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 109.468 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 70.3 m -112.65 162.73 15.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.639 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.7 m -65.45 174.62 2.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.8 mt -64.98 141.79 58.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.444 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.54 2.76 84.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -141.31 156.61 45.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -140.53 145.78 42.14 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.526 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 57.9 Cg_endo -74.24 146.81 36.58 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.754 2.302 . . . . 0.0 112.252 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.9 m -70.26 -22.8 62.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.87 -116.36 0.82 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -87.58 9.88 19.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -1.13 . . . . 0.0 109.49 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 17' ' ' ILE . 6.2 mt -102.24 138.53 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.0 m -74.03 93.72 2.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.494 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 ttmm -171.76 145.94 2.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.5 m -135.72 142.32 45.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.139 -0.976 . . . . 0.0 109.11 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.2 mt -139.44 149.75 61.39 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.351 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.38 153.82 68.04 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.761 2.307 . . . . 0.0 112.213 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.48 -21.87 40.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.907 . . . . 0.0 109.518 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.3 tt -57.13 -37.4 71.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.498 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.02 5.46 50.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 109.511 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -79.64 121.18 24.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.9 m 52.08 34.01 13.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.427 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.414 HD21 ' HB ' ' A' ' 30' ' ' VAL . 43.9 p-10 -90.53 5.73 46.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.432 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.16 38.23 59.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.414 ' HB ' HD21 ' A' ' 28' ' ' ASN . 25.2 t -136.45 138.96 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -1.153 . . . . 0.0 109.586 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -79.32 123.01 27.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.474 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.9 OUTLIER -145.9 -52.35 0.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 56.6 m -57.07 -27.2 61.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.522 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.36 -50.14 2.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.1 p-10 -86.22 8.72 20.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.447 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 53.41 33.34 15.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.398 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -75.33 -40.89 57.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.6 p-10 -64.1 -31.71 73.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 78.2 mm-40 -93.3 17.18 11.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 41' ' ' ASN . 60.2 t0 -81.97 112.42 19.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.91 . . . . 0.0 109.483 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.527 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 6.5 p-10 40.49 57.06 2.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 38' ' ' ASP . 1.7 m -58.71 -32.37 69.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.184 -0.948 . . . . 0.0 109.453 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.598 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.528 4.815 0 N-CA-C 119.422 2.529 . . . . 0.0 119.422 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 1' ' ' GLY . 44.2 t 48.49 93.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -1.183 . . . . 0.0 109.432 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 46.29 -114.9 0.53 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.47 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 59.5 t0 52.39 -122.22 1.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 109.523 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.542 HG22 ' H ' ' A' ' 7' ' ' CYS . 7.8 p -135.88 145.6 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -82.18 7.53 13.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.542 ' H ' HG22 ' A' ' 5' ' ' VAL . 19.2 m -99.19 134.28 42.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.064 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.5 m -78.33 -175.21 4.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.509 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.62 HD22 ' N ' ' A' ' 9' ' ' LEU . 3.7 mm? -74.36 143.54 44.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.432 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.67 3.84 66.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 11' ' ' TYR . 32.0 m-85 -127.64 156.51 42.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -1.151 . . . . 0.0 109.451 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -141.98 145.83 37.87 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.431 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.34 145.17 37.96 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.821 2.348 . . . . 0.0 112.24 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.0 -23.79 65.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.496 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.36 -109.8 0.49 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.74 8.41 22.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -1.136 . . . . 0.0 109.526 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 mt -103.85 138.66 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.433 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.31 60.61 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -139.06 130.12 26.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.28 -0.887 . . . . 0.0 109.515 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -121.29 143.81 48.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 108.503 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.6 mt -138.93 150.93 67.06 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.8 147.84 2.95 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.784 2.323 . . . . 0.0 112.22 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -59.72 -24.75 64.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.585 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -55.79 -38.16 69.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.474 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.2 mt -85.1 12.93 6.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -81.8 114.07 20.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.481 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m 50.86 40.49 25.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.486 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -93.15 6.86 46.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.35 33.37 58.92 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.2 t -131.87 137.62 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -1.147 . . . . 0.0 109.487 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -78.9 124.07 27.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.449 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.463 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -146.93 -54.26 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.964 . . . . 0.0 109.393 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.5 m -59.0 -23.65 62.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.631 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.01 -52.22 1.91 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 52.1 p-10 -86.32 8.09 22.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -1.179 . . . . 0.0 109.489 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 52.96 31.55 11.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.434 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -73.06 -36.76 66.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.456 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 22.2 p-10 -62.77 -30.66 71.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -79.05 3.84 16.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.462 ' O ' ' C ' ' A' ' 41' ' ' ASN . 21.6 t70 -65.64 157.32 30.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.531 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 4.3 p-10 41.84 45.76 3.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.478 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.0 m -150.79 -3.11 0.34 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.475 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.965 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 5' ' ' VAL . . . . . . . . 1 N--CA 1.529 4.857 0 N-CA-C 119.406 2.522 . . . . 0.0 119.406 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.2 p -60.98 -41.11 95.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -1.122 . . . . 0.0 109.552 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.496 ' CG ' ' N ' ' A' ' 4' ' ' ASP . 12.7 pt20 -172.34 -52.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.41 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.496 ' N ' ' CG ' ' A' ' 3' ' ' GLN . 94.1 m-20 -140.04 7.91 2.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.433 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 1' ' ' GLY . 46.5 t -97.27 137.89 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 109.486 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -136.03 130.19 33.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.45 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.0 m -124.66 166.47 16.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.309 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.7 m -56.54 163.34 1.82 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.905 . . . . 0.0 109.479 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.1 tp -68.95 139.71 55.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.526 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.563 ' O ' ' NE2' ' A' ' 23' ' ' GLN . . . 90.42 5.76 69.2 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -128.51 153.68 46.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -1.181 . . . . 0.0 109.464 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 16.2 p90 -143.88 146.68 35.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.89 . . . . 0.0 109.481 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.87 145.19 55.76 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.767 2.311 . . . . 0.0 112.239 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.28 -25.42 68.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 109.514 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.22 -99.83 0.21 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.2 10.23 34.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -1.114 . . . . 0.0 109.354 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 mt -107.63 136.54 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.472 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 18' ' ' THR . 0.3 OUTLIER -74.58 62.45 1.03 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.45 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -142.9 132.17 23.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.91 . . . . 0.0 109.412 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.96 143.26 46.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 109.124 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -138.76 149.36 61.83 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.361 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.88 154.73 73.58 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.755 2.303 . . . . 0.0 112.229 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.746 ' H ' ' NE2' ' A' ' 23' ' ' GLN . 3.0 mp0 -57.01 -22.33 37.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.5 mt -53.99 -35.81 62.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.558 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 28.8 mt -91.12 16.24 10.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.551 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.596 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.9 t-80 -85.14 124.27 31.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.885 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.596 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 80.3 m 50.83 87.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.7 p30 -144.39 3.17 1.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.04 15.38 80.65 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 t -124.34 134.97 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -1.166 . . . . 0.0 109.44 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -91.05 102.65 15.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.542 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.96 -53.31 3.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.488 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.9 m -57.5 -21.24 36.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.13 -43.73 2.22 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.522 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.1 p-10 -88.55 6.66 36.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -1.133 . . . . 0.0 109.5 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 52.21 34.05 13.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.452 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.522 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -72.14 -39.1 69.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.49 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 1.0 OUTLIER -64.86 -31.47 72.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -78.67 -28.66 45.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.28 -0.888 . . . . 0.0 109.417 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -81.75 49.17 1.3 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 37' ' ' ALA . 2.6 p-10 -172.15 22.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.479 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 87.6 m -69.4 -22.07 63.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.94 . . . . 0.0 109.454 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 CA-C-O 117.973 -1.46 . . . . 0.0 109.54 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.528 4.796 0 N-CA-C 119.453 2.541 . . . . 0.0 119.453 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 1' ' ' GLY . 20.1 m 50.46 -178.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -1.161 . . . . 0.0 109.452 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 52.68 45.34 28.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.475 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -86.92 120.44 28.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.494 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -123.87 136.2 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.553 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -139.21 151.61 46.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 68.1 m -113.14 161.99 16.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.259 -0.901 . . . . 0.0 109.376 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.8 m -57.93 165.61 1.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.471 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.7 tp -71.71 142.01 49.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.07 2.62 66.21 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -121.56 149.95 42.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -1.156 . . . . 0.0 109.467 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -138.55 146.19 49.74 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.863 . . . . 0.0 109.478 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.18 144.34 41.72 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.745 2.297 . . . . 0.0 112.262 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.2 m -63.54 -30.84 71.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.19 -108.23 0.38 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -86.24 6.52 29.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -1.11 . . . . 0.0 109.475 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.5 mt -98.8 139.87 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 109.43 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.6 m -80.48 90.37 5.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 0.0 109.44 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -172.28 167.11 5.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.504 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.15 142.94 30.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 108.939 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 21' ' ' LEU . 97.2 mt -136.21 149.06 66.91 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.378 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.41 153.47 76.74 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.688 2.258 . . . . 0.0 112.247 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -56.99 -22.67 40.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.462 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -56.23 -35.0 66.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 0.0 109.476 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.4 mt -93.65 13.45 22.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.514 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -83.32 115.86 22.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.434 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m 51.39 34.82 12.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.422 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.405 HD21 ' HB ' ' A' ' 30' ' ' VAL . 39.9 p-10 -89.54 6.23 41.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.46 56.67 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.405 ' HB ' HD21 ' A' ' 28' ' ' ASN . 39.5 t -134.54 138.09 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -1.163 . . . . 0.0 109.529 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -80.45 122.33 26.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -145.33 -52.99 0.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.493 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 67.6 m -58.48 -23.79 58.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.95 -52.43 2.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.472 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 50.7 p-10 -88.01 10.11 20.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -1.137 . . . . 0.0 109.45 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 53.69 32.96 15.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.412 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.472 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -72.19 -38.17 69.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 109.507 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.0 p-10 -65.66 -30.74 71.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 0.0 109.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 72.0 mm-40 -80.13 10.6 4.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.488 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 23.4 t70 -60.1 144.14 50.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.186 -0.946 . . . . 0.0 109.427 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 40' ' ' ASP . 9.5 p30 42.73 42.61 3.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.1 m -144.45 -32.41 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 CA-C-O 118.004 -1.442 . . . . 0.0 109.544 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.852 0 N-CA-C 119.385 2.514 . . . . 0.0 119.385 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -57.87 -37.22 73.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -1.141 . . . . 0.0 109.53 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -149.2 159.67 44.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 109.46 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -165.0 161.25 19.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.495 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.2 m -98.89 135.34 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.492 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -142.17 126.21 17.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.5 m -142.24 143.61 32.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 108.67 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.5 m -66.47 176.3 1.92 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.427 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp -75.88 143.2 41.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.469 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 -3.03 68.07 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.461 ' N ' ' CD1' ' A' ' 11' ' ' TYR . 26.0 m-85 -116.13 135.5 53.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -1.163 . . . . 0.0 109.431 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -113.84 146.68 36.08 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.463 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.82 138.08 28.19 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.837 2.358 . . . . 0.0 112.182 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.4 m -65.16 -11.38 39.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.98 -124.1 2.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -82.93 11.4 6.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.274 -1.133 . . . . 0.0 109.447 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.574 ' CD1' HD21 ' A' ' 35' ' ' ASN . 10.9 mt -100.2 140.42 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.429 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.8 m -77.28 79.13 3.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.467 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.551 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 34.9 tttm -170.03 122.09 0.68 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.5 m -112.86 151.38 30.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 108.619 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.551 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 76.1 mt -138.97 151.34 67.94 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.41 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -46.66 146.5 5.36 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.706 2.27 . . . . 0.0 112.255 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -59.33 -27.65 66.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.568 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.77 -36.14 73.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.536 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 mt -84.4 11.05 9.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.505 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -80.27 120.67 24.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.444 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.9 m 47.11 38.24 6.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -90.74 6.19 45.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.29 32.38 58.16 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.07 137.23 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.181 -1.188 . . . . 0.0 109.479 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 26.8 p30 -82.85 108.87 16.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.467 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 1.2 p30 -132.91 -43.21 0.89 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.441 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.555 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 59.8 m -53.91 -24.62 16.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 109.31 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.73 -2.63 32.11 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.574 HD21 ' CD1' ' A' ' 17' ' ' ILE . 2.1 p30 -149.37 -92.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -1.144 . . . . 0.0 109.47 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -176.85 22.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.411 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.73 76.19 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.15 -0.969 . . . . 0.0 109.519 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 25.0 p-10 -67.53 -30.64 70.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.438 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 73.3 mm-40 -87.56 15.95 6.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 109.446 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 39' ' ' GLU . 51.2 p30 -54.16 -172.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 42' ' ' CYS . 48.2 p-10 -46.85 -20.83 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.466 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.509 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 91.8 m 50.92 77.44 0.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.497 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.849 0 N-CA-C 119.412 2.525 . . . . 0.0 119.412 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.2 t -58.45 -35.16 71.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -1.119 . . . . 0.0 109.449 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -63.4 151.97 39.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.401 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.35 150.86 8.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 109.548 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 6' ' ' LYS . 6.0 m -51.4 135.47 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.519 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' VAL . 44.0 tttp -62.04 -127.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 109.489 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.3 m -106.21 159.17 16.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.92 . . . . 0.0 109.073 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.3 m -59.29 166.2 2.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.486 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp -71.84 139.32 48.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.37 0.61 67.31 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -118.99 147.36 44.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -1.123 . . . . 0.0 109.493 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.512 ' CD1' ' OE1' ' A' ' 23' ' ' GLN . 14.5 p90 -132.96 146.44 61.29 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.24 -0.912 . . . . 0.0 109.472 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.24 143.8 44.75 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.782 2.321 . . . . 0.0 112.248 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.5 m -67.45 -21.73 65.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.11 -114.77 0.73 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -84.96 9.47 14.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -1.157 . . . . 0.0 109.423 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 mt -100.16 136.38 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 m -75.59 62.8 1.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -143.42 140.74 30.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -127.34 143.29 51.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 108.756 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 21' ' ' LEU . 98.3 mt -138.51 149.9 64.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.422 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.07 154.3 71.22 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.819 2.346 . . . . 0.0 112.174 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.512 ' OE1' ' CD1' ' A' ' 12' ' ' PHE . 15.0 mm100 -57.23 -20.81 29.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.465 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.8 mt -56.69 -36.1 69.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.481 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.22 12.52 22.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -80.95 118.43 22.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.975 . . . . 0.0 109.459 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.9 m 51.45 39.14 23.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -89.27 4.52 48.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.511 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.84 26.78 68.33 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.13 135.74 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -1.139 . . . . 0.0 109.521 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -77.42 129.32 35.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.49 -51.77 0.3 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 109.422 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.501 ' SG ' ' OD1' ' A' ' 38' ' ' ASP . 87.7 m -52.08 -20.85 2.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.222 -0.924 . . . . 0.0 109.366 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.36 -2.73 34.78 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -149.46 -92.17 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -1.131 . . . . 0.0 109.525 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -176.1 22.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.12 82.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.469 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 1.1 p-10 -66.35 -30.13 70.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -82.07 11.14 5.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.45 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.473 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 51.7 p30 -63.41 158.7 19.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.473 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 21.4 p30 41.11 35.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.424 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.2 m -147.16 159.71 43.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 CA-C-O 117.978 -1.457 . . . . 0.0 109.591 179.948 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.414 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.529 4.868 0 N-CA-C 119.39 2.516 . . . . 0.0 119.39 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 1' ' ' GLY . 16.8 p 46.16 35.08 2.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -1.111 . . . . 0.0 109.493 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -58.23 -37.23 74.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.482 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.31 120.09 27.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.456 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.664 HG22 ' H ' ' A' ' 7' ' ' CYS . 7.5 p -74.52 122.65 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.46 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.61 11.2 34.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.165 -0.959 . . . . 0.0 109.462 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.664 ' H ' HG22 ' A' ' 5' ' ' VAL . 79.0 m -99.54 155.78 17.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.559 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -65.4 168.75 6.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.41 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 mt -67.23 150.67 48.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.7 -6.68 74.05 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -120.5 149.17 42.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -1.15 . . . . 0.0 109.418 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.38 146.43 48.49 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.393 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.14 142.98 39.06 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.789 2.326 . . . . 0.0 112.19 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.3 m -62.35 -28.34 69.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.434 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.69 -110.98 0.49 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -85.64 7.86 21.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.197 -1.178 . . . . 0.0 109.435 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.5 mt -99.46 139.22 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.494 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -79.74 91.31 5.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -171.27 167.36 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 109.44 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -143.75 143.41 31.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 108.801 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.7 mt -136.85 148.98 65.36 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.361 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.65 155.07 72.13 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.804 2.336 . . . . 0.0 112.182 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -57.12 -22.06 37.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.7 mp -54.89 -37.98 66.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.5 mt -88.34 14.93 8.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.484 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.531 ' NE2' ' SG ' ' A' ' 42' ' ' CYS . 11.7 t-80 -76.96 104.72 7.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.455 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 m 49.96 45.36 25.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -92.06 6.48 46.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.97 29.15 55.07 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.3 t -130.83 138.81 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -1.187 . . . . 0.0 109.556 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -80.59 127.73 32.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.452 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.438 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -148.49 -53.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.456 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 50.9 m -58.8 -22.05 57.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.94 -58.98 3.23 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.5 p-10 -81.48 11.19 4.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -1.158 . . . . 0.0 109.446 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 53.76 35.18 20.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.508 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -71.7 -40.71 69.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.488 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 18.0 p-10 -63.56 -30.69 71.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.531 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -82.86 10.56 7.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.473 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 41' ' ' ASN . 47.9 t0 -74.54 75.47 1.97 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.452 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 40' ' ' ASP . 6.0 p-10 38.64 90.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.467 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.531 ' SG ' ' NE2' ' A' ' 26' ' ' HIS . 38.2 m -68.12 154.06 42.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.286 -0.884 . . . . 0.0 109.479 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.548 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.771 0 N-CA-C 119.398 2.519 . . . . 0.0 119.398 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.3 m -64.0 156.32 28.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -1.188 . . . . 0.0 109.466 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.532 ' CD ' ' H ' ' A' ' 3' ' ' GLN . 9.0 mp0 -59.02 -34.38 71.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.483 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 50.05 -125.03 2.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.167 -0.958 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 p -137.83 144.86 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.493 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -128.27 130.53 48.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.28 -0.888 . . . . 0.0 109.457 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 m -128.28 136.64 51.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.031 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.6 m -84.14 -170.81 3.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.455 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt -72.54 147.39 46.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.252 -0.905 . . . . 0.0 109.441 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.92 4.87 66.75 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -137.18 156.32 48.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -1.151 . . . . 0.0 109.49 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.414 ' HB3' HE22 ' A' ' 23' ' ' GLN . 22.8 p90 -143.39 147.19 39.01 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.476 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.82 139.83 34.21 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.845 2.363 . . . . 0.0 112.23 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.7 m -64.87 -20.91 66.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.9 -114.26 0.84 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -83.0 5.89 20.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -1.088 . . . . 0.0 109.419 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.0 mm -91.68 154.55 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.497 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.3 p -94.3 65.33 3.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG2' ' HZ2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -154.73 165.19 37.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.486 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -143.98 147.44 33.9 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 21' ' ' LEU . 98.1 mt -136.21 149.87 69.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.451 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.49 152.54 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.793 2.329 . . . . 0.0 112.162 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.414 HE22 ' HB3' ' A' ' 12' ' ' PHE . 83.4 mm-40 -62.13 -26.86 68.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 mt -56.91 -35.34 68.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.53 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.9 mt -89.26 11.63 18.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -79.36 115.92 19.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.93 . . . . 0.0 109.483 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.3 m 46.31 39.77 6.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 109.519 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.408 HD21 ' HB ' ' A' ' 30' ' ' VAL . 41.0 p-10 -91.95 7.91 39.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.09 36.7 64.13 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.408 ' HB ' HD21 ' A' ' 28' ' ' ASN . 47.3 t -132.29 137.32 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -1.149 . . . . 0.0 109.486 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -78.32 123.54 27.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -148.27 -54.69 0.2 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.483 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.3 m -59.03 -25.17 63.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.602 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.01 -46.57 1.87 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -87.09 5.64 36.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 109.475 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 52.43 28.25 5.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.347 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.12 -37.64 75.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 17.6 p-10 -64.73 -31.08 72.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 77.5 mm-40 -87.66 20.52 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.442 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 57.8 t0 -138.85 153.41 48.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.494 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 22.1 p30 41.08 45.02 2.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.485 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 56.4 m -58.12 -30.74 66.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.496 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.528 4.799 0 N-CA-C 119.451 2.54 . . . . 0.0 119.451 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 1' ' ' GLY . 28.7 t 50.72 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -1.122 . . . . 0.0 109.484 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 54.79 73.45 0.41 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.232 -0.917 . . . . 0.0 109.5 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -58.7 148.81 28.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.484 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.2 m -129.95 154.59 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.918 . . . . 0.0 109.488 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -141.48 139.72 33.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.459 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 29.3 m -99.99 160.67 14.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.655 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.1 m -66.46 169.87 6.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.895 . . . . 0.0 109.508 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.9 mt -61.09 143.6 55.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 0.0 109.486 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.53 4.49 83.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -142.24 156.35 45.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.151 . . . . 0.0 109.466 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.53 146.01 49.02 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.46 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 59.5 Cg_endo -74.8 143.19 29.48 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.853 2.369 . . . . 0.0 112.2 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.2 m -69.1 -21.06 64.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.905 . . . . 0.0 109.537 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.48 -116.42 0.87 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -88.64 11.08 18.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -1.135 . . . . 0.0 109.469 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 mt -100.83 141.66 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.708 ' O ' HG23 ' A' ' 18' ' ' THR . 7.2 t -77.01 86.61 3.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 29.4 tttm -170.31 151.69 3.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.6 m -142.49 144.75 33.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 108.799 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.423 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 84.5 mt -135.04 150.3 72.7 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.471 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.2 146.12 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.841 2.361 . . . . 0.0 112.128 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -58.71 -26.59 64.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.481 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.0 mt -57.45 -36.12 70.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.7 mt -86.3 14.38 6.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.183 -0.948 . . . . 0.0 109.525 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.458 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 59.9 t-80 -90.26 123.13 33.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.406 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.458 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 98.6 m 50.91 34.27 10.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.481 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.422 HD21 ' HB ' ' A' ' 30' ' ' VAL . 46.0 p-10 -92.42 7.23 43.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.469 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.55 34.8 63.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.422 ' HB ' HD21 ' A' ' 28' ' ' ASN . 39.0 t -132.03 141.58 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -1.182 . . . . 0.0 109.452 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -85.25 117.91 24.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.288 -0.883 . . . . 0.0 109.497 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -142.4 -52.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.469 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 20.2 m -55.78 -35.62 66.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.041 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.13 -39.95 2.58 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -88.96 2.93 53.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.159 . . . . 0.0 109.532 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 59.51 18.39 6.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.877 . . . . 0.0 109.385 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.34 -31.91 60.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.498 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 32' ' ' ASP . 27.1 p-10 -62.56 -31.59 72.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.497 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.437 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 65.4 mm-40 -87.75 16.57 5.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.464 ' O ' ' C ' ' A' ' 41' ' ' ASN . 49.7 p30 -62.27 152.16 34.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.477 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.545 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 1.0 OUTLIER 41.21 34.23 0.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.16 -0.963 . . . . 0.0 109.467 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 94.7 m -142.48 158.96 43.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.451 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.883 0 N-CA-C 119.356 2.502 . . . . 0.0 119.356 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.3 p -62.78 -24.57 67.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -1.167 . . . . 0.0 109.458 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -57.56 -36.23 71.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' VAL . 57.1 t0 49.95 50.16 18.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.87 . . . . 0.0 109.504 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 6' ' ' LYS . 2.2 t -62.22 -136.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 109.515 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.482 ' H ' HG12 ' A' ' 5' ' ' VAL . 66.6 mmtt 51.07 -153.67 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.514 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 73.1 m -99.91 158.4 15.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.673 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.2 m -78.33 178.39 7.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.402 ' O ' ' CD2' ' A' ' 11' ' ' TYR . 37.3 mt -69.02 139.51 54.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.439 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.07 4.89 81.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 9' ' ' LEU . 25.0 m-85 -138.2 156.79 47.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -1.18 . . . . 0.0 109.471 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -136.73 146.28 54.62 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.409 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.475 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 57.5 Cg_endo -73.92 145.27 35.74 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.843 2.362 . . . . 0.0 112.242 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.6 m -70.36 -20.11 62.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.508 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.41 -118.63 1.03 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -87.6 11.69 14.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -1.172 . . . . 0.0 109.449 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.64 139.17 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.8 p -74.11 90.06 2.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.539 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.679 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 31.5 tttm -171.24 149.54 2.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.439 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.4 m -140.81 143.91 35.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 108.74 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.679 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 91.8 mt -137.82 150.92 69.34 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.362 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -47.12 143.99 9.47 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.797 2.331 . . . . 0.0 112.292 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.22 -21.91 49.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 mt -59.99 -35.33 74.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.4 mt -85.77 7.68 22.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.456 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -78.15 108.81 11.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.428 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 38' ' ' ASP . 51.9 m 51.82 50.33 18.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.43 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.638 HD21 HG12 ' A' ' 30' ' ' VAL . 17.2 p-10 -95.2 -39.97 9.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.449 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.06 29.72 0.29 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.638 HG12 HD21 ' A' ' 28' ' ' ASN . 8.4 p -144.07 143.46 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -1.161 . . . . 0.0 109.406 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -84.93 103.61 14.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.52 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.446 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -114.22 -51.24 2.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.48 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.407 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 57.8 m -54.44 -30.76 53.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.59 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.77 -44.89 2.53 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.5 p30 -86.2 10.1 15.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -1.15 . . . . 0.0 109.494 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 52.86 23.79 2.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.427 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -72.93 -37.72 67.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.522 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 21.3 p-10 -64.38 -30.98 72.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.52 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -85.9 10.42 13.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' O ' ' C ' ' A' ' 41' ' ' ASN . 59.3 t0 -77.78 126.3 30.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 109.436 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.476 ' C ' ' O ' ' A' ' 40' ' ' ASP . 6.3 p-10 39.62 84.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.472 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 88.0 m -90.48 158.04 17.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 CA-C-O 117.916 -1.491 . . . . 0.0 109.522 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.775 0 N-CA-C 119.402 2.521 . . . . 0.0 119.402 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 t 51.49 -150.37 0.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -1.171 . . . . 0.0 109.474 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -148.0 166.46 27.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.9 . . . . 0.0 109.404 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.36 146.7 28.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.509 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 6' ' ' LYS . 7.5 p -131.75 133.82 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.491 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 5' ' ' VAL . 96.6 mttt 44.8 -129.9 0.98 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 109.404 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.4 m -101.03 157.49 16.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.92 . . . . 0.0 109.229 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.3 m -72.74 175.15 6.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.508 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 tp -76.18 138.83 40.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.89 -0.44 67.11 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -115.94 152.62 33.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.507 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -136.99 146.27 54.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.472 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.44 144.09 49.4 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.788 2.325 . . . . 0.0 112.222 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.5 m -65.81 -21.41 66.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.53 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.86 -110.96 0.6 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -84.78 9.69 13.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -1.139 . . . . 0.0 109.403 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 mm -97.98 141.01 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 109.423 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 18' ' ' THR . 1.5 t -81.73 59.06 4.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.511 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -146.44 148.17 32.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.406 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.05 145.49 50.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 108.938 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 21' ' ' LEU . 98.2 mt -137.5 149.56 65.62 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.77 155.69 65.89 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.821 2.347 . . . . 0.0 112.236 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -56.74 -25.34 54.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.573 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.4 tp -51.0 -39.4 55.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -89.05 19.61 4.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.527 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -79.52 112.48 16.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -0.942 . . . . 0.0 109.454 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.4 m 47.19 45.52 16.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.439 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -87.04 4.22 42.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.16 10.2 80.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.21 134.39 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.42 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -86.2 103.32 14.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 0.0 109.459 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -103.32 -53.64 2.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.445 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 63.1 m -57.44 -25.95 60.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.46 -33.11 5.49 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.5 p-10 -89.93 5.03 48.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -1.162 . . . . 0.0 109.469 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 52.08 26.01 3.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.88 . . . . 0.0 109.402 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.509 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -72.48 -34.21 67.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.187 -0.946 . . . . 0.0 109.519 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 8.7 p30 -65.19 -30.7 71.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -81.67 11.93 4.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.496 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.469 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 93.8 m-20 -68.27 156.71 37.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.872 . . . . 0.0 109.54 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 4.2 p-10 42.0 44.66 3.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.494 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.9 m -144.74 162.04 37.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 109.552 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.539 -179.955 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.852 0 N-CA-C 119.331 2.492 . . . . 0.0 119.331 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.4 p -160.94 -23.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -1.153 . . . . 0.0 109.458 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -151.82 86.73 1.32 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -88.03 120.36 29.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 109.478 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.0 t -124.17 135.16 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.317 -0.864 . . . . 0.0 109.517 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -157.81 -130.86 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 109.503 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 m -126.68 136.31 52.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.331 -0.855 . . . . 0.0 109.122 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -83.03 -173.57 4.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.2 mt -73.67 145.46 45.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.431 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.98 6.86 66.57 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -132.31 156.43 46.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -1.134 . . . . 0.0 109.447 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -141.52 146.75 43.25 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.509 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.64 140.42 39.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.708 2.272 . . . . 0.0 112.289 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.7 m -61.58 -41.48 97.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.479 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.58 108.53 0.61 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 54.7 19.59 2.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -1.129 . . . . 0.0 109.438 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mm -124.13 138.47 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.878 . . . . 0.0 109.439 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 m -74.87 52.13 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.875 . . . . 0.0 109.478 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.684 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 37.2 tttm -140.98 142.76 34.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.431 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -132.18 148.63 52.48 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.684 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 86.9 mt -139.59 149.8 61.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.376 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.58 144.48 3.25 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.783 2.322 . . . . 0.0 112.19 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.47 -24.58 60.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.472 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.6 mp -58.96 -36.1 74.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.7 mt -84.92 11.98 8.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -81.51 118.71 22.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.948 . . . . 0.0 109.445 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.4 m 50.34 34.51 9.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.424 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.426 HD21 ' HB ' ' A' ' 30' ' ' VAL . 42.9 p-10 -88.99 6.76 38.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.82 38.32 65.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.426 ' HB ' HD21 ' A' ' 28' ' ' ASN . 48.0 t -133.75 136.37 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.9 p-10 -83.97 103.01 12.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.411 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -122.28 -51.94 1.96 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.259 -0.901 . . . . 0.0 109.475 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 76.2 m -58.73 -25.07 62.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 0.0 109.251 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.74 -43.18 2.47 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 50.5 p30 -87.91 6.25 36.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.467 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 52.26 33.66 13.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.463 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -75.22 -38.13 60.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 109.496 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 15.5 p30 -65.59 -31.07 71.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.519 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -81.22 0.99 34.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 109.474 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 42' ' ' CYS . 95.1 m-20 -50.28 173.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 43.6 p-10 -46.63 91.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.547 ' N ' ' O ' ' A' ' 40' ' ' ASP . 58.0 m -61.58 -24.98 67.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 109.471 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.949 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.527 4.763 0 N-CA-C 119.381 2.512 . . . . 0.0 119.381 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.7 t 47.2 -123.73 1.48 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -1.156 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 52.28 53.46 12.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.411 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -86.07 7.79 23.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.51 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' LYS . 48.2 t -71.87 129.77 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.422 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' VAL . 60.3 mttp 50.46 179.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 109.513 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 29.0 m -99.25 139.3 35.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.102 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.0 m -68.94 -177.83 1.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.2 mt -75.65 147.67 39.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.91 4.07 69.79 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -130.18 156.58 44.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -1.145 . . . . 0.0 109.457 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -140.08 146.65 47.31 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.449 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.34 142.57 37.47 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.748 2.299 . . . . 0.0 112.262 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.1 m -66.96 -20.85 65.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.515 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.13 -112.51 0.69 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -85.63 9.34 16.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -1.111 . . . . 0.0 109.393 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 mt -102.84 140.5 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.872 . . . . 0.0 109.429 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -78.58 58.96 2.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.921 . . . . 0.0 109.495 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -139.1 140.13 37.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 109.437 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.67 145.9 51.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.5 mt -138.93 150.41 65.22 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.361 -0.837 . . . . 0.0 109.391 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.04 152.69 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.796 2.331 . . . . 0.0 112.199 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -61.69 -28.42 69.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.6 mt -55.05 -36.19 65.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.434 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.5 mt -88.67 15.49 8.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.955 . . . . 0.0 109.488 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -82.57 114.72 21.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.408 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 38' ' ' ASP . 57.0 m 47.26 38.81 7.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.443 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.402 HD21 ' HB ' ' A' ' 30' ' ' VAL . 44.8 p-10 -89.83 8.26 32.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.905 . . . . 0.0 109.497 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.96 31.14 62.33 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' HB ' HD21 ' A' ' 28' ' ' ASN . 45.5 t -127.38 138.59 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 36.1 p-10 -83.24 115.15 21.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -139.29 -51.22 0.53 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.46 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 66.6 m -56.94 -39.26 74.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.905 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 36' ' ' GLN . . . 134.76 -72.96 0.46 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -86.93 20.96 2.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -1.125 . . . . 0.0 109.463 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 34' ' ' GLY . 27.2 mp0 53.9 40.66 31.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.28 77.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.882 . . . . 0.0 109.449 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.49 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 9.0 p30 -63.57 -31.27 72.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.0 OUTLIER -82.11 10.19 7.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.503 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 42' ' ' CYS . 50.7 p30 -60.54 -170.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.472 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 43' ' ' GLY . 31.7 p30 -46.52 -17.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.333 -0.854 . . . . 0.0 109.503 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.498 ' N ' ' O ' ' A' ' 40' ' ' ASP . 93.3 m 51.2 -89.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 3' ' ' GLN . . . . . . . . 1 N--CA 1.529 4.858 0 N-CA-C 119.382 2.513 . . . . 0.0 119.382 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 67.08 -43.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -1.153 . . . . 0.0 109.475 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 1' ' ' GLY . 92.0 mt-30 52.96 44.02 30.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.482 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -89.31 11.1 19.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.466 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.6 m -128.72 157.03 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.491 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -154.06 45.48 0.58 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.5 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.4 m -98.7 141.64 31.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 108.88 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.2 m -66.73 173.26 3.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.661 ' N ' HD12 ' A' ' 9' ' ' LEU . 8.6 mp -67.84 151.49 47.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.454 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.34 -7.53 77.98 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.26 151.98 41.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -1.158 . . . . 0.0 109.459 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 13.5 p90 -142.22 125.29 9.42 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.2 141.09 13.72 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.832 2.355 . . . . 0.0 112.17 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.1 m -64.76 -22.75 67.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 0.0 109.494 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.01 -113.88 0.66 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -84.46 8.47 16.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -1.112 . . . . 0.0 109.484 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.9 mt -98.82 140.36 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 109.504 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 p -78.89 57.9 2.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.699 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 28.5 tttm -142.49 142.75 32.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -126.7 144.49 50.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 108.983 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.699 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 99.0 mt -137.23 149.78 66.99 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.413 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.79 155.63 68.27 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.795 2.33 . . . . 0.0 112.257 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -57.67 -20.24 32.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.479 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.3 tp -56.27 -36.65 68.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.488 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.4 mt -91.2 10.2 28.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.819 . . . . 0.0 109.524 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.591 ' CE1' ' SG ' ' A' ' 42' ' ' CYS . 45.0 t-80 -74.25 104.25 4.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.413 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.7 m 52.11 50.21 18.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.639 HD21 HG12 ' A' ' 30' ' ' VAL . 15.5 p-10 -91.16 -35.42 14.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.421 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.13 26.76 0.67 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.639 HG12 HD21 ' A' ' 28' ' ' ASN . 8.5 p -144.73 142.75 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.472 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -85.73 103.59 14.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -112.32 -52.37 2.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.866 . . . . 0.0 109.475 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.446 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 37.2 m -48.68 -45.03 38.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.64 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.07 -59.73 0.66 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.513 ' CG ' ' H ' ' A' ' 36' ' ' GLN . 5.9 p30 -90.25 -89.49 0.16 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 109.478 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.513 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -173.17 23.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.882 . . . . 0.0 109.389 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.71 -47.58 80.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.2 p-10 -65.71 -30.43 71.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.415 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -85.2 21.61 1.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -65.82 179.55 0.85 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.418 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.42 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 6.2 p30 -58.32 92.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.45 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.591 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 93.1 m -87.92 157.21 19.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -0.844 . . . . 0.0 109.512 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.537 179.897 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.879 0 N-CA-C 119.385 2.514 . . . . 0.0 119.385 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -145.16 150.51 36.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -1.14 . . . . 0.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 53.6 90.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.524 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -65.69 146.56 54.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.91 . . . . 0.0 109.508 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.8 t -98.52 134.75 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.501 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -80.91 160.55 24.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.462 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 84.8 m -99.45 159.76 14.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.63 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.7 m -68.07 176.37 2.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.29 -0.882 . . . . 0.0 109.524 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.5 mt -66.18 142.53 57.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.76 2.44 84.4 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -142.31 156.91 45.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.385 -1.067 . . . . 0.0 109.441 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -141.24 146.99 45.18 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.498 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 59.8 Cg_endo -75.09 143.54 28.9 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.818 2.345 . . . . 0.0 112.216 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.7 m -69.45 -14.79 63.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.499 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.03 -118.45 1.55 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -83.47 9.77 10.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -1.152 . . . . 0.0 109.442 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 mm -94.71 141.3 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.487 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.6 m -81.48 87.98 6.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 33' ' ' CYS . 14.9 ptpt -173.14 168.14 4.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.5 m -148.82 142.98 26.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.93 150.12 70.54 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.489 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.18 145.44 5.51 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.76 2.306 . . . . 0.0 112.219 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.22 -27.12 65.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.51 -34.98 73.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 109.558 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.35 9.67 14.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 109.528 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -78.92 119.65 22.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.3 m 46.83 39.32 7.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.431 ' ND2' ' CG2' ' A' ' 30' ' ' VAL . 41.0 p-10 -93.05 5.63 50.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.62 33.83 55.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.431 ' CG2' ' ND2' ' A' ' 28' ' ' ASN . 59.7 t -127.74 136.19 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -1.137 . . . . 0.0 109.469 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 35.1 p-10 -81.73 103.57 11.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.94 . . . . 0.0 109.524 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -127.86 -49.74 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.518 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 86.0 m -59.54 -27.17 65.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.951 . . . . 0.0 109.598 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.72 -44.85 2.37 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.461 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 49.5 p-10 -87.04 6.23 33.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -1.174 . . . . 0.0 109.472 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 52.14 28.14 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.874 . . . . 0.0 109.41 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -73.91 -38.19 64.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.475 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 20.6 p-10 -64.45 -31.1 72.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 75.1 mm-40 -84.87 13.33 6.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.903 . . . . 0.0 109.438 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 42' ' ' CYS . 51.4 p30 -56.44 -171.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 42' ' ' CYS . 31.8 p30 -46.88 -18.87 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.879 . . . . 0.0 109.436 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 89.3 m 51.61 53.29 12.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 CA-C-O 117.994 -1.448 . . . . 0.0 109.525 179.998 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.868 0 N-CA-C 119.378 2.511 . . . . 0.0 119.378 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 t -145.74 149.48 34.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -1.125 . . . . 0.0 109.392 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -55.82 -35.88 66.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -65.92 144.49 56.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 0.0 109.501 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.4 134.96 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.503 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -73.46 144.88 46.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.436 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.8 m -114.83 158.8 21.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 108.983 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.7 m -61.79 170.46 2.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.498 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.44 150.5 48.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.961 . . . . 0.0 109.444 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.7 -4.21 86.41 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -127.02 153.68 45.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.144 . . . . 0.0 109.49 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -143.53 147.28 38.94 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.23 143.28 48.08 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.808 2.339 . . . . 0.0 112.21 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.46 -24.44 64.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.37 -110.32 0.54 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -84.73 6.91 22.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -1.147 . . . . 0.0 109.482 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.2 mt -102.35 137.67 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.6 p -78.1 62.63 2.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -144.93 145.47 31.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.409 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.13 146.06 51.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 108.844 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 21' ' ' LEU . 71.3 mt -140.53 152.46 66.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 109.38 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -52.73 149.76 24.19 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.783 2.322 . . . . 0.0 112.224 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -60.56 -25.61 66.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.626 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.7 mp -60.06 -34.33 73.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.565 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.553 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 31.1 mt -85.72 9.9 15.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 109.558 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -91.13 131.41 36.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.397 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.0 m 51.71 79.68 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.432 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.553 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 12.5 p30 -143.28 -3.77 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.413 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.63 3.24 89.74 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.94 140.37 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -1.142 . . . . 0.0 109.48 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -89.0 125.43 34.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.477 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.443 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -138.16 -51.8 0.6 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.4 m -53.9 -41.2 67.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.935 . . . . 0.0 109.63 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 145.37 -27.01 1.84 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.532 ' CG ' ' H ' ' A' ' 36' ' ' GLN . 1.2 p30 -136.22 -99.66 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -1.162 . . . . 0.0 109.481 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.532 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 72.7 mt-30 -155.93 15.36 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.391 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.99 91.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.489 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 33.3 p-10 -63.63 -31.54 72.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.901 . . . . 0.0 109.548 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.466 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 64.6 mm-40 -76.15 -54.64 6.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.462 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 41' ' ' ASN . 43.2 t0 44.79 -166.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.477 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.499 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 53.3 p-10 -76.41 3.73 10.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.908 . . . . 0.0 109.415 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 39' ' ' GLU . 73.0 m 47.46 -172.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -0.906 . . . . 0.0 109.526 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 CA-C-O 118.003 -1.443 . . . . 0.0 109.543 179.977 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.865 0 N-CA-C 119.38 2.512 . . . . 0.0 119.38 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 m -57.22 -36.03 70.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -1.134 . . . . 0.0 109.474 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -94.66 116.65 29.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.186 -0.946 . . . . 0.0 109.407 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -78.99 138.09 37.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.312 -0.867 . . . . 0.0 109.527 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.88 140.81 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.907 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -97.02 33.95 1.82 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.88 . . . . 0.0 109.461 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -134.63 141.81 46.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.131 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -86.63 -161.57 0.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.895 . . . . 0.0 109.493 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.58 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -81.11 142.24 33.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.437 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.77 -0.11 69.71 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -130.56 156.02 45.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -1.179 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -148.56 146.59 22.8 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.394 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.529 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 57.4 Cg_endo -73.84 148.56 41.17 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.786 2.324 . . . . 0.0 112.197 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.755 ' HB3' HD22 ' A' ' 35' ' ' ASN . 1.7 m -84.61 -7.04 59.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.591 ' C ' ' H ' ' A' ' 17' ' ' ILE . . . 88.77 132.27 4.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m120 68.01 -25.95 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -1.109 . . . . 0.0 109.447 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.591 ' H ' ' C ' ' A' ' 15' ' ' GLY . 24.1 mm -104.37 130.12 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.479 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 18' ' ' THR . 0.6 OUTLIER -80.24 57.66 2.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.504 179.695 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.645 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 33.5 tttm -146.6 137.03 23.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.47 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 1.6 m -117.17 147.38 42.52 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.645 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 67.6 mt -137.51 151.96 72.07 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.382 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.36 149.3 13.02 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.829 2.352 . . . . 0.0 112.178 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -60.24 -25.43 65.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.534 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.8 tp -58.12 -36.75 73.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.495 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.96 5.53 28.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.519 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -84.34 131.59 34.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.7 m 51.36 26.76 3.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.486 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -84.81 3.51 37.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.01 36.55 81.48 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -133.43 137.01 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.0 109.535 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -82.76 104.1 12.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.517 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.83 -58.66 2.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -0.97 . . . . 0.0 109.467 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.8 m -63.49 -27.55 69.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.3 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.07 -31.35 5.7 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.755 HD22 ' HB3' ' A' ' 14' ' ' CYS . 51.8 p-10 -83.83 4.6 28.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -1.161 . . . . 0.0 109.475 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 48.67 13.69 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.421 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 35' ' ' ASN . . . -64.77 -38.83 92.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 109.488 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 27.9 p-10 -65.81 -30.66 71.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.452 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 41' ' ' ASN . 81.2 mm-40 -91.24 13.5 17.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 0.0 109.533 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 41' ' ' ASN . 52.0 p30 -63.25 77.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.494 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 43' ' ' GLY . 20.3 p30 41.56 32.95 0.26 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.362 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 73.4 m 46.79 -92.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.46 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.294 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.579 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 3' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.918 0 N-CA-C 119.402 2.521 . . . . 0.0 119.402 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.7 t 53.12 6.5 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.352 -1.087 . . . . 0.0 109.547 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 1' ' ' GLY . 62.7 tt0 -97.0 126.88 42.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.497 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 5' ' ' VAL . 49.5 t0 -155.37 163.63 39.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 109.5 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.403 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 10.6 p -89.04 138.66 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 109.546 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -135.34 154.29 51.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.499 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.9 m -100.96 158.59 15.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.272 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.0 m -58.76 165.04 2.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 9' ' ' LEU . 9.2 mp -66.24 149.37 50.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.69 -4.03 81.73 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -127.64 152.39 47.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -1.13 . . . . 0.0 109.524 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -143.68 145.75 32.38 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.417 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.33 143.99 40.33 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.855 2.37 . . . . 0.0 112.186 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.5 m -62.94 -28.36 70.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.511 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.0 -106.82 0.32 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -86.9 8.19 24.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -1.161 . . . . 0.0 109.468 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 mt -102.54 140.93 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 109.424 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.7 m -80.93 63.5 5.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.681 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 26.4 tttm -144.09 131.98 21.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -116.16 143.6 45.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.489 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.681 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 98.0 mt -137.21 149.29 65.5 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 109.407 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.16 155.27 66.02 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.75 2.3 . . . . 0.0 112.189 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -59.21 -22.18 60.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.536 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.3 mp -57.34 -36.07 70.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.408 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 63.0 mt -91.95 3.9 54.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.41 ' NE2' ' SG ' ' A' ' 27' ' ' CYS . 11.8 t-80 -81.56 125.95 31.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 109.367 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' ' NE2' ' A' ' 26' ' ' HIS . 80.3 m 52.7 28.77 6.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.421 HD21 ' HB ' ' A' ' 30' ' ' VAL . 43.5 p-10 -88.34 5.77 40.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 109.447 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.87 42.4 78.75 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 28' ' ' ASN . 40.8 t -138.86 140.25 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -1.151 . . . . 0.0 109.481 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -80.22 121.58 25.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.5 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -144.15 -52.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.437 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.422 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 69.1 m -59.58 -22.34 61.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.367 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.41 -54.84 1.75 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.471 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 49.9 p-10 -89.45 13.82 12.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -1.102 . . . . 0.0 109.485 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 52.76 34.28 15.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.394 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -70.72 -29.84 66.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 36.2 p-10 -79.82 -27.92 40.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.514 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 74.1 mm-40 -84.08 -31.44 25.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.494 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 37' ' ' ALA . 53.8 p30 -88.87 47.92 1.56 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.902 . . . . 0.0 109.446 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 43.7 p-10 -161.22 19.18 0.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.892 . . . . 0.0 109.474 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 19.4 m -93.96 161.03 14.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 109.427 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 CA-C-O 117.938 -1.479 . . . . 0.0 109.545 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.529 4.844 0 N-CA-C 119.339 2.495 . . . . 0.0 119.339 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 1' ' ' GLY . 22.1 t 49.31 -176.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -1.164 . . . . 0.0 109.438 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -85.96 151.43 23.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.855 . . . . 0.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 4' ' ' ASP . 55.1 p30 -91.0 11.81 21.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.49 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.9 137.36 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.476 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -143.84 149.06 36.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.925 . . . . 0.0 109.518 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 66.3 m -99.29 125.23 44.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.178 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.2 m -88.35 -157.87 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.487 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 11' ' ' TYR . 20.1 mt 57.81 -168.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.446 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.93 16.45 1.97 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.473 ' H ' ' C ' ' A' ' 9' ' ' LEU . 29.2 m-85 -101.04 139.23 37.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.148 . . . . 0.0 109.451 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -139.74 146.73 48.65 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.43 139.93 42.63 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.809 2.34 . . . . 0.0 112.235 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.1 m -61.53 -33.56 74.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 0.0 109.545 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.0 -104.14 0.26 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -91.18 8.46 35.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -1.183 . . . . 0.0 109.416 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.3 mt -99.86 145.25 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 0.0 109.421 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.8 p -82.18 82.41 7.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.487 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -172.12 165.05 6.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.6 m -145.42 144.2 30.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 108.748 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.82 149.84 71.72 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.349 -0.844 . . . . 0.0 109.428 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.83 155.52 63.33 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.755 2.303 . . . . 0.0 112.186 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -58.23 -23.21 55.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.454 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.636 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.3 tt -53.57 -39.11 64.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.492 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.3 mt -88.8 13.72 11.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.507 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -77.96 117.1 18.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.3 m 46.86 40.29 8.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.534 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.4 HD21 ' HB ' ' A' ' 30' ' ' VAL . 51.9 p-10 -89.04 6.48 39.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.22 -0.925 . . . . 0.0 109.464 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.43 32.25 60.06 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.4 ' HB ' HD21 ' A' ' 28' ' ' ASN . 41.4 t -135.2 137.56 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -1.137 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -79.41 127.48 32.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -146.92 -58.53 0.28 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.912 . . . . 0.0 109.441 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 55.6 m -55.87 -25.19 41.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.352 -0.842 . . . . 0.0 109.251 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.06 -48.38 1.59 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.2 p-10 -89.44 7.18 37.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -1.14 . . . . 0.0 109.399 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 52.96 36.31 21.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.407 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -75.02 -24.49 58.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' OD2' ' SG ' ' A' ' 33' ' ' CYS . 0.4 OUTLIER -80.47 -31.19 37.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.478 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -74.45 -37.58 63.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.224 -0.923 . . . . 0.0 109.472 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 53.2 p30 -88.84 168.32 12.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.477 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER 40.03 45.55 1.65 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.93 . . . . 0.0 109.435 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.6 m -58.33 -31.49 67.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 109.476 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.505 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.529 4.848 0 N-CA-C 119.376 2.51 . . . . 0.0 119.376 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 1' ' ' GLY . 41.6 t 49.63 -177.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -1.192 . . . . 0.0 109.46 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -140.36 29.09 2.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.416 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -75.78 -5.91 48.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.502 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 5' ' ' VAL . 11.7 p -148.25 6.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -86.05 129.16 34.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.6 m -106.42 156.8 18.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 109.337 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.8 m -78.65 175.07 10.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.614 HD22 ' N ' ' A' ' 9' ' ' LEU . 3.7 mm? -73.33 140.45 46.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.429 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.02 1.6 67.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 44.7 m-85 -120.26 155.81 32.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -1.164 . . . . 0.0 109.491 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -141.87 146.1 39.37 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.41 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.64 148.39 53.13 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.811 2.341 . . . . 0.0 112.247 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.717 ' HB3' HD22 ' A' ' 35' ' ' ASN . 18.0 m -88.37 47.23 1.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.6 -154.38 28.29 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -50.34 -26.3 4.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -1.192 . . . . 0.0 109.451 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 mm -54.83 132.11 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 m -84.95 63.09 7.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.162 -0.961 . . . . 0.0 109.445 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -146.14 130.58 17.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -112.72 143.61 43.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 108.877 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.428 HD12 ' SG ' ' A' ' 33' ' ' CYS . 98.6 mt -138.06 149.65 64.56 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.937 . . . . 0.0 109.39 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.05 154.84 71.48 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.809 2.339 . . . . 0.0 112.178 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -57.07 -22.48 39.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.494 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.8 tp -53.73 -37.27 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.6 mt -90.92 16.46 9.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.518 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.589 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.5 t-80 -84.22 127.37 33.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.589 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 97.5 m 49.62 32.57 5.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.409 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 54.1 p30 -83.88 2.17 39.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.378 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.39 25.67 75.27 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t -128.64 138.28 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -1.131 . . . . 0.0 109.51 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.6 p-10 -88.29 101.87 14.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.537 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.43 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -104.58 -58.07 1.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.49 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.428 ' SG ' HD12 ' A' ' 21' ' ' LEU . 61.6 m -62.61 -25.74 68.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.265 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.88 -32.36 6.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.717 HD22 ' HB3' ' A' ' 14' ' ' CYS . 52.9 p-10 -85.2 5.09 31.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -1.18 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 48.85 19.56 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.477 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.497 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -65.87 -37.16 85.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.139 -0.975 . . . . 0.0 109.487 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.604 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 11.5 p30 -64.17 -31.84 73.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.493 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -76.76 -30.92 56.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -0.871 . . . . 0.0 109.441 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.58 57.7 0.74 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.613 ' C ' HD21 ' A' ' 41' ' ' ASN . 0.0 OUTLIER -171.19 23.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.451 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 34.0 m -96.03 159.41 14.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.493 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.59 179.995 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.83 0 N-CA-C 119.409 2.524 . . . . 0.0 119.409 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 m -58.1 -36.47 72.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -1.12 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -159.33 10.99 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -65.77 141.07 58.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.876 . . . . 0.0 109.512 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -104.65 135.59 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.871 . . . . 0.0 109.461 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -77.43 132.82 38.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 109.434 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 41.2 m -99.54 137.19 38.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 108.85 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.8 m -71.41 177.06 4.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.267 -0.896 . . . . 0.0 109.507 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.636 ' N ' HD12 ' A' ' 9' ' ' LEU . 9.5 mp -62.95 160.52 14.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.02 -8.21 80.37 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -131.81 151.57 51.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -145.01 146.84 32.46 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.498 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.12 148.22 55.84 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.822 2.348 . . . . 0.0 112.247 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.593 ' HB3' HD22 ' A' ' 35' ' ' ASN . 1.7 m -82.8 -10.76 58.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.01 -126.96 2.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -80.74 8.14 8.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -1.146 . . . . 0.0 109.486 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 mm -88.01 131.79 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.429 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -76.55 85.02 3.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 -179.573 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -171.96 164.78 6.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 109.449 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -141.4 142.62 33.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 108.57 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.1 148.87 66.43 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.408 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.77 158.19 52.09 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.844 2.363 . . . . 0.0 112.205 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -60.37 -23.03 63.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.3 mp -56.79 -34.76 67.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 -179.448 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.3 mt -94.12 11.24 30.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -85.59 122.17 29.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.427 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.2 m 51.46 31.36 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 109.431 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.421 HD21 ' HB ' ' A' ' 30' ' ' VAL . 48.2 p-10 -86.51 5.98 32.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.49 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.67 39.37 77.76 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 28' ' ' ASN . 45.4 t -140.01 140.28 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.46 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -83.56 125.47 31.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.38 -60.48 0.61 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 0.0 109.451 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.1 m -65.08 -23.28 67.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 0.0 109.211 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.81 -33.7 4.71 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.593 HD22 ' HB3' ' A' ' 14' ' ' CYS . 50.5 p-10 -86.45 3.94 41.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -1.176 . . . . 0.0 109.465 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 48.23 18.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.872 . . . . 0.0 109.439 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' A' ' 35' ' ' ASN . . . -65.51 -36.96 85.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.418 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -28.22 67.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.501 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -83.56 9.3 11.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 89.0 m-20 -60.65 151.21 29.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.498 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.516 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 4.0 p-10 41.84 42.71 2.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.945 . . . . 0.0 109.431 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 40.4 m -150.6 -8.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 CA-C-O 117.951 -1.472 . . . . 0.0 109.549 -179.984 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.826 0 N-CA-C 119.355 2.502 . . . . 0.0 119.355 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.5 m -58.38 -35.39 71.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -1.141 . . . . 0.0 109.536 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 45.73 -116.34 0.59 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.892 . . . . 0.0 109.543 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 58.8 t0 48.43 48.31 19.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.867 . . . . 0.0 109.503 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -88.23 132.51 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -165.99 45.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.485 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.5 m -136.95 158.0 45.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.193 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -58.82 164.48 2.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.13 144.94 53.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.439 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.04 -1.3 80.17 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -121.4 148.29 44.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -1.173 . . . . 0.0 109.509 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -134.98 146.63 59.39 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.421 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.23 144.41 51.45 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.828 2.352 . . . . 0.0 112.199 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.8 m -67.75 -21.2 65.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.443 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.76 -112.6 0.62 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -87.41 10.14 18.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -1.132 . . . . 0.0 109.367 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 mt -102.09 137.75 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 18' ' ' THR . 1.4 t -75.31 59.72 1.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.465 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 2.7 ttmp? -139.46 138.83 36.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.377 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -125.96 143.56 51.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 108.746 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.8 mt -138.29 149.71 64.22 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 109.388 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.56 154.56 64.01 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.738 2.292 . . . . 0.0 112.196 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -56.48 -25.02 49.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.322 -0.861 . . . . 0.0 109.519 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.7 tp -52.99 -37.97 61.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.499 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.5 mt -91.76 19.74 6.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.561 -179.34 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -82.88 114.5 21.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.507 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.1 m 46.93 36.65 4.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.477 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -85.63 8.3 20.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.382 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.75 29.22 63.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.3 t -129.4 139.67 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -1.169 . . . . 0.0 109.509 179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -84.45 122.0 28.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.88 . . . . 0.0 109.503 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -143.78 -47.77 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.455 179.862 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 56.5 m -57.84 -30.11 65.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.729 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.65 0.65 69.16 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 52.0 p30 -140.61 13.18 2.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -1.115 . . . . 0.0 109.439 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 51.94 22.9 1.93 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 109.415 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.451 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -70.76 -37.46 73.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 20.1 p30 -65.6 -30.48 71.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.467 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.2 mp0 -78.71 10.53 3.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.521 ' OD1' ' ND2' ' A' ' 41' ' ' ASN . 55.2 p30 -71.52 170.98 12.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.441 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.521 ' ND2' ' OD1' ' A' ' 40' ' ' ASP . 22.4 p30 40.6 37.84 0.53 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 109.468 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 90.9 m -146.53 -2.82 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.449 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 CA-C-O 117.944 -1.475 . . . . 0.0 109.575 179.953 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.852 0 N-CA-C 119.434 2.534 . . . . 0.0 119.434 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.7 p -64.34 -19.21 65.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -1.136 . . . . 0.0 109.532 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -56.14 -35.01 66.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 109.432 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 4' ' ' ASP . 44.1 p-10 -164.64 135.39 4.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.502 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.0 m -138.51 159.38 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? 65.17 112.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.7 m -99.28 165.06 11.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.17 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -56.32 163.87 1.53 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.465 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt -66.84 148.11 52.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.435 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.37 1.99 85.62 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -130.95 152.59 50.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -1.117 . . . . 0.0 109.505 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -143.96 146.45 34.28 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.888 . . . . 0.0 109.477 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.71 148.05 58.1 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.814 2.343 . . . . 0.0 112.222 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -63.34 -24.98 68.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.536 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.91 -76.37 0.28 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -119.86 15.01 12.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -1.118 . . . . 0.0 109.413 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.3 mt -111.33 138.03 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.456 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 18' ' ' THR . 0.2 OUTLIER -70.77 59.42 0.22 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.458 179.937 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -141.63 135.3 29.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.5 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -122.8 143.57 49.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.028 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.5 mt -138.0 149.3 63.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.358 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.34 155.08 59.42 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.788 2.325 . . . . 0.0 112.183 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -57.87 -23.97 55.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.57 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -55.14 -37.06 66.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.47 -179.405 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.4 mt -92.09 11.57 24.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 -179.175 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -84.28 123.54 30.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.458 179.704 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 98.1 m 50.86 29.65 4.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.4 HD21 ' HB ' ' A' ' 30' ' ' VAL . 44.9 p-10 -85.78 5.8 30.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.45 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.34 39.21 62.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.4 ' HB ' HD21 ' A' ' 28' ' ' ASN . 42.3 t -136.08 139.31 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -1.157 . . . . 0.0 109.444 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 38.3 p-10 -86.61 103.57 15.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.49 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.435 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -119.78 -53.33 2.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.454 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.428 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 97.1 m -60.14 -26.49 66.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.185 -0.947 . . . . 0.0 109.527 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.19 -42.94 2.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 50.8 p30 -85.29 6.22 27.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -1.169 . . . . 0.0 109.428 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 52.43 27.88 5.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.868 . . . . 0.0 109.401 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -71.32 -37.09 71.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.445 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 12.3 p30 -66.27 -31.09 71.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -88.48 15.87 7.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.54 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 41' ' ' ASN . 62.9 t0 -79.46 122.06 25.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.518 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 7.2 p-10 39.77 80.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 109.436 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.2 m -91.84 157.12 17.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.502 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 117.972 -1.46 . . . . 0.0 109.602 179.982 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.529 4.845 0 N-CA-C 119.433 2.533 . . . . 0.0 119.433 . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 1' ' ' GLY . 29.1 t 49.11 -175.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -1.137 . . . . 0.0 109.553 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.425 ' N ' ' OG ' ' A' ' 2' ' ' SER . 63.7 tt0 -87.28 124.49 33.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 109.467 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' VAL . 88.4 m-20 -67.8 143.37 55.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 4' ' ' ASP . 16.0 t 50.9 97.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.507 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -87.02 10.03 17.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.423 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 32.2 m -99.58 155.92 17.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.234 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.2 m -78.4 178.1 7.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.898 . . . . 0.0 109.502 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 mt -74.15 142.71 45.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.429 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.29 -0.09 68.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 31.0 m-85 -121.59 152.84 38.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -1.14 . . . . 0.0 109.458 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -144.6 146.06 30.81 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.296 -0.878 . . . . 0.0 109.482 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.86 145.74 41.12 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.728 2.285 . . . . 0.0 112.214 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -92.42 81.9 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.545 179.611 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.73 -145.23 31.13 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -83.89 10.91 8.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -1.19 . . . . 0.0 109.421 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.7 mt -78.58 138.1 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -82.17 61.58 5.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 109.483 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.622 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 27.5 tttm -143.85 126.17 15.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -112.61 143.02 44.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.622 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 96.7 mt -139.09 149.84 62.72 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.95 154.01 72.58 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.795 2.33 . . . . 0.0 112.241 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -57.07 -21.05 28.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.63 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.2 tt -55.81 -38.47 70.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.461 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.6 mt -89.82 15.06 10.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 0.0 109.535 -179.16 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -83.12 123.81 29.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.505 179.709 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.6 m 49.08 32.64 4.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.506 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.402 HD21 ' HB ' ' A' ' 30' ' ' VAL . 51.2 p-10 -85.25 5.37 30.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 109.445 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.45 35.0 68.35 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' HB ' HD21 ' A' ' 28' ' ' ASN . 39.3 t -133.68 137.28 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -1.184 . . . . 0.0 109.479 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.4 p-10 -84.68 103.47 13.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.486 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.4 OUTLIER -117.77 -57.86 2.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.882 . . . . 0.0 109.47 -179.824 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.494 ' SG ' ' OD2' ' A' ' 38' ' ' ASP . 74.3 m -61.65 -19.69 62.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.512 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.27 -47.52 2.4 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.709 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 53.3 p-10 -82.66 3.36 29.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -1.136 . . . . 0.0 109.502 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 51.19 31.04 6.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.541 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -67.1 -38.78 86.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.496 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.494 ' OD2' ' SG ' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -66.82 -29.95 70.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -78.74 7.82 6.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.474 ' O ' ' C ' ' A' ' 41' ' ' ASN . 50.6 p30 -62.76 156.74 22.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.536 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 0.9 OUTLIER 40.87 35.72 0.36 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.429 179.858 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 56.8 m -145.78 160.21 42.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.487 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.984 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.8 mt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.54 2.76 84.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -141.31 156.61 45.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -140.53 145.78 42.14 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.24 146.81 36.58 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.754 2.302 . . . . 0.0 112.252 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.9 m -70.26 -22.8 62.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.87 -116.36 0.82 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -87.58 9.88 19.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -1.13 . . . . 0.0 109.49 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 17' ' ' ILE . 6.2 mt -102.24 138.53 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.0 m -74.03 93.72 2.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.494 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 ttmm -171.76 145.94 2.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.5 m -135.72 142.32 45.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.139 -0.976 . . . . 0.0 109.11 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.2 mt -139.44 149.75 61.39 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.351 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.38 153.82 68.04 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.761 2.307 . . . . 0.0 112.213 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.48 -21.87 40.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.907 . . . . 0.0 109.518 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.3 tt -57.13 -37.4 71.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.498 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.02 5.46 50.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 109.511 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -79.64 121.18 24.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.9 m 52.08 34.01 13.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.427 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.414 HD21 ' HB ' ' A' ' 30' ' ' VAL . 43.9 p-10 -90.53 5.73 46.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.432 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.16 38.23 59.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.414 ' HB ' HD21 ' A' ' 28' ' ' ASN . 25.2 t -136.45 138.96 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -1.153 . . . . 0.0 109.586 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -79.32 123.01 27.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.474 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.9 OUTLIER -145.9 -52.35 0.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 56.6 m -57.07 -27.2 61.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.522 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.36 -50.14 2.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.1 p-10 -86.22 8.72 20.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.447 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 53.41 33.34 15.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.398 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.511 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -75.33 -40.89 57.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.6 p-10 -64.1 -31.71 73.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 78.2 mm-40 -93.3 17.18 11.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 60.2 t0 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.91 . . . . 0.0 109.483 -179.682 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.62 HD22 ' N ' ' A' ' 9' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.67 3.84 66.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 11' ' ' TYR . 32.0 m-85 -127.64 156.51 42.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -1.151 . . . . 0.0 109.451 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -141.98 145.83 37.87 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.431 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.34 145.17 37.96 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.821 2.348 . . . . 0.0 112.24 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.0 -23.79 65.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.496 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.36 -109.8 0.49 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.74 8.41 22.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -1.136 . . . . 0.0 109.526 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 mt -103.85 138.66 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.433 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.31 60.61 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -139.06 130.12 26.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.28 -0.887 . . . . 0.0 109.515 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -121.29 143.81 48.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 108.503 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.6 mt -138.93 150.93 67.06 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.8 147.84 2.95 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.784 2.323 . . . . 0.0 112.22 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -59.72 -24.75 64.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.585 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -55.79 -38.16 69.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.474 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.2 mt -85.1 12.93 6.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -81.8 114.07 20.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.481 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m 50.86 40.49 25.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.486 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -93.15 6.86 46.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.35 33.37 58.92 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.2 t -131.87 137.62 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -1.147 . . . . 0.0 109.487 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -78.9 124.07 27.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.449 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.463 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -146.93 -54.26 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.964 . . . . 0.0 109.393 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.5 m -59.0 -23.65 62.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.631 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.01 -52.22 1.91 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.743 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -86.32 8.09 22.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -1.179 . . . . 0.0 109.489 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.512 ' N ' HD22 ' A' ' 35' ' ' ASN . 93.2 mt-30 52.96 31.55 11.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.434 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.743 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -73.06 -36.76 66.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.456 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 22.2 p-10 -62.77 -30.66 71.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -79.05 3.84 16.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.6 t70 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 179.795 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.1 tp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.564 ' C ' HE22 ' A' ' 23' ' ' GLN . . . 90.42 5.76 69.2 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -128.51 153.68 46.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -1.181 . . . . 0.0 109.464 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 16.2 p90 -143.88 146.68 35.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.89 . . . . 0.0 109.481 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.87 145.19 55.76 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.767 2.311 . . . . 0.0 112.239 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.28 -25.42 68.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 109.514 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.22 -99.83 0.21 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.2 10.23 34.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -1.114 . . . . 0.0 109.354 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 mt -107.63 136.54 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.472 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 18' ' ' THR . 0.3 OUTLIER -74.58 62.45 1.03 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.45 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -142.9 132.17 23.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.91 . . . . 0.0 109.412 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.96 143.26 46.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 109.124 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -138.76 149.36 61.83 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.361 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.88 154.73 73.58 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.755 2.303 . . . . 0.0 112.229 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.564 HE22 ' C ' ' A' ' 10' ' ' GLY . 28.2 mp0 -57.01 -22.33 37.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.5 mt -53.99 -35.81 62.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.558 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 28.8 mt -91.12 16.24 10.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.551 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.596 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.9 t-80 -85.14 124.27 31.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.885 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.596 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 80.3 m 50.83 87.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.7 p30 -144.39 3.17 1.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.04 15.38 80.65 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 t -124.34 134.97 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -1.166 . . . . 0.0 109.44 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -91.05 102.65 15.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.542 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.96 -53.31 3.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.488 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.9 m -57.5 -21.24 36.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.13 -43.73 2.22 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.522 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.1 p-10 -88.55 6.66 36.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -1.133 . . . . 0.0 109.5 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 52.21 34.05 13.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.452 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.522 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -72.14 -39.1 69.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.49 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.86 -31.47 72.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -78.67 -28.66 45.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.28 -0.888 . . . . 0.0 109.417 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 59.2 t0 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 -179.608 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.07 2.62 66.21 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -121.56 149.95 42.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -1.156 . . . . 0.0 109.467 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -138.55 146.19 49.74 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.863 . . . . 0.0 109.478 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.18 144.34 41.72 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.745 2.297 . . . . 0.0 112.262 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.2 m -63.54 -30.84 71.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.19 -108.23 0.38 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -86.24 6.52 29.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -1.11 . . . . 0.0 109.475 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.5 mt -98.8 139.87 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 109.43 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.6 m -80.48 90.37 5.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 0.0 109.44 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -172.28 167.11 5.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.504 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.15 142.94 30.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 108.939 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 21' ' ' LEU . 97.2 mt -136.21 149.06 66.91 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.378 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.41 153.47 76.74 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.688 2.258 . . . . 0.0 112.247 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -56.99 -22.67 40.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.462 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -56.23 -35.0 66.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 0.0 109.476 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.4 mt -93.65 13.45 22.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.514 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.458 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 47.9 t-80 -83.32 115.86 22.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.434 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.458 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 74.0 m 51.39 34.82 12.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.422 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.405 HD21 ' HB ' ' A' ' 30' ' ' VAL . 39.9 p-10 -89.54 6.23 41.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.46 56.67 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.405 ' HB ' HD21 ' A' ' 28' ' ' ASN . 39.5 t -134.54 138.09 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -1.163 . . . . 0.0 109.529 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -80.45 122.33 26.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -145.33 -52.99 0.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.493 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 67.6 m -58.48 -23.79 58.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.95 -52.43 2.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.726 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -88.01 10.11 20.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -1.137 . . . . 0.0 109.45 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.497 ' N ' HD22 ' A' ' 35' ' ' ASN . 50.9 mt-30 53.69 32.96 15.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.412 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.726 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -72.19 -38.17 69.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 109.507 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.0 p-10 -65.66 -30.74 71.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 0.0 109.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 72.0 mm-40 -80.13 10.6 4.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.488 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.186 -0.946 . . . . 0.0 109.427 179.774 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 -3.03 68.07 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.461 ' N ' ' CD1' ' A' ' 11' ' ' TYR . 26.0 m-85 -116.13 135.5 53.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -1.163 . . . . 0.0 109.431 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -113.84 146.68 36.08 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.463 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.82 138.08 28.19 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.837 2.358 . . . . 0.0 112.182 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.4 m -65.16 -11.38 39.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.98 -124.1 2.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -82.93 11.4 6.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.274 -1.133 . . . . 0.0 109.447 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.574 ' CD1' HD21 ' A' ' 35' ' ' ASN . 10.9 mt -100.2 140.42 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.429 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.8 m -77.28 79.13 3.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.467 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.551 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 34.9 tttm -170.03 122.09 0.68 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.5 m -112.86 151.38 30.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 108.619 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.551 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 76.1 mt -138.97 151.34 67.94 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.41 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -46.66 146.5 5.36 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.706 2.27 . . . . 0.0 112.255 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -59.33 -27.65 66.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.568 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.77 -36.14 73.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.536 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 mt -84.4 11.05 9.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.505 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.494 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 57.5 t-80 -80.27 120.67 24.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.444 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 83.9 m 47.11 38.24 6.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -90.74 6.19 45.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.29 32.38 58.16 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.07 137.23 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.181 -1.188 . . . . 0.0 109.479 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 26.8 p30 -82.85 108.87 16.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.467 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 1.2 p30 -132.91 -43.21 0.89 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.441 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.555 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 59.8 m -53.91 -24.62 16.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 109.31 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.73 -2.63 32.11 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.574 HD21 ' CD1' ' A' ' 17' ' ' ILE . 2.1 p30 -149.37 -92.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -1.144 . . . . 0.0 109.47 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -176.85 22.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.411 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.73 76.19 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.15 -0.969 . . . . 0.0 109.519 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 25.0 p-10 -67.53 -30.64 70.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.438 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 73.3 mm-40 -87.56 15.95 6.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 109.446 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 39' ' ' GLU . 51.2 p30 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.37 0.61 67.31 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -118.99 147.36 44.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -1.123 . . . . 0.0 109.493 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.512 ' CD1' ' OE1' ' A' ' 23' ' ' GLN . 14.5 p90 -132.96 146.44 61.29 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.24 -0.912 . . . . 0.0 109.472 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.24 143.8 44.75 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.782 2.321 . . . . 0.0 112.248 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.5 m -67.45 -21.73 65.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.11 -114.77 0.73 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -84.96 9.47 14.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -1.157 . . . . 0.0 109.423 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 mt -100.16 136.38 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 m -75.59 62.8 1.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -143.42 140.74 30.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -127.34 143.29 51.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 108.756 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 21' ' ' LEU . 98.3 mt -138.51 149.9 64.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.422 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.07 154.3 71.22 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.819 2.346 . . . . 0.0 112.174 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.512 ' OE1' ' CD1' ' A' ' 12' ' ' PHE . 15.0 mm100 -57.23 -20.81 29.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.465 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.8 mt -56.69 -36.1 69.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.481 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.22 12.52 22.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.589 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.7 t-80 -80.95 118.43 22.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.975 . . . . 0.0 109.459 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.589 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 60.9 m 51.45 39.14 23.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -89.27 4.52 48.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.511 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.84 26.78 68.33 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.13 135.74 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -1.139 . . . . 0.0 109.521 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -77.42 129.32 35.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.49 -51.77 0.3 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 109.422 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.501 ' SG ' ' OD1' ' A' ' 38' ' ' ASP . 87.7 m -52.08 -20.85 2.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.222 -0.924 . . . . 0.0 109.366 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.36 -2.73 34.78 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -149.46 -92.17 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -1.131 . . . . 0.0 109.525 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -176.1 22.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.12 82.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.469 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 1.1 p-10 -66.35 -30.13 70.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -82.07 11.14 5.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.45 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 40' ' ' ASP . 51.7 p30 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 mt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.7 -6.68 74.05 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -120.5 149.17 42.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -1.15 . . . . 0.0 109.418 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.38 146.43 48.49 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.393 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.14 142.98 39.06 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.789 2.326 . . . . 0.0 112.19 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.3 m -62.35 -28.34 69.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.434 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.69 -110.98 0.49 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -85.64 7.86 21.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.197 -1.178 . . . . 0.0 109.435 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.5 mt -99.46 139.22 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.494 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -79.74 91.31 5.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -171.27 167.36 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 109.44 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -143.75 143.41 31.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 108.801 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.7 mt -136.85 148.98 65.36 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.361 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.65 155.07 72.13 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.804 2.336 . . . . 0.0 112.182 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -57.12 -22.06 37.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.7 mp -54.89 -37.98 66.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.5 mt -88.34 14.93 8.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.484 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -76.96 104.72 7.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.455 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 m 49.96 45.36 25.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -92.06 6.48 46.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.97 29.15 55.07 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.3 t -130.83 138.81 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -1.187 . . . . 0.0 109.556 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -80.59 127.73 32.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.452 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.438 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -148.49 -53.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.456 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 50.9 m -58.8 -22.05 57.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.94 -58.98 3.23 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.6 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -81.48 11.19 4.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -1.158 . . . . 0.0 109.446 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 53.76 35.18 20.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.6 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -71.7 -40.71 69.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.488 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 18.0 p-10 -63.56 -30.69 71.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.531 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -82.86 10.56 7.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.473 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 47.9 t0 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.452 -179.61 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.92 4.87 66.75 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -137.18 156.32 48.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -1.151 . . . . 0.0 109.49 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.414 ' HB3' HE22 ' A' ' 23' ' ' GLN . 22.8 p90 -143.39 147.19 39.01 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.476 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.82 139.83 34.21 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.845 2.363 . . . . 0.0 112.23 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.7 m -64.87 -20.91 66.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.9 -114.26 0.84 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -83.0 5.89 20.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -1.088 . . . . 0.0 109.419 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.0 mm -91.68 154.55 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.497 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.3 p -94.3 65.33 3.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG2' ' HZ2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -154.73 165.19 37.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.486 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -143.98 147.44 33.9 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 21' ' ' LEU . 98.1 mt -136.21 149.87 69.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.451 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.49 152.54 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.793 2.329 . . . . 0.0 112.162 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.414 HE22 ' HB3' ' A' ' 12' ' ' PHE . 83.4 mm-40 -62.13 -26.86 68.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 mt -56.91 -35.34 68.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.53 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.9 mt -89.26 11.63 18.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.468 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.0 t-80 -79.36 115.92 19.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.93 . . . . 0.0 109.483 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 61.3 m 46.31 39.77 6.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 109.519 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.408 HD21 ' HB ' ' A' ' 30' ' ' VAL . 41.0 p-10 -91.95 7.91 39.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.09 36.7 64.13 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.408 ' HB ' HD21 ' A' ' 28' ' ' ASN . 47.3 t -132.29 137.32 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -1.149 . . . . 0.0 109.486 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -78.32 123.54 27.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -148.27 -54.69 0.2 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.483 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.3 m -59.03 -25.17 63.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.602 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.01 -46.57 1.87 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.717 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -87.09 5.64 36.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 109.475 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.559 ' N ' HD22 ' A' ' 35' ' ' ASN . 89.6 mt-30 52.43 28.25 5.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.347 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.717 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -70.12 -37.64 75.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 17.6 p-10 -64.73 -31.08 72.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 77.5 mm-40 -87.66 20.52 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.442 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.8 t0 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.951 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.9 mt . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.53 4.49 83.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -142.24 156.35 45.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.151 . . . . 0.0 109.466 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.53 146.01 49.02 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.8 143.19 29.48 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.853 2.369 . . . . 0.0 112.2 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.2 m -69.1 -21.06 64.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.905 . . . . 0.0 109.537 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.48 -116.42 0.87 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -88.64 11.08 18.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -1.135 . . . . 0.0 109.469 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 mt -100.83 141.66 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.708 ' O ' HG23 ' A' ' 18' ' ' THR . 7.2 t -77.01 86.61 3.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 29.4 tttm -170.31 151.69 3.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.6 m -142.49 144.75 33.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 108.799 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.423 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 84.5 mt -135.04 150.3 72.7 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.471 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.2 146.12 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.841 2.361 . . . . 0.0 112.128 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -58.71 -26.59 64.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.481 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.0 mt -57.45 -36.12 70.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.7 mt -86.3 14.38 6.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.183 -0.948 . . . . 0.0 109.525 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.458 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 59.9 t-80 -90.26 123.13 33.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.406 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.458 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 98.6 m 50.91 34.27 10.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.481 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.422 HD21 ' HB ' ' A' ' 30' ' ' VAL . 46.0 p-10 -92.42 7.23 43.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.469 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.55 34.8 63.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.422 ' HB ' HD21 ' A' ' 28' ' ' ASN . 39.0 t -132.03 141.58 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -1.182 . . . . 0.0 109.452 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -85.25 117.91 24.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.288 -0.883 . . . . 0.0 109.497 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -142.4 -52.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.469 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 20.2 m -55.78 -35.62 66.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.041 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.13 -39.95 2.58 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.801 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -88.96 2.93 53.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.159 . . . . 0.0 109.532 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.571 ' N ' HD22 ' A' ' 35' ' ' ASN . 37.0 tp60 59.51 18.39 6.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.877 . . . . 0.0 109.385 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.801 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -75.34 -31.91 60.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.498 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 32' ' ' ASP . 27.1 p-10 -62.56 -31.59 72.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.497 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.456 ' CG ' HE21 ' A' ' 36' ' ' GLN . 65.4 mm-40 -87.75 16.57 5.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 40' ' ' ASP . 49.7 p30 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.477 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.402 ' O ' ' CD2' ' A' ' 11' ' ' TYR . 37.3 mt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.07 4.89 81.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 9' ' ' LEU . 25.0 m-85 -138.2 156.79 47.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -1.18 . . . . 0.0 109.471 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -136.73 146.28 54.62 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.409 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.92 145.27 35.74 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.843 2.362 . . . . 0.0 112.242 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.6 m -70.36 -20.11 62.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.508 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.41 -118.63 1.03 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -87.6 11.69 14.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -1.172 . . . . 0.0 109.449 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.64 139.17 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.8 p -74.11 90.06 2.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.539 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.679 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 31.5 tttm -171.24 149.54 2.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.439 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.4 m -140.81 143.91 35.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 108.74 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.679 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 91.8 mt -137.82 150.92 69.34 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.362 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -47.12 143.99 9.47 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.797 2.331 . . . . 0.0 112.292 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.22 -21.91 49.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 mt -59.99 -35.33 74.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.4 mt -85.77 7.68 22.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.456 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -78.15 108.81 11.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.428 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 38' ' ' ASP . 51.9 m 51.82 50.33 18.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.43 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.638 HD21 HG12 ' A' ' 30' ' ' VAL . 17.2 p-10 -95.2 -39.97 9.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.449 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.06 29.72 0.29 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.638 HG12 HD21 ' A' ' 28' ' ' ASN . 8.4 p -144.07 143.46 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -1.161 . . . . 0.0 109.406 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -84.93 103.61 14.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.52 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.446 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -114.22 -51.24 2.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.48 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.407 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 57.8 m -54.44 -30.76 53.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.59 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.77 -44.89 2.53 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.5 p30 -86.2 10.1 15.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -1.15 . . . . 0.0 109.494 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 52.86 23.79 2.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.427 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -72.93 -37.72 67.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.522 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 21.3 p-10 -64.38 -30.98 72.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.52 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -85.9 10.42 13.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 59.3 t0 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 109.436 -179.89 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 tp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.89 -0.44 67.11 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -115.94 152.62 33.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.507 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -136.99 146.27 54.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.472 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.44 144.09 49.4 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.788 2.325 . . . . 0.0 112.222 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.5 m -65.81 -21.41 66.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.53 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.86 -110.96 0.6 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -84.78 9.69 13.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -1.139 . . . . 0.0 109.403 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 mm -97.98 141.01 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 109.423 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 18' ' ' THR . 1.5 t -81.73 59.06 4.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.511 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -146.44 148.17 32.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.406 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.05 145.49 50.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 108.938 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 21' ' ' LEU . 98.2 mt -137.5 149.56 65.62 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.77 155.69 65.89 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.821 2.347 . . . . 0.0 112.236 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -56.74 -25.34 54.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.573 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.4 tp -51.0 -39.4 55.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -89.05 19.61 4.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.527 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -79.52 112.48 16.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -0.942 . . . . 0.0 109.454 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.4 m 47.19 45.52 16.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.439 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -87.04 4.22 42.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.16 10.2 80.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.21 134.39 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.42 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -86.2 103.32 14.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 0.0 109.459 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -103.32 -53.64 2.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.445 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 63.1 m -57.44 -25.95 60.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.46 -33.11 5.49 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.5 p-10 -89.93 5.03 48.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -1.162 . . . . 0.0 109.469 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 52.08 26.01 3.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.88 . . . . 0.0 109.402 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.509 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -72.48 -34.21 67.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.187 -0.946 . . . . 0.0 109.519 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 8.7 p30 -65.19 -30.7 71.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -81.67 11.93 4.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.496 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.872 . . . . 0.0 109.54 179.842 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.2 mt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.98 6.86 66.57 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -132.31 156.43 46.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -1.134 . . . . 0.0 109.447 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -141.52 146.75 43.25 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.509 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.64 140.42 39.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.708 2.272 . . . . 0.0 112.289 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.7 m -61.58 -41.48 97.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.479 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.58 108.53 0.61 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 54.7 19.59 2.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -1.129 . . . . 0.0 109.438 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mm -124.13 138.47 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.878 . . . . 0.0 109.439 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 m -74.87 52.13 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.875 . . . . 0.0 109.478 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.684 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 37.2 tttm -140.98 142.76 34.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.431 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -132.18 148.63 52.48 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.684 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 86.9 mt -139.59 149.8 61.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.376 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.58 144.48 3.25 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.783 2.322 . . . . 0.0 112.19 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.47 -24.58 60.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.472 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.6 mp -58.96 -36.1 74.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.7 mt -84.92 11.98 8.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -81.51 118.71 22.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.948 . . . . 0.0 109.445 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.4 m 50.34 34.51 9.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.424 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.426 HD21 ' HB ' ' A' ' 30' ' ' VAL . 42.9 p-10 -88.99 6.76 38.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.82 38.32 65.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.426 ' HB ' HD21 ' A' ' 28' ' ' ASN . 48.0 t -133.75 136.37 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.9 p-10 -83.97 103.01 12.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.411 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -122.28 -51.94 1.96 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.259 -0.901 . . . . 0.0 109.475 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 76.2 m -58.73 -25.07 62.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 0.0 109.251 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.74 -43.18 2.47 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 50.5 p30 -87.91 6.25 36.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.467 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 52.26 33.66 13.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.463 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -75.22 -38.13 60.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 109.496 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 15.5 p30 -65.59 -31.07 71.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.519 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -81.22 0.99 34.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 109.474 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.856 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.2 mt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.91 4.07 69.79 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -130.18 156.58 44.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -1.145 . . . . 0.0 109.457 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -140.08 146.65 47.31 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.449 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.34 142.57 37.47 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.748 2.299 . . . . 0.0 112.262 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.1 m -66.96 -20.85 65.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.515 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.13 -112.51 0.69 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -85.63 9.34 16.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -1.111 . . . . 0.0 109.393 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 mt -102.84 140.5 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.872 . . . . 0.0 109.429 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -78.58 58.96 2.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.921 . . . . 0.0 109.495 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -139.1 140.13 37.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 109.437 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.67 145.9 51.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.5 mt -138.93 150.41 65.22 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.361 -0.837 . . . . 0.0 109.391 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.04 152.69 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.796 2.331 . . . . 0.0 112.199 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -61.69 -28.42 69.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.6 mt -55.05 -36.19 65.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.434 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.5 mt -88.67 15.49 8.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.955 . . . . 0.0 109.488 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.431 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 55.7 t-80 -82.57 114.72 21.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.408 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.431 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 57.0 m 47.26 38.81 7.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.443 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.402 HD21 ' HB ' ' A' ' 30' ' ' VAL . 44.8 p-10 -89.83 8.26 32.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.905 . . . . 0.0 109.497 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.96 31.14 62.33 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.402 ' HB ' HD21 ' A' ' 28' ' ' ASN . 45.5 t -127.38 138.59 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 36.1 p-10 -83.24 115.15 21.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -139.29 -51.22 0.53 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.46 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 66.6 m -56.94 -39.26 74.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.905 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 36' ' ' GLN . . . 134.76 -72.96 0.46 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -86.93 20.96 2.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -1.125 . . . . 0.0 109.463 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 34' ' ' GLY . 27.2 mp0 53.9 40.66 31.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.28 77.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.882 . . . . 0.0 109.449 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 9.0 p30 -63.57 -31.27 72.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.0 OUTLIER -82.11 10.19 7.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.503 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.7 p30 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.472 179.844 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 9' ' ' LEU . 8.6 mp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.34 -7.53 77.98 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.26 151.98 41.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -1.158 . . . . 0.0 109.459 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 13.5 p90 -142.22 125.29 9.42 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.2 141.09 13.72 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.832 2.355 . . . . 0.0 112.17 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.1 m -64.76 -22.75 67.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 0.0 109.494 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.01 -113.88 0.66 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -84.46 8.47 16.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -1.112 . . . . 0.0 109.484 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.9 mt -98.82 140.36 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 109.504 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 p -78.89 57.9 2.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.699 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 28.5 tttm -142.49 142.75 32.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -126.7 144.49 50.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 108.983 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.699 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 99.0 mt -137.23 149.78 66.99 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.413 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.79 155.63 68.27 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.795 2.33 . . . . 0.0 112.257 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -57.67 -20.24 32.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.479 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.3 tp -56.27 -36.65 68.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.488 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.4 mt -91.2 10.2 28.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.819 . . . . 0.0 109.524 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -74.25 104.25 4.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.413 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.7 m 52.11 50.21 18.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.639 HD21 HG12 ' A' ' 30' ' ' VAL . 15.5 p-10 -91.16 -35.42 14.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.421 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.13 26.76 0.67 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.639 HG12 HD21 ' A' ' 28' ' ' ASN . 8.5 p -144.73 142.75 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.472 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -85.73 103.59 14.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -112.32 -52.37 2.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.866 . . . . 0.0 109.475 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.446 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 37.2 m -48.68 -45.03 38.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.64 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.07 -59.73 0.66 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.738 ' H ' ' ND2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -90.25 -89.49 0.16 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 109.478 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.654 ' H ' ' ND2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -173.17 23.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.882 . . . . 0.0 109.389 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.71 -47.58 80.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.2 p-10 -65.71 -30.43 71.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.415 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -85.2 21.61 1.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 54.2 p30 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.418 -179.919 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.5 mt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.76 2.44 84.4 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -142.31 156.91 45.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.385 -1.067 . . . . 0.0 109.441 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -141.24 146.99 45.18 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.09 143.54 28.9 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.818 2.345 . . . . 0.0 112.216 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.7 m -69.45 -14.79 63.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.499 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.03 -118.45 1.55 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -83.47 9.77 10.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -1.152 . . . . 0.0 109.442 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 mm -94.71 141.3 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.487 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.6 m -81.48 87.98 6.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 33' ' ' CYS . 14.9 ptpt -173.14 168.14 4.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.5 m -148.82 142.98 26.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.93 150.12 70.54 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.489 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.18 145.44 5.51 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.76 2.306 . . . . 0.0 112.219 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.22 -27.12 65.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.51 -34.98 73.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 109.558 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.35 9.67 14.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 109.528 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.593 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 53.7 t-80 -78.92 119.65 22.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.593 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 84.3 m 46.83 39.32 7.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.431 ' ND2' ' CG2' ' A' ' 30' ' ' VAL . 41.0 p-10 -93.05 5.63 50.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.62 33.83 55.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.431 ' CG2' ' ND2' ' A' ' 28' ' ' ASN . 59.7 t -127.74 136.19 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -1.137 . . . . 0.0 109.469 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 35.1 p-10 -81.73 103.57 11.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.94 . . . . 0.0 109.524 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -127.86 -49.74 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.518 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 86.0 m -59.54 -27.17 65.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.951 . . . . 0.0 109.598 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.72 -44.85 2.37 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.714 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -87.04 6.23 33.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -1.174 . . . . 0.0 109.472 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.495 ' N ' HD22 ' A' ' 35' ' ' ASN . 93.2 mt-30 52.14 28.14 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.874 . . . . 0.0 109.41 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.714 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -73.91 -38.19 64.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.475 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 20.6 p-10 -64.45 -31.1 72.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 75.1 mm-40 -84.87 13.33 6.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.903 . . . . 0.0 109.438 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 51.4 p30 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.2 mt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.7 -4.21 86.41 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -127.02 153.68 45.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.144 . . . . 0.0 109.49 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CD1' ' NE2' ' A' ' 23' ' ' GLN . 20.8 p90 -143.53 147.28 38.94 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.23 143.28 48.08 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.808 2.339 . . . . 0.0 112.21 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.46 -24.44 64.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.37 -110.32 0.54 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -84.73 6.91 22.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -1.147 . . . . 0.0 109.482 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.2 mt -102.35 137.67 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.6 p -78.1 62.63 2.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -144.93 145.47 31.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.409 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.13 146.06 51.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 108.844 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 21' ' ' LEU . 71.3 mt -140.53 152.46 66.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 109.38 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -52.73 149.76 24.19 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.783 2.322 . . . . 0.0 112.224 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.515 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 94.0 mm-40 -60.56 -25.61 66.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.626 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.7 mp -60.06 -34.33 73.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.565 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.553 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 31.1 mt -85.72 9.9 15.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 109.558 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.494 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 55.1 t-80 -91.13 131.41 36.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.397 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 64.0 m 51.71 79.68 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.432 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.553 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 12.5 p30 -143.28 -3.77 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.413 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.63 3.24 89.74 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.94 140.37 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -1.142 . . . . 0.0 109.48 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -89.0 125.43 34.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.477 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.443 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -138.16 -51.8 0.6 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.4 m -53.9 -41.2 67.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.935 . . . . 0.0 109.63 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 145.37 -27.01 1.84 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.532 ' CG ' ' H ' ' A' ' 36' ' ' GLN . 1.2 p30 -136.22 -99.66 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -1.162 . . . . 0.0 109.481 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.532 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 72.7 mt-30 -155.93 15.36 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.391 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.99 91.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.489 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 33.3 p-10 -63.63 -31.54 72.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.901 . . . . 0.0 109.548 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 64.6 mm-40 -76.15 -54.64 6.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.462 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.427 ' O ' ' O ' ' A' ' 39' ' ' GLU . 43.2 t0 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.477 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.77 -0.11 69.71 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -130.56 156.02 45.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -1.179 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CD1' ' NE2' ' A' ' 23' ' ' GLN . 12.6 p90 -148.56 146.59 22.8 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.394 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.529 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 57.4 Cg_endo -73.84 148.56 41.17 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.786 2.324 . . . . 0.0 112.197 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.61 -7.04 59.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.591 ' C ' ' H ' ' A' ' 17' ' ' ILE . . . 88.77 132.27 4.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m120 68.01 -25.95 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -1.109 . . . . 0.0 109.447 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.591 ' H ' ' C ' ' A' ' 15' ' ' GLY . 24.1 mm -104.37 130.12 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.479 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 18' ' ' THR . 0.6 OUTLIER -80.24 57.66 2.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.504 179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.645 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 33.5 tttm -146.6 137.03 23.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.47 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 1.6 m -117.17 147.38 42.52 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.645 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 67.6 mt -137.51 151.96 72.07 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.382 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.36 149.3 13.02 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.829 2.352 . . . . 0.0 112.178 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.515 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 92.9 mm-40 -60.24 -25.43 65.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.534 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.8 tp -58.12 -36.75 73.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.495 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.96 5.53 28.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.519 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -84.34 131.59 34.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.7 m 51.36 26.76 3.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.486 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -84.81 3.51 37.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.01 36.55 81.48 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -133.43 137.01 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.0 109.535 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -82.76 104.1 12.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.517 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.83 -58.66 2.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -0.97 . . . . 0.0 109.467 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.8 m -63.49 -27.55 69.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.3 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.07 -31.35 5.7 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.713 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -83.83 4.6 28.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -1.161 . . . . 0.0 109.475 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.581 ' N ' HD22 ' A' ' 35' ' ' ASN . 94.2 mt-30 48.67 13.69 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.421 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.713 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -64.77 -38.83 92.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 109.488 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 27.9 p-10 -65.81 -30.66 71.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.452 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 81.2 mm-40 -91.24 13.5 17.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 0.0 109.533 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 52.0 p30 . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.494 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.64 ' N ' HD12 ' A' ' 9' ' ' LEU . 9.2 mp . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.69 -4.03 81.73 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -127.64 152.39 47.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -1.13 . . . . 0.0 109.524 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -143.68 145.75 32.38 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.417 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.33 143.99 40.33 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.855 2.37 . . . . 0.0 112.186 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.5 m -62.94 -28.36 70.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.511 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.0 -106.82 0.32 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -86.9 8.19 24.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -1.161 . . . . 0.0 109.468 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 mt -102.54 140.93 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 109.424 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.7 m -80.93 63.5 5.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.681 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 26.4 tttm -144.09 131.98 21.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -116.16 143.6 45.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.489 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.681 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 98.0 mt -137.21 149.29 65.5 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 109.407 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.16 155.27 66.02 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.75 2.3 . . . . 0.0 112.189 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.21 -22.18 60.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.536 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.3 mp -57.34 -36.07 70.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.408 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 63.0 mt -91.95 3.9 54.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.41 ' NE2' ' SG ' ' A' ' 27' ' ' CYS . 11.8 t-80 -81.56 125.95 31.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 109.367 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' ' NE2' ' A' ' 26' ' ' HIS . 80.3 m 52.7 28.77 6.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.421 HD21 ' HB ' ' A' ' 30' ' ' VAL . 43.5 p-10 -88.34 5.77 40.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 109.447 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.87 42.4 78.75 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 28' ' ' ASN . 40.8 t -138.86 140.25 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -1.151 . . . . 0.0 109.481 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -80.22 121.58 25.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.5 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -144.15 -52.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.437 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.422 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 69.1 m -59.58 -22.34 61.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.367 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.41 -54.84 1.75 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.611 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -89.45 13.82 12.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -1.102 . . . . 0.0 109.485 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 52.76 34.28 15.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.394 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.611 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -70.72 -29.84 66.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.474 ' OD2' ' OD1' ' A' ' 32' ' ' ASP . 36.2 p-10 -79.82 -27.92 40.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.514 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 74.1 mm-40 -84.08 -31.44 25.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.494 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 37' ' ' ALA . 53.8 p30 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.902 . . . . 0.0 109.446 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 11' ' ' TYR . 20.1 mt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.323 0.582 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.93 16.45 1.97 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.473 ' H ' ' C ' ' A' ' 9' ' ' LEU . 29.2 m-85 -101.04 139.23 37.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.148 . . . . 0.0 109.451 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -139.74 146.73 48.65 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.43 139.93 42.63 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.809 2.34 . . . . 0.0 112.235 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.1 m -61.53 -33.56 74.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 0.0 109.545 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.0 -104.14 0.26 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -91.18 8.46 35.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -1.183 . . . . 0.0 109.416 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.3 mt -99.86 145.25 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 0.0 109.421 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.8 p -82.18 82.41 7.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.487 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -172.12 165.05 6.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.6 m -145.42 144.2 30.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 108.748 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.82 149.84 71.72 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.349 -0.844 . . . . 0.0 109.428 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.83 155.52 63.33 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.755 2.303 . . . . 0.0 112.186 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -58.23 -23.21 55.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.454 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.636 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.3 tt -53.57 -39.11 64.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.492 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.3 mt -88.8 13.72 11.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.507 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.581 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.5 t-80 -77.96 117.1 18.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.581 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 14.3 m 46.86 40.29 8.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.534 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.4 HD21 ' HB ' ' A' ' 30' ' ' VAL . 51.9 p-10 -89.04 6.48 39.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.22 -0.925 . . . . 0.0 109.464 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.43 32.25 60.06 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.4 ' HB ' HD21 ' A' ' 28' ' ' ASN . 41.4 t -135.2 137.56 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -1.137 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -79.41 127.48 32.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -146.92 -58.53 0.28 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.912 . . . . 0.0 109.441 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 55.6 m -55.87 -25.19 41.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.352 -0.842 . . . . 0.0 109.251 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.06 -48.38 1.59 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.2 p-10 -89.44 7.18 37.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -1.14 . . . . 0.0 109.399 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 52.96 36.31 21.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.407 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -75.02 -24.49 58.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' OD2' ' SG ' ' A' ' 33' ' ' CYS . 0.4 OUTLIER -80.47 -31.19 37.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.478 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -74.45 -37.58 63.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.224 -0.923 . . . . 0.0 109.472 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 37' ' ' ALA . 53.2 p30 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.477 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.614 HD22 ' N ' ' A' ' 9' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.02 1.6 67.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 44.7 m-85 -120.26 155.81 32.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -1.164 . . . . 0.0 109.491 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -141.87 146.1 39.37 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.41 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.64 148.39 53.13 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.811 2.341 . . . . 0.0 112.247 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 m -88.37 47.23 1.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.6 -154.38 28.29 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -50.34 -26.3 4.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -1.192 . . . . 0.0 109.451 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 mm -54.83 132.11 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 m -84.95 63.09 7.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.162 -0.961 . . . . 0.0 109.445 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -146.14 130.58 17.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -112.72 143.61 43.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 108.877 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.428 HD12 ' SG ' ' A' ' 33' ' ' CYS . 98.6 mt -138.06 149.65 64.56 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.937 . . . . 0.0 109.39 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.05 154.84 71.48 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.809 2.339 . . . . 0.0 112.178 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -57.07 -22.48 39.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.494 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.8 tp -53.73 -37.27 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.6 mt -90.92 16.46 9.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.518 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.589 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.5 t-80 -84.22 127.37 33.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.589 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 97.5 m 49.62 32.57 5.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.409 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 54.1 p30 -83.88 2.17 39.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.378 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.39 25.67 75.27 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t -128.64 138.28 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -1.131 . . . . 0.0 109.51 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.6 p-10 -88.29 101.87 14.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.537 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.43 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -104.58 -58.07 1.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.49 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.428 ' SG ' HD12 ' A' ' 21' ' ' LEU . 61.6 m -62.61 -25.74 68.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.265 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.88 -32.36 6.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.722 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -85.2 5.09 31.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -1.18 . . . . 0.0 109.506 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.49 ' N ' HD22 ' A' ' 35' ' ' ASN . 56.1 mt-30 48.85 19.56 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.477 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.722 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -65.87 -37.16 85.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.139 -0.975 . . . . 0.0 109.487 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 11.5 p30 -64.17 -31.84 73.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.493 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -76.76 -30.92 56.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -0.871 . . . . 0.0 109.441 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 -179.731 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.636 ' N ' HD12 ' A' ' 9' ' ' LEU . 9.5 mp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.02 -8.21 80.37 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -131.81 151.57 51.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -145.01 146.84 32.46 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.498 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.12 148.22 55.84 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.822 2.348 . . . . 0.0 112.247 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -82.8 -10.76 58.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.01 -126.96 2.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -80.74 8.14 8.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -1.146 . . . . 0.0 109.486 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 mm -88.01 131.79 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.429 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -76.55 85.02 3.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 -179.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -171.96 164.78 6.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 109.449 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -141.4 142.62 33.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 108.57 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.1 148.87 66.43 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.408 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.77 158.19 52.09 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.844 2.363 . . . . 0.0 112.205 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -60.37 -23.03 63.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.3 mp -56.79 -34.76 67.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 -179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.3 mt -94.12 11.24 30.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.526 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 45.3 t-80 -85.59 122.17 29.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.427 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 72.2 m 51.46 31.36 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 109.431 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.421 HD21 ' HB ' ' A' ' 30' ' ' VAL . 48.2 p-10 -86.51 5.98 32.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.49 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.67 39.37 77.76 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 28' ' ' ASN . 45.4 t -140.01 140.28 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.46 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -83.56 125.47 31.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.38 -60.48 0.61 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 0.0 109.451 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.1 m -65.08 -23.28 67.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 0.0 109.211 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.81 -33.7 4.71 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.719 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -86.45 3.94 41.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -1.176 . . . . 0.0 109.465 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.594 ' N ' HD22 ' A' ' 35' ' ' ASN . 93.1 mt-30 48.23 18.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.872 . . . . 0.0 109.439 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.719 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -65.51 -36.96 85.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.418 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -28.22 67.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.501 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -83.56 9.3 11.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.498 179.996 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.04 -1.3 80.17 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -121.4 148.29 44.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -1.173 . . . . 0.0 109.509 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -134.98 146.63 59.39 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.421 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.23 144.41 51.45 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.828 2.352 . . . . 0.0 112.199 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.8 m -67.75 -21.2 65.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.443 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.76 -112.6 0.62 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -87.41 10.14 18.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -1.132 . . . . 0.0 109.367 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 mt -102.09 137.75 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 18' ' ' THR . 1.4 t -75.31 59.72 1.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.465 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 2.7 ttmp? -139.46 138.83 36.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.377 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -125.96 143.56 51.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 108.746 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.8 mt -138.29 149.71 64.22 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 109.388 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.56 154.56 64.01 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.738 2.292 . . . . 0.0 112.196 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -56.48 -25.02 49.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.322 -0.861 . . . . 0.0 109.519 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.7 tp -52.99 -37.97 61.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.499 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.5 mt -91.76 19.74 6.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.561 -179.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -82.88 114.5 21.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.507 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.1 m 46.93 36.65 4.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.477 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -85.63 8.3 20.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.382 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.75 29.22 63.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.3 t -129.4 139.67 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -1.169 . . . . 0.0 109.509 179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -84.45 122.0 28.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.88 . . . . 0.0 109.503 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -143.78 -47.77 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.455 179.862 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 56.5 m -57.84 -30.11 65.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.729 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.65 0.65 69.16 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 52.0 p30 -140.61 13.18 2.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -1.115 . . . . 0.0 109.439 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 51.94 22.9 1.93 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 109.415 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.451 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -70.76 -37.46 73.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 20.1 p30 -65.6 -30.48 71.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.467 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.2 mp0 -78.71 10.53 3.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.2 p30 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.441 179.95 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.37 1.99 85.62 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -130.95 152.59 50.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -1.117 . . . . 0.0 109.505 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CD1' ' NE2' ' A' ' 23' ' ' GLN . 17.3 p90 -143.96 146.45 34.28 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.888 . . . . 0.0 109.477 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.71 148.05 58.1 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.814 2.343 . . . . 0.0 112.222 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -63.34 -24.98 68.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.536 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.91 -76.37 0.28 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -119.86 15.01 12.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -1.118 . . . . 0.0 109.413 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.3 mt -111.33 138.03 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.456 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 18' ' ' THR . 0.2 OUTLIER -70.77 59.42 0.22 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.458 179.937 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -141.63 135.3 29.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.5 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -122.8 143.57 49.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.028 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.5 mt -138.0 149.3 63.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.358 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.34 155.08 59.42 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.788 2.325 . . . . 0.0 112.183 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.463 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 98.6 mm-40 -57.87 -23.97 55.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.57 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -55.14 -37.06 66.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.47 -179.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.4 mt -92.09 11.57 24.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 -179.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.547 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.7 t-80 -84.28 123.54 30.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.458 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.547 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 98.1 m 50.86 29.65 4.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.4 HD21 ' HB ' ' A' ' 30' ' ' VAL . 44.9 p-10 -85.78 5.8 30.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.45 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.34 39.21 62.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.4 ' HB ' HD21 ' A' ' 28' ' ' ASN . 42.3 t -136.08 139.31 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -1.157 . . . . 0.0 109.444 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 38.3 p-10 -86.61 103.57 15.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.49 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.435 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -119.78 -53.33 2.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.454 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.428 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 97.1 m -60.14 -26.49 66.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.185 -0.947 . . . . 0.0 109.527 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.19 -42.94 2.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 50.8 p30 -85.29 6.22 27.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -1.169 . . . . 0.0 109.428 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 52.43 27.88 5.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.868 . . . . 0.0 109.401 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -71.32 -37.09 71.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.445 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 12.3 p30 -66.27 -31.09 71.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -88.48 15.87 7.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.54 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.9 t0 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 -179.717 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 mt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.29 -0.09 68.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 31.0 m-85 -121.59 152.84 38.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -1.14 . . . . 0.0 109.458 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -144.6 146.06 30.81 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.296 -0.878 . . . . 0.0 109.482 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.86 145.74 41.12 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.728 2.285 . . . . 0.0 112.214 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -92.42 81.9 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.545 179.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.73 -145.23 31.13 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -83.89 10.91 8.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -1.19 . . . . 0.0 109.421 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.7 mt -78.58 138.1 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -82.17 61.58 5.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 109.483 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.622 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 27.5 tttm -143.85 126.17 15.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -112.61 143.02 44.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.622 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 96.7 mt -139.09 149.84 62.72 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.95 154.01 72.58 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.795 2.33 . . . . 0.0 112.241 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -57.07 -21.05 28.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.63 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.2 tt -55.81 -38.47 70.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.461 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.6 mt -89.82 15.06 10.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 0.0 109.535 -179.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.582 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 53.5 t-80 -83.12 123.81 29.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.505 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.582 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 73.6 m 49.08 32.64 4.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.506 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.402 HD21 ' HB ' ' A' ' 30' ' ' VAL . 51.2 p-10 -85.25 5.37 30.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 109.445 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.45 35.0 68.35 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.402 ' HB ' HD21 ' A' ' 28' ' ' ASN . 39.3 t -133.68 137.28 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -1.184 . . . . 0.0 109.479 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.4 p-10 -84.68 103.47 13.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.486 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.4 OUTLIER -117.77 -57.86 2.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.882 . . . . 0.0 109.47 -179.824 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.494 ' SG ' ' OD2' ' A' ' 38' ' ' ASP . 74.3 m -61.65 -19.69 62.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.512 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.27 -47.52 2.4 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.709 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -82.66 3.36 29.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -1.136 . . . . 0.0 109.502 179.977 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.562 ' N ' HD22 ' A' ' 35' ' ' ASN . 94.0 mt-30 51.19 31.04 6.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.709 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -67.1 -38.78 86.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.496 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.494 ' OD2' ' SG ' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -66.82 -29.95 70.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -78.74 7.82 6.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 40' ' ' ASP . 50.6 p30 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.772 0 N-CA-C 119.424 2.53 . . . . 0.0 119.424 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.511 ' O ' ' NE2' ' A' ' 3' ' ' GLN . 46.8 m -63.86 149.61 46.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -1.154 . . . . 0.0 109.379 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 2' ' ' SER . 94.4 mm-40 -137.44 155.54 49.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.088 -1.008 . . . . 0.0 109.504 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 52.06 47.27 25.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.491 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 6' ' ' LYS . 7.5 p -110.32 127.38 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.505 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 5' ' ' VAL . 29.4 mmtm 49.81 179.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 109.468 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 70.3 m -112.65 162.73 15.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.639 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.7 m -65.45 174.62 2.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.8 mt -64.98 141.79 58.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.444 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.54 2.76 84.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -141.31 156.61 45.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -140.53 145.78 42.14 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.526 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 57.9 Cg_endo -74.24 146.81 36.58 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.754 2.302 . . . . 0.0 112.252 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.9 m -70.26 -22.8 62.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.87 -116.36 0.82 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -87.58 9.88 19.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -1.13 . . . . 0.0 109.49 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 17' ' ' ILE . 6.2 mt -102.24 138.53 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.0 m -74.03 93.72 2.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.494 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.8 ttmm -171.76 145.94 2.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.5 m -135.72 142.32 45.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.139 -0.976 . . . . 0.0 109.11 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.2 mt -139.44 149.75 61.39 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.351 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.38 153.82 68.04 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.761 2.307 . . . . 0.0 112.213 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.48 -21.87 40.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.907 . . . . 0.0 109.518 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.3 tt -57.13 -37.4 71.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.498 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.8 mt -92.02 5.46 50.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 109.511 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -79.64 121.18 24.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.9 m 52.08 34.01 13.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.427 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.414 HD21 ' HB ' ' A' ' 30' ' ' VAL . 43.9 p-10 -90.53 5.73 46.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.432 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.16 38.23 59.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.414 ' HB ' HD21 ' A' ' 28' ' ' ASN . 25.2 t -136.45 138.96 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -1.153 . . . . 0.0 109.586 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -79.32 123.01 27.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.474 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.9 OUTLIER -145.9 -52.35 0.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 56.6 m -57.07 -27.2 61.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.522 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.36 -50.14 2.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.1 p-10 -86.22 8.72 20.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.447 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 53.41 33.34 15.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.398 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -75.33 -40.89 57.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.6 p-10 -64.1 -31.71 73.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.419 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 78.2 mm-40 -93.3 17.18 11.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 41' ' ' ASN . 60.2 t0 -81.97 112.42 19.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.91 . . . . 0.0 109.483 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.527 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 6.5 p-10 40.49 57.06 2.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 38' ' ' ASP . 1.7 m -58.71 -32.37 69.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.184 -0.948 . . . . 0.0 109.453 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.598 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.528 4.815 0 N-CA-C 119.422 2.529 . . . . 0.0 119.422 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 1' ' ' GLY . 44.2 t 48.49 93.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -1.183 . . . . 0.0 109.432 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 46.29 -114.9 0.53 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.47 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 59.5 t0 52.39 -122.22 1.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 109.523 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.542 HG22 ' H ' ' A' ' 7' ' ' CYS . 7.8 p -135.88 145.6 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -82.18 7.53 13.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.542 ' H ' HG22 ' A' ' 5' ' ' VAL . 19.2 m -99.19 134.28 42.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.064 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.5 m -78.33 -175.21 4.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.509 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.62 HD22 ' N ' ' A' ' 9' ' ' LEU . 3.7 mm? -74.36 143.54 44.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.432 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.67 3.84 66.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 11' ' ' TYR . 32.0 m-85 -127.64 156.51 42.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -1.151 . . . . 0.0 109.451 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -141.98 145.83 37.87 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.431 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.34 145.17 37.96 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.821 2.348 . . . . 0.0 112.24 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.0 -23.79 65.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.496 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.36 -109.8 0.49 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.74 8.41 22.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -1.136 . . . . 0.0 109.526 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 mt -103.85 138.66 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.433 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.31 60.61 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -139.06 130.12 26.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.28 -0.887 . . . . 0.0 109.515 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -121.29 143.81 48.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 108.503 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.6 mt -138.93 150.93 67.06 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.8 147.84 2.95 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.784 2.323 . . . . 0.0 112.22 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -59.72 -24.75 64.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.585 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -55.79 -38.16 69.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.474 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.2 mt -85.1 12.93 6.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -81.8 114.07 20.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.481 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m 50.86 40.49 25.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.486 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -93.15 6.86 46.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.35 33.37 58.92 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.2 t -131.87 137.62 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -1.147 . . . . 0.0 109.487 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -78.9 124.07 27.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 109.449 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.463 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -146.93 -54.26 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.964 . . . . 0.0 109.393 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.5 m -59.0 -23.65 62.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.631 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.01 -52.22 1.91 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.743 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -86.32 8.09 22.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -1.179 . . . . 0.0 109.489 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.512 ' N ' HD22 ' A' ' 35' ' ' ASN . 93.2 mt-30 52.96 31.55 11.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.434 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.743 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -73.06 -36.76 66.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.456 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 22.2 p-10 -62.77 -30.66 71.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -79.05 3.84 16.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 109.476 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.462 ' O ' ' C ' ' A' ' 41' ' ' ASN . 21.6 t70 -65.64 157.32 30.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.531 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 4.3 p-10 41.84 45.76 3.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.478 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.0 m -150.79 -3.11 0.34 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.475 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.965 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 5' ' ' VAL . . . . . . . . 1 N--CA 1.529 4.857 0 N-CA-C 119.406 2.522 . . . . 0.0 119.406 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.2 p -60.98 -41.11 95.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -1.122 . . . . 0.0 109.552 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.496 ' CG ' ' N ' ' A' ' 4' ' ' ASP . 12.7 pt20 -172.34 -52.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.41 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.496 ' N ' ' CG ' ' A' ' 3' ' ' GLN . 94.1 m-20 -140.04 7.91 2.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.433 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 1' ' ' GLY . 46.5 t -97.27 137.89 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 109.486 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -136.03 130.19 33.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.45 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.0 m -124.66 166.47 16.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.309 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.7 m -56.54 163.34 1.82 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.905 . . . . 0.0 109.479 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.1 tp -68.95 139.71 55.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.526 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.564 ' C ' HE22 ' A' ' 23' ' ' GLN . . . 90.42 5.76 69.2 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -128.51 153.68 46.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -1.181 . . . . 0.0 109.464 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 16.2 p90 -143.88 146.68 35.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.89 . . . . 0.0 109.481 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.87 145.19 55.76 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.767 2.311 . . . . 0.0 112.239 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.28 -25.42 68.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 109.514 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.22 -99.83 0.21 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.2 10.23 34.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -1.114 . . . . 0.0 109.354 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 mt -107.63 136.54 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.472 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 18' ' ' THR . 0.3 OUTLIER -74.58 62.45 1.03 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.45 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -142.9 132.17 23.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.91 . . . . 0.0 109.412 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -117.96 143.26 46.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 109.124 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -138.76 149.36 61.83 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.361 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.88 154.73 73.58 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.755 2.303 . . . . 0.0 112.229 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.564 HE22 ' C ' ' A' ' 10' ' ' GLY . 28.2 mp0 -57.01 -22.33 37.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.5 mt -53.99 -35.81 62.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.558 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 28.8 mt -91.12 16.24 10.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.551 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.596 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.9 t-80 -85.14 124.27 31.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.885 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.596 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 80.3 m 50.83 87.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.7 p30 -144.39 3.17 1.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.04 15.38 80.65 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 t -124.34 134.97 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -1.166 . . . . 0.0 109.44 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -91.05 102.65 15.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.542 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.96 -53.31 3.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.488 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.9 m -57.5 -21.24 36.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.13 -43.73 2.22 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.522 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.1 p-10 -88.55 6.66 36.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -1.133 . . . . 0.0 109.5 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 52.21 34.05 13.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.452 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.522 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -72.14 -39.1 69.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.49 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 1.0 OUTLIER -64.86 -31.47 72.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -78.67 -28.66 45.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.28 -0.888 . . . . 0.0 109.417 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -81.75 49.17 1.3 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 37' ' ' ALA . 2.6 p-10 -172.15 22.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.479 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 87.6 m -69.4 -22.07 63.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.94 . . . . 0.0 109.454 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 CA-C-O 117.973 -1.46 . . . . 0.0 109.54 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.528 4.796 0 N-CA-C 119.453 2.541 . . . . 0.0 119.453 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 1' ' ' GLY . 20.1 m 50.46 -178.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -1.161 . . . . 0.0 109.452 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 52.68 45.34 28.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.475 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -86.92 120.44 28.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.494 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -123.87 136.2 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.553 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -139.21 151.61 46.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 68.1 m -113.14 161.99 16.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.259 -0.901 . . . . 0.0 109.376 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.8 m -57.93 165.61 1.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.471 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.7 tp -71.71 142.01 49.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.07 2.62 66.21 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -121.56 149.95 42.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -1.156 . . . . 0.0 109.467 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -138.55 146.19 49.74 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.863 . . . . 0.0 109.478 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.18 144.34 41.72 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.745 2.297 . . . . 0.0 112.262 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.2 m -63.54 -30.84 71.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.19 -108.23 0.38 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -86.24 6.52 29.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -1.11 . . . . 0.0 109.475 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.5 mt -98.8 139.87 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 109.43 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.6 m -80.48 90.37 5.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 0.0 109.44 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -172.28 167.11 5.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.504 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.15 142.94 30.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 108.939 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 21' ' ' LEU . 97.2 mt -136.21 149.06 66.91 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.378 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.41 153.47 76.74 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.688 2.258 . . . . 0.0 112.247 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -56.99 -22.67 40.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.462 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -56.23 -35.0 66.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 0.0 109.476 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.4 mt -93.65 13.45 22.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.514 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.458 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 47.9 t-80 -83.32 115.86 22.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.434 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.458 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 74.0 m 51.39 34.82 12.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.422 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.405 HD21 ' HB ' ' A' ' 30' ' ' VAL . 39.9 p-10 -89.54 6.23 41.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.46 56.67 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.405 ' HB ' HD21 ' A' ' 28' ' ' ASN . 39.5 t -134.54 138.09 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -1.163 . . . . 0.0 109.529 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -80.45 122.33 26.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -145.33 -52.99 0.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.493 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 67.6 m -58.48 -23.79 58.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.95 -52.43 2.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.726 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -88.01 10.11 20.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -1.137 . . . . 0.0 109.45 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.497 ' N ' HD22 ' A' ' 35' ' ' ASN . 50.9 mt-30 53.69 32.96 15.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.412 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.726 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -72.19 -38.17 69.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 109.507 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.0 p-10 -65.66 -30.74 71.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.858 . . . . 0.0 109.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 72.0 mm-40 -80.13 10.6 4.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.488 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 23.4 t70 -60.1 144.14 50.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.186 -0.946 . . . . 0.0 109.427 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 40' ' ' ASP . 9.5 p30 42.73 42.61 3.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.1 m -144.45 -32.41 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 CA-C-O 118.004 -1.442 . . . . 0.0 109.544 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.852 0 N-CA-C 119.385 2.514 . . . . 0.0 119.385 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -57.87 -37.22 73.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -1.141 . . . . 0.0 109.53 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -149.2 159.67 44.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 109.46 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -165.0 161.25 19.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.495 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.2 m -98.89 135.34 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.492 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -142.17 126.21 17.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.5 m -142.24 143.61 32.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 108.67 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.5 m -66.47 176.3 1.92 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.427 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp -75.88 143.2 41.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.469 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 -3.03 68.07 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.461 ' N ' ' CD1' ' A' ' 11' ' ' TYR . 26.0 m-85 -116.13 135.5 53.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -1.163 . . . . 0.0 109.431 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -113.84 146.68 36.08 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.463 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.82 138.08 28.19 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.837 2.358 . . . . 0.0 112.182 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.4 m -65.16 -11.38 39.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.98 -124.1 2.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -82.93 11.4 6.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.274 -1.133 . . . . 0.0 109.447 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.574 ' CD1' HD21 ' A' ' 35' ' ' ASN . 10.9 mt -100.2 140.42 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.429 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.8 m -77.28 79.13 3.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.467 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.551 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 34.9 tttm -170.03 122.09 0.68 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.5 m -112.86 151.38 30.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 108.619 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.551 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 76.1 mt -138.97 151.34 67.94 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.41 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -46.66 146.5 5.36 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.706 2.27 . . . . 0.0 112.255 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -59.33 -27.65 66.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.568 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.77 -36.14 73.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.536 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 mt -84.4 11.05 9.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.902 . . . . 0.0 109.505 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.494 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 57.5 t-80 -80.27 120.67 24.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.444 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 83.9 m 47.11 38.24 6.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.468 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -90.74 6.19 45.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.29 32.38 58.16 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.07 137.23 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.181 -1.188 . . . . 0.0 109.479 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 26.8 p30 -82.85 108.87 16.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.467 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 1.2 p30 -132.91 -43.21 0.89 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.441 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.555 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 59.8 m -53.91 -24.62 16.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 109.31 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.73 -2.63 32.11 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.574 HD21 ' CD1' ' A' ' 17' ' ' ILE . 2.1 p30 -149.37 -92.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -1.144 . . . . 0.0 109.47 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -176.85 22.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.411 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.73 76.19 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.15 -0.969 . . . . 0.0 109.519 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 25.0 p-10 -67.53 -30.64 70.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.438 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 73.3 mm-40 -87.56 15.95 6.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 109.446 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 39' ' ' GLU . 51.2 p30 -54.16 -172.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.417 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 42' ' ' CYS . 48.2 p-10 -46.85 -20.83 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.466 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.509 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 91.8 m 50.92 77.44 0.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.497 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.849 0 N-CA-C 119.412 2.525 . . . . 0.0 119.412 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.2 t -58.45 -35.16 71.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -1.119 . . . . 0.0 109.449 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -63.4 151.97 39.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.401 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.35 150.86 8.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 109.548 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 6' ' ' LYS . 6.0 m -51.4 135.47 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.519 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' VAL . 44.0 tttp -62.04 -127.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 109.489 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.3 m -106.21 159.17 16.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.92 . . . . 0.0 109.073 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.3 m -59.29 166.2 2.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.486 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp -71.84 139.32 48.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.37 0.61 67.31 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -118.99 147.36 44.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -1.123 . . . . 0.0 109.493 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.512 ' CD1' ' OE1' ' A' ' 23' ' ' GLN . 14.5 p90 -132.96 146.44 61.29 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.24 -0.912 . . . . 0.0 109.472 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.24 143.8 44.75 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.782 2.321 . . . . 0.0 112.248 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.5 m -67.45 -21.73 65.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.11 -114.77 0.73 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -84.96 9.47 14.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -1.157 . . . . 0.0 109.423 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 mt -100.16 136.38 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 m -75.59 62.8 1.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -143.42 140.74 30.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -127.34 143.29 51.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 108.756 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 21' ' ' LEU . 98.3 mt -138.51 149.9 64.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.422 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.07 154.3 71.22 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.819 2.346 . . . . 0.0 112.174 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.512 ' OE1' ' CD1' ' A' ' 12' ' ' PHE . 15.0 mm100 -57.23 -20.81 29.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.465 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.8 mt -56.69 -36.1 69.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.481 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.22 12.52 22.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.589 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.7 t-80 -80.95 118.43 22.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.975 . . . . 0.0 109.459 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.589 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 60.9 m 51.45 39.14 23.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -89.27 4.52 48.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.511 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.84 26.78 68.33 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.13 135.74 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -1.139 . . . . 0.0 109.521 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -77.42 129.32 35.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.49 -51.77 0.3 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 109.422 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.501 ' SG ' ' OD1' ' A' ' 38' ' ' ASP . 87.7 m -52.08 -20.85 2.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.222 -0.924 . . . . 0.0 109.366 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.36 -2.73 34.78 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -149.46 -92.17 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -1.131 . . . . 0.0 109.525 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -176.1 22.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.12 82.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.469 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 1.1 p-10 -66.35 -30.13 70.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -82.07 11.14 5.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.45 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.473 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 51.7 p30 -63.41 158.7 19.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.473 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 21.4 p30 41.11 35.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.424 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.2 m -147.16 159.71 43.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 CA-C-O 117.978 -1.457 . . . . 0.0 109.591 179.948 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.414 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.529 4.868 0 N-CA-C 119.39 2.516 . . . . 0.0 119.39 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 1' ' ' GLY . 16.8 p 46.16 35.08 2.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -1.111 . . . . 0.0 109.493 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -58.23 -37.23 74.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.482 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.31 120.09 27.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.456 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.664 HG22 ' H ' ' A' ' 7' ' ' CYS . 7.5 p -74.52 122.65 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.46 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.61 11.2 34.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.165 -0.959 . . . . 0.0 109.462 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.664 ' H ' HG22 ' A' ' 5' ' ' VAL . 79.0 m -99.54 155.78 17.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.559 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -65.4 168.75 6.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.41 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 mt -67.23 150.67 48.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.7 -6.68 74.05 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -120.5 149.17 42.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -1.15 . . . . 0.0 109.418 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.38 146.43 48.49 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.393 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.14 142.98 39.06 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.789 2.326 . . . . 0.0 112.19 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.3 m -62.35 -28.34 69.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.434 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.69 -110.98 0.49 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -85.64 7.86 21.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.197 -1.178 . . . . 0.0 109.435 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.5 mt -99.46 139.22 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.494 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -79.74 91.31 5.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -171.27 167.36 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 109.44 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -143.75 143.41 31.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 108.801 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.7 mt -136.85 148.98 65.36 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.361 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.65 155.07 72.13 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.804 2.336 . . . . 0.0 112.182 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -57.12 -22.06 37.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.7 mp -54.89 -37.98 66.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.5 mt -88.34 14.93 8.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.484 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.531 ' NE2' ' SG ' ' A' ' 42' ' ' CYS . 11.7 t-80 -76.96 104.72 7.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.455 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 m 49.96 45.36 25.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -92.06 6.48 46.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.97 29.15 55.07 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.3 t -130.83 138.81 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -1.187 . . . . 0.0 109.556 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -80.59 127.73 32.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.452 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.438 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -148.49 -53.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.456 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 50.9 m -58.8 -22.05 57.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.94 -58.98 3.23 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.6 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -81.48 11.19 4.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -1.158 . . . . 0.0 109.446 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 53.76 35.18 20.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.6 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -71.7 -40.71 69.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.488 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 18.0 p-10 -63.56 -30.69 71.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.531 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -82.86 10.56 7.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.473 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 41' ' ' ASN . 47.9 t0 -74.54 75.47 1.97 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.452 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 40' ' ' ASP . 6.0 p-10 38.64 90.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.467 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.531 ' SG ' ' NE2' ' A' ' 26' ' ' HIS . 38.2 m -68.12 154.06 42.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.286 -0.884 . . . . 0.0 109.479 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.548 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.771 0 N-CA-C 119.398 2.519 . . . . 0.0 119.398 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.3 m -64.0 156.32 28.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -1.188 . . . . 0.0 109.466 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.532 ' CD ' ' H ' ' A' ' 3' ' ' GLN . 9.0 mp0 -59.02 -34.38 71.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.483 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 50.05 -125.03 2.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.167 -0.958 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 p -137.83 144.86 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.493 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -128.27 130.53 48.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.28 -0.888 . . . . 0.0 109.457 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 m -128.28 136.64 51.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.031 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.6 m -84.14 -170.81 3.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.455 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt -72.54 147.39 46.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.252 -0.905 . . . . 0.0 109.441 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.92 4.87 66.75 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -137.18 156.32 48.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -1.151 . . . . 0.0 109.49 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.414 ' HB3' HE22 ' A' ' 23' ' ' GLN . 22.8 p90 -143.39 147.19 39.01 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.476 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.82 139.83 34.21 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.845 2.363 . . . . 0.0 112.23 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.7 m -64.87 -20.91 66.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.9 -114.26 0.84 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -83.0 5.89 20.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -1.088 . . . . 0.0 109.419 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.0 mm -91.68 154.55 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.497 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.3 p -94.3 65.33 3.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG2' ' HZ2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -154.73 165.19 37.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.486 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -143.98 147.44 33.9 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 21' ' ' LEU . 98.1 mt -136.21 149.87 69.29 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.451 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.49 152.54 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.793 2.329 . . . . 0.0 112.162 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.414 HE22 ' HB3' ' A' ' 12' ' ' PHE . 83.4 mm-40 -62.13 -26.86 68.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 mt -56.91 -35.34 68.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.53 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.9 mt -89.26 11.63 18.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.468 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.0 t-80 -79.36 115.92 19.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.93 . . . . 0.0 109.483 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 61.3 m 46.31 39.77 6.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 109.519 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.408 HD21 ' HB ' ' A' ' 30' ' ' VAL . 41.0 p-10 -91.95 7.91 39.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.09 36.7 64.13 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.408 ' HB ' HD21 ' A' ' 28' ' ' ASN . 47.3 t -132.29 137.32 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -1.149 . . . . 0.0 109.486 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -78.32 123.54 27.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -148.27 -54.69 0.2 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.483 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.3 m -59.03 -25.17 63.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.602 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.01 -46.57 1.87 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.717 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -87.09 5.64 36.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -1.136 . . . . 0.0 109.475 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.559 ' N ' HD22 ' A' ' 35' ' ' ASN . 89.6 mt-30 52.43 28.25 5.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.347 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.717 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -70.12 -37.64 75.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 17.6 p-10 -64.73 -31.08 72.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 77.5 mm-40 -87.66 20.52 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 109.442 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 57.8 t0 -138.85 153.41 48.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.494 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 22.1 p30 41.08 45.02 2.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.485 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 56.4 m -58.12 -30.74 66.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.496 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.528 4.799 0 N-CA-C 119.451 2.54 . . . . 0.0 119.451 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 1' ' ' GLY . 28.7 t 50.72 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -1.122 . . . . 0.0 109.484 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 54.79 73.45 0.41 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.232 -0.917 . . . . 0.0 109.5 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -58.7 148.81 28.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.484 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.2 m -129.95 154.59 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.918 . . . . 0.0 109.488 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -141.48 139.72 33.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.459 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 29.3 m -99.99 160.67 14.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.655 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.1 m -66.46 169.87 6.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.895 . . . . 0.0 109.508 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.9 mt -61.09 143.6 55.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 0.0 109.486 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.53 4.49 83.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -142.24 156.35 45.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.151 . . . . 0.0 109.466 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.53 146.01 49.02 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.46 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 59.5 Cg_endo -74.8 143.19 29.48 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.853 2.369 . . . . 0.0 112.2 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.2 m -69.1 -21.06 64.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.905 . . . . 0.0 109.537 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.48 -116.42 0.87 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -88.64 11.08 18.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -1.135 . . . . 0.0 109.469 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 mt -100.83 141.66 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 18' ' ' THR . 7.2 t -77.01 86.61 3.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 29.4 tttm -170.31 151.69 3.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.6 m -142.49 144.75 33.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 108.799 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.423 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 84.5 mt -135.04 150.3 72.7 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.471 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.2 146.12 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.841 2.361 . . . . 0.0 112.128 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -58.71 -26.59 64.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.481 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.0 mt -57.45 -36.12 70.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.7 mt -86.3 14.38 6.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.183 -0.948 . . . . 0.0 109.525 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.458 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 59.9 t-80 -90.26 123.13 33.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.406 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.458 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 98.6 m 50.91 34.27 10.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.481 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.422 HD21 ' HB ' ' A' ' 30' ' ' VAL . 46.0 p-10 -92.42 7.23 43.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.469 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.55 34.8 63.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.422 ' HB ' HD21 ' A' ' 28' ' ' ASN . 39.0 t -132.03 141.58 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -1.182 . . . . 0.0 109.452 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -85.25 117.91 24.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.288 -0.883 . . . . 0.0 109.497 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -142.4 -52.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.469 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 20.2 m -55.78 -35.62 66.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.041 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.13 -39.95 2.58 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.801 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -88.96 2.93 53.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.159 . . . . 0.0 109.532 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.571 ' N ' HD22 ' A' ' 35' ' ' ASN . 37.0 tp60 59.51 18.39 6.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.877 . . . . 0.0 109.385 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.801 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -75.34 -31.91 60.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.498 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 32' ' ' ASP . 27.1 p-10 -62.56 -31.59 72.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.497 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.456 ' CG ' HE21 ' A' ' 36' ' ' GLN . 65.4 mm-40 -87.75 16.57 5.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.464 ' O ' ' C ' ' A' ' 41' ' ' ASN . 49.7 p30 -62.27 152.16 34.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.477 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' A' ' 40' ' ' ASP . 15.9 p30 41.21 34.23 0.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.16 -0.963 . . . . 0.0 109.467 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 94.7 m -142.48 158.96 43.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.451 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.883 0 N-CA-C 119.356 2.502 . . . . 0.0 119.356 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.3 p -62.78 -24.57 67.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -1.167 . . . . 0.0 109.458 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -57.56 -36.23 71.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' VAL . 57.1 t0 49.95 50.16 18.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.87 . . . . 0.0 109.504 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 6' ' ' LYS . 2.2 t -62.22 -136.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 109.515 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.482 ' H ' HG12 ' A' ' 5' ' ' VAL . 66.6 mmtt 51.07 -153.67 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.514 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 73.1 m -99.91 158.4 15.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.673 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.2 m -78.33 178.39 7.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.402 ' O ' ' CD2' ' A' ' 11' ' ' TYR . 37.3 mt -69.02 139.51 54.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.439 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.07 4.89 81.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 9' ' ' LEU . 25.0 m-85 -138.2 156.79 47.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -1.18 . . . . 0.0 109.471 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -136.73 146.28 54.62 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.409 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.475 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 57.5 Cg_endo -73.92 145.27 35.74 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.843 2.362 . . . . 0.0 112.242 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.6 m -70.36 -20.11 62.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.508 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.41 -118.63 1.03 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -87.6 11.69 14.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -1.172 . . . . 0.0 109.449 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.64 139.17 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.8 p -74.11 90.06 2.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.539 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.679 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 31.5 tttm -171.24 149.54 2.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.439 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.4 m -140.81 143.91 35.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 108.74 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.679 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 91.8 mt -137.82 150.92 69.34 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.362 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -47.12 143.99 9.47 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.797 2.331 . . . . 0.0 112.292 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.22 -21.91 49.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.294 -0.879 . . . . 0.0 109.473 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 mt -59.99 -35.33 74.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.4 mt -85.77 7.68 22.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.456 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -78.15 108.81 11.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.428 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 38' ' ' ASP . 51.9 m 51.82 50.33 18.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.43 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.638 HD21 HG12 ' A' ' 30' ' ' VAL . 17.2 p-10 -95.2 -39.97 9.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.449 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.06 29.72 0.29 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.638 HG12 HD21 ' A' ' 28' ' ' ASN . 8.4 p -144.07 143.46 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -1.161 . . . . 0.0 109.406 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -84.93 103.61 14.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.52 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.446 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -114.22 -51.24 2.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.48 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.407 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 57.8 m -54.44 -30.76 53.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.59 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.77 -44.89 2.53 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.5 p30 -86.2 10.1 15.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -1.15 . . . . 0.0 109.494 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 52.86 23.79 2.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.427 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -72.93 -37.72 67.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.522 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 21.3 p-10 -64.38 -30.98 72.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.52 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -85.9 10.42 13.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' O ' ' C ' ' A' ' 41' ' ' ASN . 59.3 t0 -77.78 126.3 30.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 109.436 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.476 ' C ' ' O ' ' A' ' 40' ' ' ASP . 6.3 p-10 39.62 84.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.472 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 88.0 m -90.48 158.04 17.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 CA-C-O 117.916 -1.491 . . . . 0.0 109.522 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.775 0 N-CA-C 119.402 2.521 . . . . 0.0 119.402 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 t 51.49 -150.37 0.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -1.171 . . . . 0.0 109.474 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -148.0 166.46 27.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.9 . . . . 0.0 109.404 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.36 146.7 28.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.509 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 6' ' ' LYS . 7.5 p -131.75 133.82 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.491 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 5' ' ' VAL . 96.6 mttt 44.8 -129.9 0.98 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 109.404 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.4 m -101.03 157.49 16.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.92 . . . . 0.0 109.229 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.3 m -72.74 175.15 6.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.508 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 tp -76.18 138.83 40.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.89 -0.44 67.11 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -115.94 152.62 33.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.507 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -136.99 146.27 54.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.472 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.44 144.09 49.4 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.788 2.325 . . . . 0.0 112.222 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.5 m -65.81 -21.41 66.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.53 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.86 -110.96 0.6 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -84.78 9.69 13.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -1.139 . . . . 0.0 109.403 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 mm -97.98 141.01 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 109.423 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 18' ' ' THR . 1.5 t -81.73 59.06 4.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.511 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -146.44 148.17 32.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.406 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.05 145.49 50.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 108.938 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 21' ' ' LEU . 98.2 mt -137.5 149.56 65.62 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.77 155.69 65.89 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.821 2.347 . . . . 0.0 112.236 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -56.74 -25.34 54.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.573 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.4 tp -51.0 -39.4 55.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -89.05 19.61 4.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.527 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -79.52 112.48 16.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -0.942 . . . . 0.0 109.454 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.4 m 47.19 45.52 16.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.439 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -87.04 4.22 42.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.16 10.2 80.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.21 134.39 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.42 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -86.2 103.32 14.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 0.0 109.459 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -103.32 -53.64 2.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.445 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 63.1 m -57.44 -25.95 60.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.46 -33.11 5.49 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.5 p-10 -89.93 5.03 48.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -1.162 . . . . 0.0 109.469 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 52.08 26.01 3.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.88 . . . . 0.0 109.402 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.509 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -72.48 -34.21 67.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.187 -0.946 . . . . 0.0 109.519 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 8.7 p30 -65.19 -30.7 71.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -81.67 11.93 4.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.496 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.469 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 93.8 m-20 -68.27 156.71 37.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.872 . . . . 0.0 109.54 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 4.2 p-10 42.0 44.66 3.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.494 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.9 m -144.74 162.04 37.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 109.552 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.539 -179.955 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.852 0 N-CA-C 119.331 2.492 . . . . 0.0 119.331 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.4 p -160.94 -23.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -1.153 . . . . 0.0 109.458 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -151.82 86.73 1.32 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -88.03 120.36 29.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 109.478 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.0 t -124.17 135.16 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.317 -0.864 . . . . 0.0 109.517 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -157.81 -130.86 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 109.503 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 m -126.68 136.31 52.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.331 -0.855 . . . . 0.0 109.122 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -83.03 -173.57 4.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.2 mt -73.67 145.46 45.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.431 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.98 6.86 66.57 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -132.31 156.43 46.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -1.134 . . . . 0.0 109.447 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -141.52 146.75 43.25 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.509 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.64 140.42 39.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.708 2.272 . . . . 0.0 112.289 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.7 m -61.58 -41.48 97.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.479 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.58 108.53 0.61 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 54.7 19.59 2.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -1.129 . . . . 0.0 109.438 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mm -124.13 138.47 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.878 . . . . 0.0 109.439 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 m -74.87 52.13 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.875 . . . . 0.0 109.478 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.684 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 37.2 tttm -140.98 142.76 34.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.431 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -132.18 148.63 52.48 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.684 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 86.9 mt -139.59 149.8 61.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.376 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.58 144.48 3.25 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.783 2.322 . . . . 0.0 112.19 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.47 -24.58 60.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.472 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.6 mp -58.96 -36.1 74.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.7 mt -84.92 11.98 8.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -81.51 118.71 22.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.948 . . . . 0.0 109.445 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.4 m 50.34 34.51 9.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.424 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.426 HD21 ' HB ' ' A' ' 30' ' ' VAL . 42.9 p-10 -88.99 6.76 38.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.82 38.32 65.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.426 ' HB ' HD21 ' A' ' 28' ' ' ASN . 48.0 t -133.75 136.37 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.9 p-10 -83.97 103.01 12.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.411 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -122.28 -51.94 1.96 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.259 -0.901 . . . . 0.0 109.475 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 76.2 m -58.73 -25.07 62.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 0.0 109.251 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.74 -43.18 2.47 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 50.5 p30 -87.91 6.25 36.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.467 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 52.26 33.66 13.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.463 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -75.22 -38.13 60.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 109.496 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 15.5 p30 -65.59 -31.07 71.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.519 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -81.22 0.99 34.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 109.474 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 42' ' ' CYS . 95.1 m-20 -50.28 173.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 43.6 p-10 -46.63 91.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.547 ' N ' ' O ' ' A' ' 40' ' ' ASP . 58.0 m -61.58 -24.98 67.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 109.471 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.949 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.527 4.763 0 N-CA-C 119.381 2.512 . . . . 0.0 119.381 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.7 t 47.2 -123.73 1.48 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -1.156 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 52.28 53.46 12.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.411 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -86.07 7.79 23.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.51 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' LYS . 48.2 t -71.87 129.77 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.422 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' VAL . 60.3 mttp 50.46 179.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 109.513 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 29.0 m -99.25 139.3 35.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.102 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.0 m -68.94 -177.83 1.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.2 mt -75.65 147.67 39.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.91 4.07 69.79 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -130.18 156.58 44.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -1.145 . . . . 0.0 109.457 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -140.08 146.65 47.31 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.449 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.34 142.57 37.47 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.748 2.299 . . . . 0.0 112.262 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.1 m -66.96 -20.85 65.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.515 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.13 -112.51 0.69 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -85.63 9.34 16.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -1.111 . . . . 0.0 109.393 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 mt -102.84 140.5 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.872 . . . . 0.0 109.429 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -78.58 58.96 2.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.921 . . . . 0.0 109.495 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -139.1 140.13 37.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 109.437 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.67 145.9 51.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 83.5 mt -138.93 150.41 65.22 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.361 -0.837 . . . . 0.0 109.391 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.04 152.69 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.796 2.331 . . . . 0.0 112.199 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -61.69 -28.42 69.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.6 mt -55.05 -36.19 65.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.434 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.5 mt -88.67 15.49 8.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.955 . . . . 0.0 109.488 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.431 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 55.7 t-80 -82.57 114.72 21.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.408 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 38' ' ' ASP . 57.0 m 47.26 38.81 7.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.443 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.402 HD21 ' HB ' ' A' ' 30' ' ' VAL . 44.8 p-10 -89.83 8.26 32.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.905 . . . . 0.0 109.497 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.96 31.14 62.33 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' HB ' HD21 ' A' ' 28' ' ' ASN . 45.5 t -127.38 138.59 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 36.1 p-10 -83.24 115.15 21.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -139.29 -51.22 0.53 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.46 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 66.6 m -56.94 -39.26 74.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.905 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 36' ' ' GLN . . . 134.76 -72.96 0.46 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -86.93 20.96 2.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -1.125 . . . . 0.0 109.463 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 34' ' ' GLY . 27.2 mp0 53.9 40.66 31.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.28 77.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.882 . . . . 0.0 109.449 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.49 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 9.0 p30 -63.57 -31.27 72.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.0 OUTLIER -82.11 10.19 7.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.503 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 42' ' ' CYS . 50.7 p30 -60.54 -170.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.472 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 43' ' ' GLY . 31.7 p30 -46.52 -17.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.333 -0.854 . . . . 0.0 109.503 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.498 ' N ' ' O ' ' A' ' 40' ' ' ASP . 93.3 m 51.2 -89.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 3' ' ' GLN . . . . . . . . 1 N--CA 1.529 4.858 0 N-CA-C 119.382 2.513 . . . . 0.0 119.382 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 67.08 -43.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -1.153 . . . . 0.0 109.475 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 1' ' ' GLY . 92.0 mt-30 52.96 44.02 30.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.482 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -89.31 11.1 19.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.466 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.6 m -128.72 157.03 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.491 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -154.06 45.48 0.58 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.5 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.4 m -98.7 141.64 31.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 108.88 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.2 m -66.73 173.26 3.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 9' ' ' LEU . 8.6 mp -67.84 151.49 47.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.454 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.34 -7.53 77.98 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.26 151.98 41.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -1.158 . . . . 0.0 109.459 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 13.5 p90 -142.22 125.29 9.42 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.2 141.09 13.72 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.832 2.355 . . . . 0.0 112.17 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.1 m -64.76 -22.75 67.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 0.0 109.494 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.01 -113.88 0.66 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -84.46 8.47 16.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -1.112 . . . . 0.0 109.484 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.9 mt -98.82 140.36 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 109.504 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 p -78.89 57.9 2.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.699 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 28.5 tttm -142.49 142.75 32.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -126.7 144.49 50.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 108.983 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.699 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 99.0 mt -137.23 149.78 66.99 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.413 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.79 155.63 68.27 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.795 2.33 . . . . 0.0 112.257 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -57.67 -20.24 32.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.479 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.3 tp -56.27 -36.65 68.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.488 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.4 mt -91.2 10.2 28.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.819 . . . . 0.0 109.524 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.591 ' CE1' ' SG ' ' A' ' 42' ' ' CYS . 45.0 t-80 -74.25 104.25 4.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.413 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.7 m 52.11 50.21 18.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.639 HD21 HG12 ' A' ' 30' ' ' VAL . 15.5 p-10 -91.16 -35.42 14.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.421 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.13 26.76 0.67 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.639 HG12 HD21 ' A' ' 28' ' ' ASN . 8.5 p -144.73 142.75 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.472 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -85.73 103.59 14.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -112.32 -52.37 2.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.866 . . . . 0.0 109.475 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.446 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 37.2 m -48.68 -45.03 38.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.64 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.07 -59.73 0.66 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.738 ' H ' ' ND2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -90.25 -89.49 0.16 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 109.478 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.654 ' H ' ' ND2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -173.17 23.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.882 . . . . 0.0 109.389 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.71 -47.58 80.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 28.2 p-10 -65.71 -30.43 71.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.415 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -85.2 21.61 1.65 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -65.82 179.55 0.85 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.418 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 41' ' ' ASN . 6.2 p30 -58.32 92.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.45 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.591 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 93.1 m -87.92 157.21 19.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -0.844 . . . . 0.0 109.512 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.537 179.897 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.879 0 N-CA-C 119.385 2.514 . . . . 0.0 119.385 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -145.16 150.51 36.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -1.14 . . . . 0.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 53.6 90.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.524 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -65.69 146.56 54.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.91 . . . . 0.0 109.508 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.8 t -98.52 134.75 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.501 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -80.91 160.55 24.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.462 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 84.8 m -99.45 159.76 14.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.63 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.7 m -68.07 176.37 2.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.29 -0.882 . . . . 0.0 109.524 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.5 mt -66.18 142.53 57.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.76 2.44 84.4 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -142.31 156.91 45.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.385 -1.067 . . . . 0.0 109.441 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -141.24 146.99 45.18 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.498 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 59.8 Cg_endo -75.09 143.54 28.9 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.818 2.345 . . . . 0.0 112.216 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.7 m -69.45 -14.79 63.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.499 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.03 -118.45 1.55 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -83.47 9.77 10.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -1.152 . . . . 0.0 109.442 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 mm -94.71 141.3 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.487 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.6 m -81.48 87.98 6.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 33' ' ' CYS . 14.9 ptpt -173.14 168.14 4.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.5 m -148.82 142.98 26.02 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.93 150.12 70.54 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.489 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.18 145.44 5.51 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.76 2.306 . . . . 0.0 112.219 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.22 -27.12 65.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.51 -34.98 73.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 109.558 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.35 9.67 14.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 109.528 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.593 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 53.7 t-80 -78.92 119.65 22.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.593 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 84.3 m 46.83 39.32 7.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.431 ' ND2' ' CG2' ' A' ' 30' ' ' VAL . 41.0 p-10 -93.05 5.63 50.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.62 33.83 55.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.431 ' CG2' ' ND2' ' A' ' 28' ' ' ASN . 59.7 t -127.74 136.19 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -1.137 . . . . 0.0 109.469 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 35.1 p-10 -81.73 103.57 11.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.94 . . . . 0.0 109.524 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -127.86 -49.74 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.518 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 86.0 m -59.54 -27.17 65.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.951 . . . . 0.0 109.598 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.72 -44.85 2.37 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.714 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -87.04 6.23 33.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -1.174 . . . . 0.0 109.472 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.495 ' N ' HD22 ' A' ' 35' ' ' ASN . 93.2 mt-30 52.14 28.14 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.874 . . . . 0.0 109.41 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.714 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -73.91 -38.19 64.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.475 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 20.6 p-10 -64.45 -31.1 72.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 75.1 mm-40 -84.87 13.33 6.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.903 . . . . 0.0 109.438 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 42' ' ' CYS . 51.4 p30 -56.44 -171.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 42' ' ' CYS . 31.8 p30 -46.88 -18.87 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.879 . . . . 0.0 109.436 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 89.3 m 51.61 53.29 12.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 CA-C-O 117.994 -1.448 . . . . 0.0 109.525 179.998 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.868 0 N-CA-C 119.378 2.511 . . . . 0.0 119.378 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 t -145.74 149.48 34.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -1.125 . . . . 0.0 109.392 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -55.82 -35.88 66.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -65.92 144.49 56.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 0.0 109.501 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.4 134.96 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.503 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -73.46 144.88 46.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.436 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.8 m -114.83 158.8 21.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 108.983 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.7 m -61.79 170.46 2.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.498 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.44 150.5 48.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.961 . . . . 0.0 109.444 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.7 -4.21 86.41 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -127.02 153.68 45.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.144 . . . . 0.0 109.49 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CD1' ' NE2' ' A' ' 23' ' ' GLN . 20.8 p90 -143.53 147.28 38.94 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.23 143.28 48.08 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.808 2.339 . . . . 0.0 112.21 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.46 -24.44 64.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.37 -110.32 0.54 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -84.73 6.91 22.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -1.147 . . . . 0.0 109.482 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.2 mt -102.35 137.67 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.6 p -78.1 62.63 2.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -144.93 145.47 31.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.409 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.13 146.06 51.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 108.844 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 21' ' ' LEU . 71.3 mt -140.53 152.46 66.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 109.38 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -52.73 149.76 24.19 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.783 2.322 . . . . 0.0 112.224 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.515 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 94.0 mm-40 -60.56 -25.61 66.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.626 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.7 mp -60.06 -34.33 73.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.565 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.553 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 31.1 mt -85.72 9.9 15.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 109.558 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.494 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 55.1 t-80 -91.13 131.41 36.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.397 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 64.0 m 51.71 79.68 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.432 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.553 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 12.5 p30 -143.28 -3.77 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.413 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.63 3.24 89.74 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.94 140.37 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -1.142 . . . . 0.0 109.48 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -89.0 125.43 34.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.477 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.443 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -138.16 -51.8 0.6 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.4 m -53.9 -41.2 67.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.935 . . . . 0.0 109.63 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 145.37 -27.01 1.84 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.532 ' CG ' ' H ' ' A' ' 36' ' ' GLN . 1.2 p30 -136.22 -99.66 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -1.162 . . . . 0.0 109.481 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.532 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 72.7 mt-30 -155.93 15.36 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.391 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.99 91.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.489 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 33.3 p-10 -63.63 -31.54 72.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.901 . . . . 0.0 109.548 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.466 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 64.6 mm-40 -76.15 -54.64 6.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.462 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 41' ' ' ASN . 43.2 t0 44.79 -166.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.477 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.567 HD22 ' N ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -76.41 3.73 10.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.908 . . . . 0.0 109.415 179.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.567 ' N ' HD22 ' A' ' 41' ' ' ASN . 73.0 m 47.46 -172.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -0.906 . . . . 0.0 109.526 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 CA-C-O 118.003 -1.443 . . . . 0.0 109.543 179.977 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.865 0 N-CA-C 119.38 2.512 . . . . 0.0 119.38 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 m -57.22 -36.03 70.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -1.134 . . . . 0.0 109.474 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -94.66 116.65 29.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.186 -0.946 . . . . 0.0 109.407 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -78.99 138.09 37.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.312 -0.867 . . . . 0.0 109.527 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.88 140.81 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.907 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -97.02 33.95 1.82 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.88 . . . . 0.0 109.461 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -134.63 141.81 46.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.131 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -86.63 -161.57 0.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.895 . . . . 0.0 109.493 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.58 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -81.11 142.24 33.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.437 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.77 -0.11 69.71 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -130.56 156.02 45.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -1.179 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CD1' ' NE2' ' A' ' 23' ' ' GLN . 12.6 p90 -148.56 146.59 22.8 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.394 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.529 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 57.4 Cg_endo -73.84 148.56 41.17 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.786 2.324 . . . . 0.0 112.197 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.61 -7.04 59.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.591 ' C ' ' H ' ' A' ' 17' ' ' ILE . . . 88.77 132.27 4.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m120 68.01 -25.95 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -1.109 . . . . 0.0 109.447 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.591 ' H ' ' C ' ' A' ' 15' ' ' GLY . 24.1 mm -104.37 130.12 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.479 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 18' ' ' THR . 0.6 OUTLIER -80.24 57.66 2.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.504 179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.645 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 33.5 tttm -146.6 137.03 23.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.47 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 13' ' ' PRO . 1.6 m -117.17 147.38 42.52 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.645 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 67.6 mt -137.51 151.96 72.07 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.382 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.36 149.3 13.02 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.829 2.352 . . . . 0.0 112.178 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.515 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 92.9 mm-40 -60.24 -25.43 65.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.534 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.8 tp -58.12 -36.75 73.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.495 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.96 5.53 28.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.519 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -84.34 131.59 34.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 57.7 m 51.36 26.76 3.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.486 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -84.81 3.51 37.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.01 36.55 81.48 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -133.43 137.01 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.0 109.535 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -82.76 104.1 12.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.517 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.83 -58.66 2.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -0.97 . . . . 0.0 109.467 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.8 m -63.49 -27.55 69.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.3 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.07 -31.35 5.7 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.713 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -83.83 4.6 28.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -1.161 . . . . 0.0 109.475 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.581 ' N ' HD22 ' A' ' 35' ' ' ASN . 94.2 mt-30 48.67 13.69 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.421 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.713 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -64.77 -38.83 92.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 109.488 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 27.9 p-10 -65.81 -30.66 71.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.452 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 41' ' ' ASN . 81.2 mm-40 -91.24 13.5 17.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 0.0 109.533 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 41' ' ' ASN . 52.0 p30 -63.25 77.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.494 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 43' ' ' GLY . 20.3 p30 41.56 32.95 0.26 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.362 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 73.4 m 46.79 -92.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.46 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.294 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.579 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 3' ' ' GLN . . . . . . . . 1 N--CA 1.53 4.918 0 N-CA-C 119.402 2.521 . . . . 0.0 119.402 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.7 t 53.12 6.5 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.352 -1.087 . . . . 0.0 109.547 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 1' ' ' GLY . 62.7 tt0 -97.0 126.88 42.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.497 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 5' ' ' VAL . 49.5 t0 -155.37 163.63 39.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 109.5 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.403 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 10.6 p -89.04 138.66 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 109.546 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -135.34 154.29 51.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.499 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.9 m -100.96 158.59 15.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.272 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.0 m -58.76 165.04 2.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 9' ' ' LEU . 9.2 mp -66.24 149.37 50.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.69 -4.03 81.73 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -127.64 152.39 47.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -1.13 . . . . 0.0 109.524 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -143.68 145.75 32.38 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.417 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.33 143.99 40.33 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.855 2.37 . . . . 0.0 112.186 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.5 m -62.94 -28.36 70.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.511 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.0 -106.82 0.32 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -86.9 8.19 24.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -1.161 . . . . 0.0 109.468 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 mt -102.54 140.93 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 109.424 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.7 m -80.93 63.5 5.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.681 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 26.4 tttm -144.09 131.98 21.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -116.16 143.6 45.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.489 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.681 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 98.0 mt -137.21 149.29 65.5 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 109.407 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.16 155.27 66.02 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.75 2.3 . . . . 0.0 112.189 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.21 -22.18 60.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.536 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.3 mp -57.34 -36.07 70.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.408 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 63.0 mt -91.95 3.9 54.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.41 ' NE2' ' SG ' ' A' ' 27' ' ' CYS . 11.8 t-80 -81.56 125.95 31.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 109.367 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' ' NE2' ' A' ' 26' ' ' HIS . 80.3 m 52.7 28.77 6.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.421 HD21 ' HB ' ' A' ' 30' ' ' VAL . 43.5 p-10 -88.34 5.77 40.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 109.447 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.87 42.4 78.75 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 28' ' ' ASN . 40.8 t -138.86 140.25 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -1.151 . . . . 0.0 109.481 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -80.22 121.58 25.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.5 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -144.15 -52.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.437 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.422 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 69.1 m -59.58 -22.34 61.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.367 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.41 -54.84 1.75 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.611 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -89.45 13.82 12.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -1.102 . . . . 0.0 109.485 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 52.76 34.28 15.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.394 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.611 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -70.72 -29.84 66.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 36.2 p-10 -79.82 -27.92 40.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.514 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 74.1 mm-40 -84.08 -31.44 25.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.494 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 37' ' ' ALA . 53.8 p30 -88.87 47.92 1.56 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.902 . . . . 0.0 109.446 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 43.7 p-10 -161.22 19.18 0.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.892 . . . . 0.0 109.474 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 19.4 m -93.96 161.03 14.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 109.427 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 CA-C-O 117.938 -1.479 . . . . 0.0 109.545 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.529 4.844 0 N-CA-C 119.339 2.495 . . . . 0.0 119.339 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 1' ' ' GLY . 22.1 t 49.31 -176.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -1.164 . . . . 0.0 109.438 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -85.96 151.43 23.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.855 . . . . 0.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 4' ' ' ASP . 55.1 p30 -91.0 11.81 21.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.49 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.9 137.36 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.476 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -143.84 149.06 36.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.925 . . . . 0.0 109.518 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 66.3 m -99.29 125.23 44.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.178 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.2 m -88.35 -157.87 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.487 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 11' ' ' TYR . 20.1 mt 57.81 -168.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.446 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.93 16.45 1.97 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.473 ' H ' ' C ' ' A' ' 9' ' ' LEU . 29.2 m-85 -101.04 139.23 37.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.148 . . . . 0.0 109.451 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -139.74 146.73 48.65 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.43 139.93 42.63 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.809 2.34 . . . . 0.0 112.235 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.1 m -61.53 -33.56 74.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 0.0 109.545 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.0 -104.14 0.26 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -91.18 8.46 35.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -1.183 . . . . 0.0 109.416 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.3 mt -99.86 145.25 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 0.0 109.421 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.8 p -82.18 82.41 7.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.487 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -172.12 165.05 6.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.6 m -145.42 144.2 30.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 108.748 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.82 149.84 71.72 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.349 -0.844 . . . . 0.0 109.428 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.83 155.52 63.33 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.755 2.303 . . . . 0.0 112.186 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -58.23 -23.21 55.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.454 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.636 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.3 tt -53.57 -39.11 64.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.492 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.3 mt -88.8 13.72 11.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.507 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.581 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.5 t-80 -77.96 117.1 18.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.581 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 14.3 m 46.86 40.29 8.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.534 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.4 HD21 ' HB ' ' A' ' 30' ' ' VAL . 51.9 p-10 -89.04 6.48 39.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.22 -0.925 . . . . 0.0 109.464 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.43 32.25 60.06 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.4 ' HB ' HD21 ' A' ' 28' ' ' ASN . 41.4 t -135.2 137.56 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -1.137 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -79.41 127.48 32.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.909 . . . . 0.0 109.459 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -146.92 -58.53 0.28 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.912 . . . . 0.0 109.441 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 55.6 m -55.87 -25.19 41.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.352 -0.842 . . . . 0.0 109.251 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.06 -48.38 1.59 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 51.2 p-10 -89.44 7.18 37.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -1.14 . . . . 0.0 109.399 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 52.96 36.31 21.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.407 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -75.02 -24.49 58.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' OD2' ' SG ' ' A' ' 33' ' ' CYS . 0.4 OUTLIER -80.47 -31.19 37.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.478 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -74.45 -37.58 63.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.224 -0.923 . . . . 0.0 109.472 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 53.2 p30 -88.84 168.32 12.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.477 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER 40.03 45.55 1.65 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.93 . . . . 0.0 109.435 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.6 m -58.33 -31.49 67.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 109.476 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.505 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.529 4.848 0 N-CA-C 119.376 2.51 . . . . 0.0 119.376 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 1' ' ' GLY . 41.6 t 49.63 -177.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -1.192 . . . . 0.0 109.46 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -140.36 29.09 2.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.416 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -75.78 -5.91 48.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.502 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 5' ' ' VAL . 11.7 p -148.25 6.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -86.05 129.16 34.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.6 m -106.42 156.8 18.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 109.337 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.8 m -78.65 175.07 10.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.614 HD22 ' N ' ' A' ' 9' ' ' LEU . 3.7 mm? -73.33 140.45 46.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.429 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.02 1.6 67.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 44.7 m-85 -120.26 155.81 32.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -1.164 . . . . 0.0 109.491 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -141.87 146.1 39.37 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.41 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.64 148.39 53.13 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.811 2.341 . . . . 0.0 112.247 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 m -88.37 47.23 1.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.6 -154.38 28.29 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -50.34 -26.3 4.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -1.192 . . . . 0.0 109.451 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 mm -54.83 132.11 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 m -84.95 63.09 7.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.162 -0.961 . . . . 0.0 109.445 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -146.14 130.58 17.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -112.72 143.61 43.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 108.877 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.428 HD12 ' SG ' ' A' ' 33' ' ' CYS . 98.6 mt -138.06 149.65 64.56 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.937 . . . . 0.0 109.39 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.05 154.84 71.48 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.809 2.339 . . . . 0.0 112.178 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -57.07 -22.48 39.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.494 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.8 tp -53.73 -37.27 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.446 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.6 mt -90.92 16.46 9.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.518 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.701 ' CD2' HD21 ' A' ' 41' ' ' ASN . 51.5 t-80 -84.22 127.37 33.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.589 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 97.5 m 49.62 32.57 5.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.409 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 54.1 p30 -83.88 2.17 39.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.378 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.39 25.67 75.27 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t -128.64 138.28 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -1.131 . . . . 0.0 109.51 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.6 p-10 -88.29 101.87 14.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.537 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.43 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -104.58 -58.07 1.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.49 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.428 ' SG ' HD12 ' A' ' 21' ' ' LEU . 61.6 m -62.61 -25.74 68.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.265 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.88 -32.36 6.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.722 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -85.2 5.09 31.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -1.18 . . . . 0.0 109.506 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.49 ' N ' HD22 ' A' ' 35' ' ' ASN . 56.1 mt-30 48.85 19.56 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.477 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.722 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -65.87 -37.16 85.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.139 -0.975 . . . . 0.0 109.487 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 11.5 p30 -64.17 -31.84 73.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.493 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.506 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -76.76 -30.92 56.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -0.871 . . . . 0.0 109.441 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.58 57.7 0.74 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.701 HD21 ' CD2' ' A' ' 26' ' ' HIS . 48.7 p-10 -171.19 23.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.451 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 34.0 m -96.03 159.41 14.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.493 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.59 179.995 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.83 0 N-CA-C 119.409 2.524 . . . . 0.0 119.409 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 m -58.1 -36.47 72.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -1.12 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -159.33 10.99 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -65.77 141.07 58.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.876 . . . . 0.0 109.512 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -104.65 135.59 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.871 . . . . 0.0 109.461 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -77.43 132.82 38.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 109.434 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 41.2 m -99.54 137.19 38.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 108.85 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.8 m -71.41 177.06 4.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.267 -0.896 . . . . 0.0 109.507 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.636 ' N ' HD12 ' A' ' 9' ' ' LEU . 9.5 mp -62.95 160.52 14.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.02 -8.21 80.37 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -131.81 151.57 51.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -145.01 146.84 32.46 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.498 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.12 148.22 55.84 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.822 2.348 . . . . 0.0 112.247 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -82.8 -10.76 58.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.01 -126.96 2.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -80.74 8.14 8.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -1.146 . . . . 0.0 109.486 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 mm -88.01 131.79 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.429 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -76.55 85.02 3.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 -179.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -171.96 164.78 6.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 109.449 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -141.4 142.62 33.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 108.57 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.1 148.87 66.43 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.408 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.77 158.19 52.09 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.844 2.363 . . . . 0.0 112.205 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -60.37 -23.03 63.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.3 mp -56.79 -34.76 67.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 -179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.3 mt -94.12 11.24 30.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.526 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 45.3 t-80 -85.59 122.17 29.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.427 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.526 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 72.2 m 51.46 31.36 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 109.431 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.421 HD21 ' HB ' ' A' ' 30' ' ' VAL . 48.2 p-10 -86.51 5.98 32.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.49 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.67 39.37 77.76 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 28' ' ' ASN . 45.4 t -140.01 140.28 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.46 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -83.56 125.47 31.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.38 -60.48 0.61 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 0.0 109.451 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.1 m -65.08 -23.28 67.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 0.0 109.211 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.81 -33.7 4.71 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.719 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -86.45 3.94 41.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -1.176 . . . . 0.0 109.465 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.594 ' N ' HD22 ' A' ' 35' ' ' ASN . 93.1 mt-30 48.23 18.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.872 . . . . 0.0 109.439 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.719 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -65.51 -36.96 85.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.418 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -28.22 67.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.501 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -83.56 9.3 11.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 89.0 m-20 -60.65 151.21 29.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.498 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.516 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 4.0 p-10 41.84 42.71 2.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.945 . . . . 0.0 109.431 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 40.4 m -150.6 -8.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 CA-C-O 117.951 -1.472 . . . . 0.0 109.549 -179.984 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.826 0 N-CA-C 119.355 2.502 . . . . 0.0 119.355 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.5 m -58.38 -35.39 71.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -1.141 . . . . 0.0 109.536 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 45.73 -116.34 0.59 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.892 . . . . 0.0 109.543 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 58.8 t0 48.43 48.31 19.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.867 . . . . 0.0 109.503 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -88.23 132.51 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -165.99 45.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.485 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.5 m -136.95 158.0 45.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.193 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -58.82 164.48 2.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.13 144.94 53.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.439 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.04 -1.3 80.17 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -121.4 148.29 44.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -1.173 . . . . 0.0 109.509 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -134.98 146.63 59.39 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.421 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.23 144.41 51.45 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.828 2.352 . . . . 0.0 112.199 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.8 m -67.75 -21.2 65.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.443 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.76 -112.6 0.62 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -87.41 10.14 18.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -1.132 . . . . 0.0 109.367 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 mt -102.09 137.75 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 18' ' ' THR . 1.4 t -75.31 59.72 1.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.465 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 2.7 ttmp? -139.46 138.83 36.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.377 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -125.96 143.56 51.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 108.746 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.8 mt -138.29 149.71 64.22 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 109.388 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.56 154.56 64.01 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.738 2.292 . . . . 0.0 112.196 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -56.48 -25.02 49.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.322 -0.861 . . . . 0.0 109.519 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.7 tp -52.99 -37.97 61.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.499 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.5 mt -91.76 19.74 6.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.561 -179.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -82.88 114.5 21.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.507 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.1 m 46.93 36.65 4.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.477 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -85.63 8.3 20.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.382 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.75 29.22 63.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.3 t -129.4 139.67 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -1.169 . . . . 0.0 109.509 179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -84.45 122.0 28.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.88 . . . . 0.0 109.503 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -143.78 -47.77 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.455 179.862 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 56.5 m -57.84 -30.11 65.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.729 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.65 0.65 69.16 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 52.0 p30 -140.61 13.18 2.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -1.115 . . . . 0.0 109.439 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 51.94 22.9 1.93 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 109.415 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.451 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -70.76 -37.46 73.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 39' ' ' GLU . 20.1 p30 -65.6 -30.48 71.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.467 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.2 mp0 -78.71 10.53 3.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.521 ' OD1' ' ND2' ' A' ' 41' ' ' ASN . 55.2 p30 -71.52 170.98 12.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.441 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.521 ' ND2' ' OD1' ' A' ' 40' ' ' ASP . 22.4 p30 40.6 37.84 0.53 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 109.468 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 90.9 m -146.53 -2.82 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.449 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 CA-C-O 117.944 -1.475 . . . . 0.0 109.575 179.953 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.852 0 N-CA-C 119.434 2.534 . . . . 0.0 119.434 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.7 p -64.34 -19.21 65.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -1.136 . . . . 0.0 109.532 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -56.14 -35.01 66.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 109.432 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 4' ' ' ASP . 44.1 p-10 -164.64 135.39 4.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.502 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.0 m -138.51 159.38 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? 65.17 112.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.7 m -99.28 165.06 11.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.17 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -56.32 163.87 1.53 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.465 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt -66.84 148.11 52.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.435 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.37 1.99 85.62 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -130.95 152.59 50.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -1.117 . . . . 0.0 109.505 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CD1' ' NE2' ' A' ' 23' ' ' GLN . 17.3 p90 -143.96 146.45 34.28 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.888 . . . . 0.0 109.477 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.71 148.05 58.1 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.814 2.343 . . . . 0.0 112.222 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.3 m -63.34 -24.98 68.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.536 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.91 -76.37 0.28 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -119.86 15.01 12.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -1.118 . . . . 0.0 109.413 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.3 mt -111.33 138.03 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.456 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 18' ' ' THR . 0.2 OUTLIER -70.77 59.42 0.22 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.458 179.937 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -141.63 135.3 29.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.5 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 m -122.8 143.57 49.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.028 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 99.5 mt -138.0 149.3 63.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.358 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.34 155.08 59.42 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.788 2.325 . . . . 0.0 112.183 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.463 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 98.6 mm-40 -57.87 -23.97 55.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.57 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -55.14 -37.06 66.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.47 -179.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.4 mt -92.09 11.57 24.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 -179.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.547 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 51.7 t-80 -84.28 123.54 30.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.458 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.547 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 98.1 m 50.86 29.65 4.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.4 HD21 ' HB ' ' A' ' 30' ' ' VAL . 44.9 p-10 -85.78 5.8 30.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.45 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.34 39.21 62.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.4 ' HB ' HD21 ' A' ' 28' ' ' ASN . 42.3 t -136.08 139.31 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -1.157 . . . . 0.0 109.444 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 38.3 p-10 -86.61 103.57 15.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.49 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.435 ' OD1' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -119.78 -53.33 2.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.454 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.428 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 97.1 m -60.14 -26.49 66.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.185 -0.947 . . . . 0.0 109.527 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.19 -42.94 2.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 37' ' ' ALA . 50.8 p30 -85.29 6.22 27.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -1.169 . . . . 0.0 109.428 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 52.43 27.88 5.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.868 . . . . 0.0 109.401 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB2' ' ND2' ' A' ' 35' ' ' ASN . . . -71.32 -37.09 71.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.445 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 12.3 p30 -66.27 -31.09 71.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -88.48 15.87 7.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.54 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 41' ' ' ASN . 62.9 t0 -79.46 122.06 25.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.518 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 7.2 p-10 39.77 80.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 109.436 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.2 m -91.84 157.12 17.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.502 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 117.972 -1.46 . . . . 0.0 109.602 179.982 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.529 4.845 0 N-CA-C 119.433 2.533 . . . . 0.0 119.433 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 1' ' ' GLY . 29.1 t 49.11 -175.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -1.137 . . . . 0.0 109.553 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.425 ' N ' ' OG ' ' A' ' 2' ' ' SER . 63.7 tt0 -87.28 124.49 33.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 109.467 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' VAL . 88.4 m-20 -67.8 143.37 55.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 4' ' ' ASP . 16.0 t 50.9 97.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.507 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -87.02 10.03 17.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.423 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 32.2 m -99.58 155.92 17.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.234 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.2 m -78.4 178.1 7.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.898 . . . . 0.0 109.502 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 mt -74.15 142.71 45.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.429 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.29 -0.09 68.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 31.0 m-85 -121.59 152.84 38.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -1.14 . . . . 0.0 109.458 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -144.6 146.06 30.81 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.296 -0.878 . . . . 0.0 109.482 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.86 145.74 41.12 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.728 2.285 . . . . 0.0 112.214 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -92.42 81.9 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.545 179.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.73 -145.23 31.13 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -83.89 10.91 8.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -1.19 . . . . 0.0 109.421 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.7 mt -78.58 138.1 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -82.17 61.58 5.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 109.483 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.622 ' NZ ' HD21 ' A' ' 21' ' ' LEU . 27.5 tttm -143.85 126.17 15.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -112.61 143.02 44.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.622 HD21 ' NZ ' ' A' ' 19' ' ' LYS . 96.7 mt -139.09 149.84 62.72 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.364 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.95 154.01 72.58 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.795 2.33 . . . . 0.0 112.241 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -57.07 -21.05 28.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.63 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.2 tt -55.81 -38.47 70.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.461 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.6 mt -89.82 15.06 10.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 0.0 109.535 -179.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.582 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 53.5 t-80 -83.12 123.81 29.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.505 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.582 ' SG ' ' CE1' ' A' ' 26' ' ' HIS . 73.6 m 49.08 32.64 4.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.506 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.402 HD21 ' HB ' ' A' ' 30' ' ' VAL . 51.2 p-10 -85.25 5.37 30.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 109.445 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.45 35.0 68.35 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' HB ' HD21 ' A' ' 28' ' ' ASN . 39.3 t -133.68 137.28 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -1.184 . . . . 0.0 109.479 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 41.4 p-10 -84.68 103.47 13.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.486 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 33' ' ' CYS . 0.4 OUTLIER -117.77 -57.86 2.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.882 . . . . 0.0 109.47 -179.824 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.494 ' SG ' ' OD2' ' A' ' 38' ' ' ASP . 74.3 m -61.65 -19.69 62.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.512 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.27 -47.52 2.4 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.709 ' ND2' ' H ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -82.66 3.36 29.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -1.136 . . . . 0.0 109.502 179.977 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.562 ' N ' HD22 ' A' ' 35' ' ' ASN . 94.0 mt-30 51.19 31.04 6.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.709 ' H ' ' ND2' ' A' ' 35' ' ' ASN . . . -67.1 -38.78 86.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.496 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.494 ' OD2' ' SG ' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -66.82 -29.95 70.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -78.74 7.82 6.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.474 ' O ' ' C ' ' A' ' 41' ' ' ASN . 50.6 p30 -62.76 156.74 22.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 41' ' ' ASN . 0.9 OUTLIER 40.87 35.72 0.36 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.429 179.858 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 56.8 m -145.78 160.21 42.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.487 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.984 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_